\r\n\tFrom practice to a mathematical and technological application, scheduling has become another form of art: an algorithmic art, declined in as many OS and hardware constraints, from embedded systems onboard an aircraft or a spacecraft to databases in all financial and Internet servers. \r\n\tThey have become ubiquitous so that a large part of our civilisational development is supported by their reliability, redundancy, and optimisation capacity. Like all of our civilisational assets, they are benefiting from scientific breakthrough in computational sciences such as evolutionary algorithms, Artificial Intelligence, and quantum computing. If not by using it, by being in need of adapting to the next generation of computing. Space development is also bringing new challenges, especially in redundancy and reliability.
",isbn:"978-1-83768-278-2",printIsbn:"978-1-83768-277-5",pdfIsbn:"978-1-83768-279-9",doi:null,price:0,priceEur:0,priceUsd:0,slug:null,numberOfPages:0,isOpenForSubmission:!0,isSalesforceBook:!1,isNomenclature:!1,hash:"51b9b6eb5e1f6fd01c84879bc8182486",bookSignature:"Dr. Yann H. Chemin",publishedDate:null,coverURL:"https://cdn.intechopen.com/books/images_new/11913.jpg",keywords:"Operating Systems, Advanced Scheduling, Embedded Systems, AI, IoT Mesh Networks, Optimization, Space, Health, 3D Printing, Communication Infrastructure, Security, Emergency",numberOfDownloads:null,numberOfWosCitations:0,numberOfCrossrefCitations:null,numberOfDimensionsCitations:null,numberOfTotalCitations:null,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"June 1st 2022",dateEndSecondStepPublish:"June 29th 2022",dateEndThirdStepPublish:"August 28th 2022",dateEndFourthStepPublish:"November 16th 2022",dateEndFifthStepPublish:"January 15th 2023",dateConfirmationOfParticipation:null,remainingDaysToSecondStep:"6 days",secondStepPassed:!0,areRegistrationsClosed:!1,currentStepOfPublishingProcess:3,editedByType:null,kuFlag:!1,biosketch:"Dr. Yann H. Chemin worked on Spatiotemporal fusion with Genetic Algorithms, and other evolutionary algorithms, on deep space probes data analysis, and creating/programming algorithms for Earth and non-Earth scientific problems.",coeditorOneBiosketch:null,coeditorTwoBiosketch:null,coeditorThreeBiosketch:null,coeditorFourBiosketch:null,coeditorFiveBiosketch:null,editors:[{id:"270578",title:"Dr.",name:"Yann",middleName:"H.",surname:"Chemin",slug:"yann-chemin",fullName:"Yann Chemin",profilePictureURL:"https://mts.intechopen.com/storage/users/270578/images/system/270578.png",biography:"Dr. Chemin graduated in Planetary Sciences with Astronomy in 2016, after a full academic path in Earth Observation in Asia. He is now concentrating on Security, Defense and Space Industries (2022), a field filled with both commercial endeavours and highly technical advances. He worked on the hyperspectral analysis of the Apollo 12 landing site and its vicinity on the Moon\\'s surface. He also worked on the thermodynamic energy balance of the surface-atmosphere interactions of the moon Titan and on the mapping of craters on the dwarf planet called Ceres., and keeps a keen eye on challenges to settle on the moon and Mars, especially food creation, settlements construction, and in situ resource utilization. His interests include philosophy, innovation, space science and exploration challenges, spatial sciences, and geopolitical impacts on space.",institutionString:"Joint Research Centre",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"2",institution:{name:"European Commission",institutionURL:null,country:{name:"Belgium"}}}],coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"9",title:"Computer and Information Science",slug:"computer-and-information-science"}],chapters:null,productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},personalPublishingAssistant:{id:"440204",firstName:"Ana",lastName:"Cink",middleName:null,title:"Ms.",imageUrl:"https://mts.intechopen.com/storage/users/440204/images/20006_n.jpg",email:"ana.c@intechopen.com",biography:"As an Author Service Manager my responsibilities include monitoring and facilitating all publishing activities for authors and editors. From chapter submission and review, to approval and revision, copyediting and design, until final publication, I work closely with authors and editors to ensure a simple and easy publishing process. I maintain constant and effective communication with authors, editors and reviewers, which allows for a level of personal support that enables contributors to fully commit and concentrate on the chapters they are writing, editing, or reviewing. I assist authors in the preparation of their full chapter submissions and track important deadlines and ensure they are met. I help to coordinate internal processes such as linguistic review, and monitor the technical aspects of the process. As an ASM I am also involved in the acquisition of editors. Whether that be identifying an exceptional author and proposing an editorship collaboration, or contacting researchers who would like the opportunity to work with IntechOpen, I establish and help manage author and editor acquisition and contact."}},relatedBooks:[{type:"book",id:"1591",title:"Infrared Spectroscopy",subtitle:"Materials Science, Engineering and Technology",isOpenForSubmission:!1,hash:"99b4b7b71a8caeb693ed762b40b017f4",slug:"infrared-spectroscopy-materials-science-engineering-and-technology",bookSignature:"Theophile Theophanides",coverURL:"https://cdn.intechopen.com/books/images_new/1591.jpg",editedByType:"Edited by",editors:[{id:"37194",title:"Dr.",name:"Theophile",surname:"Theophanides",slug:"theophile-theophanides",fullName:"Theophile Theophanides"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3161",title:"Frontiers in Guided Wave Optics and Optoelectronics",subtitle:null,isOpenForSubmission:!1,hash:"deb44e9c99f82bbce1083abea743146c",slug:"frontiers-in-guided-wave-optics-and-optoelectronics",bookSignature:"Bishnu Pal",coverURL:"https://cdn.intechopen.com/books/images_new/3161.jpg",editedByType:"Edited by",editors:[{id:"4782",title:"Prof.",name:"Bishnu",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"371",title:"Abiotic Stress in Plants",subtitle:"Mechanisms and Adaptations",isOpenForSubmission:!1,hash:"588466f487e307619849d72389178a74",slug:"abiotic-stress-in-plants-mechanisms-and-adaptations",bookSignature:"Arun Shanker and B. Venkateswarlu",coverURL:"https://cdn.intechopen.com/books/images_new/371.jpg",editedByType:"Edited by",editors:[{id:"58592",title:"Dr.",name:"Arun",surname:"Shanker",slug:"arun-shanker",fullName:"Arun Shanker"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3092",title:"Anopheles mosquitoes",subtitle:"New insights into malaria vectors",isOpenForSubmission:!1,hash:"c9e622485316d5e296288bf24d2b0d64",slug:"anopheles-mosquitoes-new-insights-into-malaria-vectors",bookSignature:"Sylvie Manguin",coverURL:"https://cdn.intechopen.com/books/images_new/3092.jpg",editedByType:"Edited by",editors:[{id:"50017",title:"Prof.",name:"Sylvie",surname:"Manguin",slug:"sylvie-manguin",fullName:"Sylvie Manguin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"72",title:"Ionic Liquids",subtitle:"Theory, Properties, New Approaches",isOpenForSubmission:!1,hash:"d94ffa3cfa10505e3b1d676d46fcd3f5",slug:"ionic-liquids-theory-properties-new-approaches",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/72.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"2270",title:"Fourier Transform",subtitle:"Materials Analysis",isOpenForSubmission:!1,hash:"5e094b066da527193e878e160b4772af",slug:"fourier-transform-materials-analysis",bookSignature:"Salih Mohammed Salih",coverURL:"https://cdn.intechopen.com/books/images_new/2270.jpg",editedByType:"Edited by",editors:[{id:"111691",title:"Dr.Ing.",name:"Salih",surname:"Salih",slug:"salih-salih",fullName:"Salih Salih"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"117",title:"Artificial Neural Networks",subtitle:"Methodological Advances and Biomedical Applications",isOpenForSubmission:!1,hash:null,slug:"artificial-neural-networks-methodological-advances-and-biomedical-applications",bookSignature:"Kenji Suzuki",coverURL:"https://cdn.intechopen.com/books/images_new/117.jpg",editedByType:"Edited by",editors:[{id:"3095",title:"Prof.",name:"Kenji",surname:"Suzuki",slug:"kenji-suzuki",fullName:"Kenji Suzuki"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3828",title:"Application of Nanotechnology in Drug Delivery",subtitle:null,isOpenForSubmission:!1,hash:"51a27e7adbfafcfedb6e9683f209cba4",slug:"application-of-nanotechnology-in-drug-delivery",bookSignature:"Ali Demir Sezer",coverURL:"https://cdn.intechopen.com/books/images_new/3828.jpg",editedByType:"Edited by",editors:[{id:"62389",title:"PhD.",name:"Ali Demir",surname:"Sezer",slug:"ali-demir-sezer",fullName:"Ali Demir Sezer"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"872",title:"Organic Pollutants Ten Years After the Stockholm Convention",subtitle:"Environmental and Analytical Update",isOpenForSubmission:!1,hash:"f01dc7077e1d23f3d8f5454985cafa0a",slug:"organic-pollutants-ten-years-after-the-stockholm-convention-environmental-and-analytical-update",bookSignature:"Tomasz Puzyn and Aleksandra Mostrag-Szlichtyng",coverURL:"https://cdn.intechopen.com/books/images_new/872.jpg",editedByType:"Edited by",editors:[{id:"84887",title:"Dr.",name:"Tomasz",surname:"Puzyn",slug:"tomasz-puzyn",fullName:"Tomasz Puzyn"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3569",title:"Biodegradation",subtitle:"Life of Science",isOpenForSubmission:!1,hash:"bb737eb528a53e5106c7e218d5f12ec6",slug:"biodegradation-life-of-science",bookSignature:"Rolando Chamy and Francisca Rosenkranz",coverURL:"https://cdn.intechopen.com/books/images_new/3569.jpg",editedByType:"Edited by",editors:[{id:"165784",title:"Dr.",name:"Rolando",surname:"Chamy",slug:"rolando-chamy",fullName:"Rolando Chamy"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},chapter:{item:{type:"chapter",id:"61139",title:"Tools for Assessment of Occupational Health Risks of some Engineered Nanoparticles and Carbon Materials Used in Semiconductor Applications",doi:"10.5772/intechopen.76567",slug:"tools-for-assessment-of-occupational-health-risks-of-some-engineered-nanoparticles-and-carbon-materi",body:'
1. Introduction
An increasing number of engineered nanomaterials (ENM) enter the market in everyday products spanning from healthcare and leisure to electronics, cosmetics, energy, agriculture, food, and transport. By 2014, there have been more than 1600 nanotechnology-enabled products in commerce [1]. A summary of ENM applications is given in Table 1. While there are natural sources of nanoparticles, such as volcanoes, forest fires, or sea storms, the engineered nanomaterials are purposefully made to achieve certain prescribed functionality. Such desirable characteristics can include increased strength of the material, its chemical reactivity, or altered electrical properties. The terms ENM and nanomaterials will be used interchangeably throughout the chapter.
Sector
Applications/products
Nanomaterial
Electronics
Electrically conductive polymers
CNTs
Abrasive particles in CMP processes
SiO2, CeO2, Al2O3
Sensors
CNTs, graphenes
Supercapacitors
CNTs, graphenes
Energy
Electrodes in energy conversion and storage
CNTs, graphenes, other metallic NPs
Batteries
Al2O3
Fuel cells
Graphenes
Textiles
Nanofibers and antibacterial textiles
Nano-Ag
Construction
Insulation
Silica-aerogel
Light transmission
Silica-aerogel
Dirt-repellent paints
SiO2
Medicine
Drug carriers
SiO2, CeO2
Biomedical imaging
SiO2
Dental implants
Al2O3, SiO2
Biosensors
CNTs, graphenes
Automotive
Hydrogen storage
MOFs
Antifog coating for windshield/mirror
TiO2
Scratch proof lacquer
Nanoceramics
Fuel additives
CeO2
Catalysis
SiO2
Cosmetics
Sun screen
TiO2
Various
Nanofillers
CNTs, graphenes
Nanocomposites
CNT/polymer matrix, CNT/ceramic matrix
Filters
CNTs
Anticorrosive coatings
Graphenes
Nanofilms
Table 1.
Leading industrial applications of common engineered nanomaterials.
Nanomaterials can be classified broadly as particles, which have oval shapes; fibers, which are tube-like but may exhibit complex branching; and sheets, which are film-like but again may exhibit branching or defects. Interested readers are directed to Buzea et al., for a review [6]. The European Commission defines nanomaterials as “natural, incidental or manufactured material containing particles, in an unbound or as an aggregate or agglomerate and where 50% or more in the number size distribution, one or more dimensions is in the range of 1–100 nm.”
The size cutoff in common definitions is somehow arbitrary. It, however, conveys the understanding that properties of the material features at the nanoscale (i.e., the so-called nanoforms of materials) can substantially differ from the properties of materials in bulk. This can be explained by two main factors affecting the physicochemical properties because of their small sizes—surface effects and quantum effects [7]. The surface effects occur due to the fact that as the size of nanoparticle decreases, the surface area relative to the volume increases as the inverse power of the diameter ~1/d. The relative increase in area provides a greater overall surface per unit mass available for reactions as well as higher charge and energy densities, which influence the surface chemistry of ENM (reviews in [6, 8]). Quantum effects result from the confinement of electrons when the particle radius decreases [6]. Electron confinement in turn influences the capability for electrons to be donated or accepted, hence influencing their electrical charge distribution and the catalytic capability.
This chapter aims to familiarize readers with nanomaterials, which are either used in the semiconductor manufacturing or have current and promising future applications in electronics industries. Due to the limited volume, we have focused on silica, certain metallic nanoparticles, and carbon materials, such as carbon nanotubes and graphene. The applications of these ENMs will be discussed in Section 2. At the same time, the use of ENMs raises questions about potential unintended risks for the workers, consumers, or environment. Consequently, an overview of the nanotoxicological studies for all these three classes of nanomaterials is presented in Section 3. Since the manipulation and use of ENMs warrant for safety precautions, different relevant control banding tools for risk assessment will be summarized in Section 4. Finally, the concept of tiered risk assessment approach is introduced in Section 4.5 as a flexible framework, which is able to decrease uncertainty as new information becomes gradually available.
2. Applications
2.1. Nanoelectronics as a case study
Nanoelectronics relies on multiple semiconductor processes resulting in pattering of macroscopic objects (silicon wafers) on the nanoscale. Overall, the semiconductor industry can be considered predominantly as a downstream user of nanomaterials. Nanoelectronics enjoys a very fast innovation cycle governed by Moore’s law. This brings about a variety of new materials and combinations into production, while some of them are in nanoform. As a result, new materials, including a variety of nanoparticles, have been introduced in the development of advanced technology nodes predominantly in polishing operations. Engineered nanomaterials are used in several processing steps, but they can also be generated as side products of several generic processes.
The background of materials studies in the field of occupational health naturally focuses on the release, monitoring, mitigation of exposure, and health implications. The relevance of the work for the semiconductor industry is in those studies proven by naming few examples for the application of nanomaterials in semiconductor technology [9]. The semiconductor industry can be taken as a use case on how potential occupational and environmental risks brought about by nano-enabled products are governed. Specifics of this industry, which make it interesting, are several:
Semiconductor mass manufacturing employs top-down high-precision approaches, which are highly standardized.
Nanoelectronics enjoy a very fast innovation cycle.
Due to the fast innovation cycle, there is a safety culture used to dealing with uncertainties.
An example of such standardized process is the complementary metal-oxide-semiconductor (CMOS) fabrication, which is the focus of the safety assessment undergoing in the H2020 project NanoStreeM [4]. The project findings demonstrate that chemical mechanical planarization (CMP) is the most common standard process, where ENMs are used. It should be noted that wafer-scale integration of carbon nanomaterials is not yet industrially available.
2.2. Metal oxides NPs and silica
Semiconductor industry uses nanoparticles in several processing steps, particularly in CMP, which is a standardized processing step during the manufacturing of semiconductors, for example, the CMOS processing. The purpose of CMP is to achieve a high degree of planarity for the wafer surface and remove the excess of deposited material. The importance of having very flat surface is due to the fact that even very slight undulations, or small defects and scratches on the wafer surface, would degrade the yield from a wafer and thus result in an economic loss [5, 10, 11].
The planarization process employs a mechanical force to synergistically work with the chemical reactions to remove metallic surfaces in order to achieve planarity for the wafers [12]. During CMP processing, the wafer is loaded onto the wafer carrier. Then the slurry emulsion is released from the dispersing head and reacts with the wafer surface so that chemical reactions help create chemically modified surface. Simultaneously, slight force is applied downward so that friction force develops between the wafer carrier, polishing pad and the abrasives in the slurry. This results in removal of deposited materials. Additionally, CMP tools also require pad conditioning. This conditioning is needed in order to maintain a stable rate of material removal. These pad conditioners are usually disks with diamond particles that will help stabilize the surface roughness of the pad [10].
Besides nanoparticle abrasives different slurries are composed of proprietary components, which optimize the desired functionalities. The roles of each component can be summarized in general as [5, 12]:
Molecules for pH adjustments maintain stable pH for the slurry.
Complexing agents aid in the solubilization of the dissolved metallic components.
Oxidizers improve the selectivity of the slurry by promoting dissolution or protecting against the removal of a certain surface component.
Corrosion inhibitors stop the corrosive effects on the wafer surfaces.
Biocides inhibit growth of biological organisms.
Abrasive particles increase the frictional force needed to remove the chemically modified surfaces during the CMP process.
The abrasive particles are nanoparticles in the range of 20–100 nm [10]. An important point for the use of nanoparticles in the CMP slurry is that the nanoparticles tend to aggregate or agglomerate into bigger sizes. Agglomeration and aggregation of particles can cause pH variations at different areas of the slurry. This in turn causes nonuniformity on the wafer surfaces after the polishing process [11]. To avoid the agglomeration or aggregation of the abrasive nanoparticles, CMP slurries are often mixed on site prior to the use via a CMP slurry mixing and distribution system. Alternatively, coating of the abrasive nanoparticles can also be used to maintain stability. Currently, the most widely used nanoparticles acting as abrasives in CMP slurries are silica (silicon dioxide), alumina (aluminum oxide), and cerium oxide [5].
2.3. Carbon nanotubes
Carbon nanotubes (CNTs) were discovered in 1991 and since then have found many applications [13, 14]. There are three main categories of CNTs based on the wall structure: single-walled carbon nanotubes (SWCNTs), double-walled carbon nanotubes (DWCNTs), and multiwalled carbon nanotubes (MWCNTs) (overview in [13]). The main structural difference between MWCNTs and the SWCNTs is that MWCNTs contain multiple concentric carbon sheets [14]. CNTs possess many unique physicochemical properties that supersede other carbon-based materials used formerly, such as graphite, diamond, and fullerenes. The main physicochemical properties of CNTs are summarized in Table 2.
In the field of energy conversion and storage, CNTs are mostly applied in mainly two applications: electrodes in lithium-ion batteries and supercapacitors [13, 14]. The use of CNTs provides high surface area. CNTs, especially SWCNTs, are good candidates for use as electrodes for Li-ion batteries. It was shown that SWCNTs exhibit good intercalation of Li-ions on their walls as well as have higher interstitial density than the traditionally used graphite electrodes [15]. Additionally, the incorporation of CNTs as electrodes for Li-ion batteries has a simpler fabrication process than those of the conventional electrodes [16]. This is because layers of metal mixture substrates and electrical conductor must be deposited on the conventional electrodes, while CNTs can be directly grown onto the electrodes themselves. However, the potential discharge of the CNT electrodes is lower than those of the conventional types [14]. Beyond the use with Li-ion batteries, CNTs are also depicted and studied as candidate material for supercapacitors.
Supercapacitors are considered as a high-performing alternative for Li-ion batteries. The energy storage properties of supercapacitors are highly dependent on the surface area since the energy is stored in a charged double layer that is formed after the application of a voltage source. Hence, CNTs, having high surface-area-to-volume ratio, are especially suitable [17]. CNTs are also widely used in the field of sensors due to their unique properties like the high surface area, electrical conductivity and adsorptive properties. These properties contribute to a simpler fabrication of the CNT-based sensor with lower response time and higher sensitivity. The easier fabrication steps also led to easier incorporation into various electronic circuits, miniaturization of the component, and lower production cost and energy consumption [14].
CNTs could be functionalized with metals, metal oxides, polymers, or biomacromolecules [3]. Although CNTs are promising candidate materials for use in electronics industry, the synthesis and purification of CNTs are two of the biggest concerns. The syntheses of CNTs are mostly conducted either via chemical vapor deposition, arc discharge, or laser ablation [14, 17]. All of these processes require metal catalysts during the synthesis. These metallic catalysts left residual particles on the CNT surfaces which decrease the purity of the obtained CNTs. Impurities or changes in surface composition can affect the surface effect of the nanomaterial, which in turn modifies the physicochemical properties of the aforementioned nanomaterial. Subsequently, their environmental fate, uptake, and toxicological properties will also be affected and can differ from other nanomaterials of the same kind. Many purification steps involving liquid/gas phases as well as oxidation reactions were proposed, but these methods affect the physicochemical properties of the CNTs accordingly [18, 19].
2.4. Graphene
Graphene contains sp2 planar carbon sheet structure. Due to this two-dimensional structure, graphene is one of the thinnest yet mechanically strongest nanomaterials available [20, 21]. Additionally, graphenes also possess excellent optical properties as well as high mobility of electrons. The physicochemical properties of graphene are summarized in Table 2. When referring to graphene-based materials, the other two derivatives of pristine graphene are also included: graphene oxide (GO) and reduced graphene oxide (rGO).
When referring to the field of energy storage and conversion, graphenes are mostly used in Li-ion batteries as well as in optoelectronic devices, such as solar cells [3, 22, 23]. In Li-ion batteries, graphene-based nanomaterials, specifically, graphene oxides (GO), are mostly used as buffers to prolong the storage lifespan. The unique tensile strength and electrical conductivity of graphene-based nanomaterials protect the electrodes from being pulverized and facilitate the charge–discharge cycles of the batteries [20]. In the applications with solar cells, graphene-based nanomaterials are functionalized with quantum dots (QDs) to form a hybrid matrix that raises the performance of a photovoltaic array [20, 22]. In contrast to CNTs, graphene-based materials are more flexible due to their mechanical properties. The use of graphene-based materials for sensors is increasing gradually. Owing to their extremely high available surface-area-to-volume ratio and electrical conductivity, graphene-based sensors have a performance on par or even higher than those of CNTs or Si-based sensors [20].
In contrast to CNTs, the problems of impurities faced during the synthesis of graphenes are much less. However, the degree of reproducibility during the fabrication of graphene-nanoparticle matrix is a topic of concern [3, 20, 21]. It is particularly complicated to obtain uniformly dispersed nanoparticles on these graphene sheets. Hence, the nonuniformity can and will affect the physicochemical properties of these graphenes and eventually hinder the industrial use of graphenes. Therefore, additional studies on the industrial applications of graphene-based nanomaterials are still needed to overcome this drawback and exploit the potential of the material in the electronics industry.
3. Nanotoxicology
3.1. Nanotoxicology of silica
Silica ENM is used in slurry formulations. Their density is 2.196 (amorphous) g/cm3 [24]. Recent publications have demonstrated that silica NPs can become cytotoxic both in vitro and in vivo in a dose-, size-, and cell-type-dependent manner [25, 26, 27]. The most common route of exposure for silica NPs is via inhalation [28, 29, 30]. On a second place is the ingestion exposure route.
In vitro studies have demonstrated that silica NP toxicity is mostly caused by the production of reactive oxidative species (ROS) [31, 32, 33, 34, 35]. The surface silica radical groups can generate free radicals and ROS by the Fenton reactions. In particular, ROS can be generated by the failed phagocytosis of silica NPs. The latter mechanism is valid for all cases of incomplete phagocytosis of NPs; thus, it is also applicable for alumina and cerium oxide. Fubini, Hubbard, and Lehman demonstrated that the fractured silica surfaces, which are more prone to release free silanol radicals, can initiate Fenton reactions in water [35, 36]:
which are catalyzed by the Fe oxidation as Fe2++O2→Fe3++.•O2− [33]. The hydroxyl radicals can increase cytotoxicity by increasing oxidative stress (e.g., the intracellular concentration of hydrogen peroxide). It was also shown that when undergoing incomplete phagocytosis, cells tend to produce ROS and increase the level of intracellular oxidative stress [31]. Subsequently, this leads to an increase in cytotoxicity and damage to various cellular compartments. Excessive intracellular ROS concentration has been reported to contribute to higher cytotoxicity by directly increasing cellular stress and by indirectly damaging the mitochondria and macromolecules which can further lead to genetic damage, carcinogenesis, or reproductive defects [8, 37].
As noted previously, as the particle size decreases, there is an increase in the surface area fraction which influences the surface chemistry. Moreover, the small size of the NPs helps them to evade clearance mechanisms in the body; therefore, the retention time is further increased, rendering them more biopersistent [7]. These factors contribute to a increased potential for reactivity, resulting in higher ROS production, lipid peroxidation, and the damage to cell membranes [38, 39, 40]. This can ultimately lead to apoptotic cell death.
Several in vitro studies emulating ingestion as a route of exposure by using cell lines from the gastrointestinal tract have been conducted. According to a recent review, in vitro studies of immunotoxicity were conducted mainly on monocytes and macrophages which showed inflammatory responses more severe than exposure to silica in the micron range [25]. However, this result is not representative of the entire immune system; hence, further studies are still needed before firm conclusions can be drawn.
The 2016 Organization for Economic Co-operation and Development (OECD) dossier on silicon dioxide suggested that amorphous nanosilica seems not to exhibit carcinogenic, mutagenic, and reprotoxic (CMR) properties [41]. This is in accordance with other studies showing no genotoxic effects of silica NPs [42].
In vivo studies with nanosilica were mostly done to study inhalation exposure. The numbers are significantly less when compared to in vitro studies, and no chronic exposure study was found. The results reported in literature are conflicting due to different dosages, sizes, and animal species used. At present, it is still not possible to draw definite conclusions from the in vivo studies due to their limited number. Moreover, most of these studies do not follow a standardized operating procedures, and therefore, it is not possible to compare the results or difficult to interpret the results [43]. Readers are directed to the recent review of Murugadoss et al. for more information [25]. Different studies have shown that silica NPs can induce cytotoxicity by forming ROS due to their small sizes resulting in increased reactivity. Although ROS formation has also been linked to CMR properties, no CMR effects were found after exposure to silica NPs. In addition, the studies have shown that silica NPs are capable of forming protein corona which influences the effective concentration used in toxicological studies. This further puts an emphasis on the importance of the appropriate dosage/concentration selection for in vitro and in vivo studies as the NPs could interact with the biological media and form aggregates/agglomerates or protein corona which could give non-representative toxicity results.
3.2. Nanotoxicology of CeO2
Cerium oxide nanoparticles are widely used as catalysts in automotive industry, components in the fuel cells, or hydrogen production in energy-related industry, additives for consumer products like sunscreen, drug carriers in the pharmaceutical industry, and as abrasive particles for semiconductor industry [44, 45]. The mass density of CeO2 is 7.215 g/cm3 [24]. The variety of applications for nano-cerium oxide warrants occupational health studies to ensure safety of production, use, and disposal throughout the life cycle. Literature studies have shown that the main route of exposure for cerium oxide NPs is via inhalation [28, 29, 30, 44, 45, 46].
Nano-cerium oxide exerts both protective and toxic effects due to its oxidative properties [44, 45]. Cerium oxide NPs can scavenge radicals, which lowers the amount of ROS present in cells. However, cerium oxide can also increase cytotoxicity by increasing the intracellular hydrogen peroxide levels as well as increasing the ROS levels in some studies [44]. Red-ox reactions involving Ce2+ ions were proposed by Korsvik et al. to explain the possible mechanism of ROS formation [47]:
Several studies have demonstrated contradicting results whether nano-cerium oxide is related to the synthesis method, particle size, and cell type [24, 44, 45]. It was shown that the temperature can influence the size and subsequently the zeta potential of the NPs [48]. This in turn affects the aggregation behavior of the NPs as well as their cytotoxicity. Another study showed that the difference in synthesis temperature can influence the size of the NPs which could in turn lead to a higher Ce3+/Ce4+ ratio on the surface of the particle as the size of the of the NP decreases.
As is the case for silica, the cytotoxicity of nano-cerium oxide can also involve the formation of ROS, which, in excess, can increase the cellular stress and decrease cell viability.
An in vivo study showed a time-dependent increase in oxidative stress in the spleen and liver as well as the presence of hepatic granuloma when male Sprague-Dawley rats were infused intravenously with 70 mg/kg (30 nm cerium NPs) [49]. Another study demonstrated that cerium oxide NPs were able to induce DNA damage in leukocytes and liver cells as well as form micronuclei in the bone marrow and blood cells when female Wistar rats ingested 1000 mg/kg of 25 nm cerium oxide NPs [50]. The study also established a dose-, time-, and organ-dependent relationship with the bioaccummulation of cerium oxide NPs after performing histopathological analysis.
In summary, cerium oxide NPs can exhibit both adverse and protective effects. This depends on the synthesis method, the cell types being studied, and possibly the particle size, although the latter should be studied in more detail as at present is not possible to draw a definitive conclusion. As is the case for silica, standardized tests should be performed so that the results will be more comparable and a more definitive conclusion can be made. Nanoceria is suspected to have CMR properties; however, this still needs to be demonstrated in vivo in relevant doses.
3.3. Nanotoxicology of Al2O3
Nano-aluminim oxide (alumina) has been used in various applications ranging from being components in cements, acting as catalysts and surface coatings, to being abrasive particles in semiconductor production [46, 51]. The mass density of Al2O3 is 3.987 g/cm3 [24]. Despite their wide use, alumina NPs are the least studied of the three nanoparticles presented so far. This is reflected by the limited number of toxicological studies for alumina NPs as well as the absent of an OECD dossier for alumina NPs. As is the case for most NPs, the most common route of exposure for nano-alumina is via inhalation [28, 29, 30, 46, 51].
Several studies have shown that alumina NPs are also able to induce excessive ROS production which could in turn damage other cellular compartments like the plasma membrane and mitochondria, thus decreasing the cellular activity and/or viability. Moreover, excessive intracellular ROS could interact with the cellular genetic material that could further lead to mutations [6, 7, 8, 28, 30, 37, 52, 53]. According to present toxicological reports [51, 54, 55, 56, 57], alumina NPs are less cytotoxic than NPs, such as cerium oxide, gold, silver, or copper oxide NPs, but they may be also capable of inducing sufficient amount of ROS to decrease cell viability. In addition, it was shown that nano-alumina can cause impairments to the cellular innate defense mechanisms against airborne pathogenic organisms [58]. Similarly, another in vitro study demonstrated that RAW264 macrophages that were incubated with 13 nm alumina NPs at 200 and 400 μg/mL for 72 hours exhibit changes in the morphology as well as a dose-dependent cytotoxicty which results in the decrease in cell viability by up to 40% of the control [54].
It should be noted that the choice of cell line used can also influence the outcome of the toxicological assay [51]. In this study, six cell lines (BEAS-2B representing the lung, Chang for the liver, HaCaT for the skin, H9C2 for the heart, T98G for the brain, and HEK-293 for the kidney) were exposed to 5 and 20 μg/mL 180–200 nm of nano-alumina for 48 hours. The results showed that there is a dose-dependent decrease in the viability for all six cell lines ranging from a 15% decrease to as much as 50%. The most sensitive cell line was HaCaT and BEAS-2B.
In summary, nano-alumina has been shown to be able to induce cytoxic damages via the producion of ROS which in turn reduce the cell viability. However, the number of articles focusing on cytotoxicity of alumina NPs and the exact mechanism of toxicity is very limited and nonexistent, respectively. As in the case of mutagenicity, conflicting reports of alumina NPs render their possession of CMR properties inconclusive. The difference between toxicological studies can possibly be explained by the synthesis method or the cell culture conditions or differences in cell types sensitivity. Therefore, standardized tests should be conducted so that different results become more comparable.
3.4. Nanotoxicology of CNTs
Carbon nanotubes are believed to fit the fiber paradigm on par with asbestos [28, 29, 30, 46]. In summary, the fiber paradigm refers to any (nano)materials with:
Diameter less than 3 μm
Length of more than 10–20 μm
Aspect ratio greater than 3
Aerodynamic diameter of less than 10 μm
Biopersistent and rigid
Therefore, many toxicological studies have been conducted so far [28, 29, 30, 46, 59, 60, 61, 62, 63]. Published in vivo studies have shown that CNTs can enter the body via several pathways including inhalation, oral uptake, and dermal uptake. Many of these articles focus on the inhalation or intratracheal instillation; however, the most relevant exposure route to humans based on the electronic and biomedicine applications of CNTs would be oral uptake or intraveneous injection [60, 61]. The studies based on the latter two exposure routes are, unfortunately, presently quite limited.
The mechanism of CNTs toxicity is believed to be also linked to the excessive ROS production induced by oxidative stress [59, 60, 61, 62, 63]. Due to size limitations, this chapter will not discuss in vitro studies. Interested readers are directed to [61] for an overview.
An in vivo intratracheal instillation study showed that mice that were instilled with 0, 1, and 0.5 mg of SWCNT exhibited granulomas after 7 days with a dose-dependent relation and severe inflammation in the lungs after 90 days [59]. The dimensions of the SWCNT are reported as aerodynamic diameters. A 9-day intratracheal instillation study on F344 rats was conducted where 0.5 μg/ml MWCNTs was given five times a day [63]. The results showed hyperplastic lesions and inflammations in a dose-dependent manner. The MWCNT was of 13 μm in length and more than 50 nm in diameter. Interestingly, an inhalation study where C57BL/6 mice were exposed to maximally 5 mg/m3 MWCNTs for 14 days showed no inflammation in the lung or any other tissue damage [64]. Finally, the study conducted by Poland et al. [62] demonstrated that MWCNTs that were injected intraperitoneally at a dosage of 100 μg/ml into the body of the C57Bl/6 mice for up to 7 days induced asbestos-like effects such as inflammation and granulomas. The MWCNT samples used in the study were quite polydisperse, having a diameter ranging from 10 to 165 nm and length ranging from 1 to 56 μm.
In summary, most in vivo toxicological studies for CNTs concur on the fact that the mechanism of CNT toxicity is linked to overproduction of ROS. This property can be exacerbated or mitigated by the specific physicochemical properties of the CNTs [60, 61]. Although many articles exist on the toxicological studies of CNTs, the results obtained are difficult to be compared to each other due to the lack of standard characterization of CNTs as well as the protocol for exposure and cytotoxic assays. As for the CMR properties of CNTs, different studies suggested that CNTs may exhibit genotoxic properties and, hence, more standardized studies should be conducted to yield more comparable results between different studies so that a definite conclusion can be made.
3.5. Nanotoxicology of graphene
Graphene-based nanomaterials are the most novel group of nanomaterials covered in this review. In comparison to CNTs, toxicological studies of graphene-based nanomaterials are less but gradually increasing and are less coherent in terms of their conclusions [65, 66, 67, 68]. This can be most likely attributed to differences in synthesis methods. As is the case with the metallic nanoparticles and the CNTs, the most probable routes of exposure are inhalation, followed by oral and dermal routes [28, 29, 30, 46, 65, 66]. It should be noted that the available in vivo studies up to date have focused on intravenous and oral administration with the intent of studying the mechanistic effects and biodistribution rather than relating to the relevancy of occupational exposures.
Analogous to the in vitro studies, most in vivo studies also showed a dose-dependent toxicity for the exposure of graphene-based nanomaterials. Zhang et al. conducted an intravenous injection of GO, with the size of 100–800 nm and a thickness of 1 nm, into Kun Ming mice at a dose of 1 and 10 mg/kg [69]. After 14 days, inflammation and the formation of edemas and granulomas were observed during histopathological analysis in a dose-dependent manner. The studies of Singh et al. demonstrated how functionalization can influence the degree of toxicity of the graphene oxides [70, 71]. Pristine GO and GO functionalized with amine (NH2) having size range between 0.2 and 5 μm were injected intravenously into Swiss male mice at a concentration of 250 μg/kg. Histopathological analysis was conducted after 15 min and found that mice injected with aminated GO showed no sign of thrombotoxicity, whereas on the other hand, mice injected with GO showed thrombotoxicity as well as aggregation of blood platelets in as much as 48% of the lung blood vessels. Finally, an oral uptake study in ICR mice showed atrophic characteristics in all major organs as well as lowered weight of the body and tail length [36]. The mice were fed with 0.05 and 0.5 mg/ml of GO (size of 2000 nm and height of 1.8 nm) in drinking water.
Studies on the CMR properties of graphene-based materials are very limited. Bengtson et al. conducted an intratracheal instillation study with GO and multilayer reduced GO into C57BL/6 J mice at a dose of 18 up to 162 μg/mouse. Analysis was performed at various time points during the 90-day study period [72]. In addition to inflammatory responses, it has been observed that both GO and reduced GO were able to cause DNA damage in the BAL cells at the lowest dose of 18 μg/mouse from day 3 of the study. However, DNA damage was not significantly observed in the lungs or liver. Another study demonstrated micronuclei formation in B and T lymphocytes as well as the primary lymphocytes when these cell lines were exposed to 6.25–400 μg/ml of GO (size ranging from one to tens of μm) [73].
The toxicological mechanisms of graphene-based nanomaterials are believed to be related to the excessive formation of ROS [65, 66, 67, 68]. When internalized within a cell, graphenes could disrupt the electron transport chain which causes the production of excess peroxide and hydroxyl radicals. Subsequently, the homeostasis of the intracellular reactive oxidative species is disrupted. Additionally, graphenes may cause membrane disruptions as well as damage the cell integrity directly by their sharp edges [65, 66]. Nevertheless, the exact mechanism of graphene-based nanotoxicoloy is still largely unknown [65, 66, 67, 68].
In vivo studies suggest that graphenes could have been taken up and retained in various organs for a prolonged period of time. However, most in vivo studies focused on explaining the mechanism of the toxicity and did not take the realistic dosage or route of exposure into account [66]. Hence, more uniform in vivo studies with regard to occupational settings will have to be conducted in the future in order to draw a definite conclusion from these studies. Finally, limited number of genotoxic studies suggested that graphenes are capable of interacting with DNA and could hold genotoxic properties.
3.6. Overview of the nanotoxicological properties of studied ENM
There is an emerging consensus in literature that the toxicity of engineered nanomaterials seems to be higher than the toxicity of bulk material (review in [74]). The toxicodynamic mechanisms are summarized in Table 3. Furthermore, an insufficient hazard characterization leads to limited availability of data on physicochemical properties, (eco)toxicological properties, and the environmental fate information, all of which are prerequisites for comprehensive and quantitative risk assessment [52]. According to Pietroiusti et al. [74], the following knowledge gaps of ENM can be listed at present:
Data gaps in toxicokinetics of ENM in organisms and cells
Insufficient understanding of the mechanisms of toxicity
Nano-specific biomarkers of ENM toxicity or ENM-induced diseases
Predictive models of ENM toxicity
ENM
OEL [1/cm3]
Source
SiO2
40,000
IFA, SER
CeO2
20,000
IFA, SER
CNT
0.01
IFA, SER, BSI
Table 3.
Summary of the toxicological mechanisms of target ENM and proposed OEL.
IFA, German Social Accident Insurance (Germany); SER, Social and Economic Council (Netherlands); BSI, British Standards Institute (UK).
All this leads to impossibility of establishing OEL for the predominant majority of ENMs rendering quantitative risk assessment for nanomaterials impossible.
The OELs for bulk parent materials can significantly differ from their nano-counterparts due to the discussed differences in their physicochemical properties. The complexity also arises from the fact that the best metric (by mass, concentration, or number) for nanoparticle exposure characterization is still debatable [75, 76, 77]. OELs for nanomaterials are available only in few cases (see Table 3).
Due to this situation, the concept of OEL has been replaced by nano-reference value (NRV), however, without regulatory significance. Such NRVs can be sector or organization specific. Furthermore, quality of available data can be also problematic. This is a concern already recognized in literature [76, 78]. These recent publications have demanded for a uniform standard operating procedure so that results obtained from different studies can be compared faithfully. Such standardized protocols should meet the criteria of the nanomaterial testing program coordinated by OECD [41].
The process of chemical or nanomaterial risk assessment is conducted in order to estimate the risks associated with a particular operation and materials. In a further step, the risk assessment derives a set of protective measures that allow for reduction of the risk for the workers and the environment. The availability of the toxicological data defines which type of risk assessment method can be used. If extensive data is available, quantitative risk assessment can be used to derive OELs for a particular material. Subsequently, the emission could be controlled to confirm that the exposure does not exceed the predetermined OELs. Almost by definition, this is not the case for novel ENM, which may bring about unanticipated interactions that alter their safety profile compared to the bulk material.
Challenges in the traditional chemical risk assessment approach can be traced to the assumption that the hazard and the risk can be quantified in an absolute way [86]. In contrast, since hazard profile data for novel material are inherently uncertain, the risk can be estimated only in a relative way. Such reasoning is supported also by the facts that there are conventional strong anthropogenic sources of nanomaterials, such as wax candles, radiator, frying, burning cigarettes, and traffic [87]. A way to estimate the risk is by grouping of materials based on certain similarity metrics. Such an approach favors categorical risk assessment tools, which result in a classification into a hazard and control band for the process under investigation (Table 4).
Control banding was developed in the pharmaceutical industry as a pragmatic tool to manage the risk resulting from exposure to a wide variety of potentially hazardous substances in the absence of firm toxicological and exposure data [88]. Its applications to safety of nanomaterials have been reviewed in [89]. The control banding approach is based on two pillars: the fact that there are a limited number of control approaches and that many problems have been met and solved before. The second pillar assumes that risks are at least qualitatively similar, even if no numerical probabilities can be assigned to them.
4.1. Hazard banding
For most cases, control banding tools follow a decision tree approach to characterize the hazards. The ISO Technical Standard 12901-2:2014 “Nanotechnologies—Occupational risk management applied to engineered nanomaterials” (in short ISO tool) uses only few physicochemical parameters of the NPs, namely, the water solubility and fibrocity, as preliminary questions to decide whether the NPs can be classified. Eventually, the NPs will be designated into one of the five classes of hazard bands (HB) based on the available toxicological data. In the case where the toxicological data are insufficient or unknown, the ISO tool makes use of the hazard band of the bulk or an analogous substance with an additional penalty. Similarly, the hazard banding for ANSES also follows a decision tree. Three preliminary questions are used to identify the “nanorelevance” and to determine whether the use of the ANSES tool is warranted. Interestingly, according to the ANSES tool, a persistent fiber will automatically be designated the highest HB of 5. This is also the case for the ISO decision tree. Subsequently, a substance of reference (be it a bulk or an analogous material) is used in order to assign a hazard band with additional penalties depending on the physicochemical properties like water solubility and chemical reactivity in the nanoform. One point of interest is that the ANSES tool does not include toxicological information, such as acute toxicity or the CMR properties when designating hazard bands.
The hazard banding of Stoffenmanager Nano tool follows a tiered approach which results in a decision tree. If the material is “nano-relevant,” the decision tree can be followed to the next tier. Subsequently, physicochemical properties of the nanomaterials including the water solubility, fibrocity, as well as the toxicological information are used to designate a hazard band for the material of interest. In the case where the toxicological information of the nanomaterial is not known, Stoffenmanager Nano refers to the data available for the ENM studies conducted by OECD, or if the material of interest is not ranked or included within the OECD framework, the toxicological information from the bulk materials will be used.
The hazard banding for the Imec tool is a questionnaire assessment. Several physicochemical parameters are collected, such as solubility, persistency, and dispersibility in water, the size, and morphology and the toxicological information of the nanomaterial. The CB Nanotool sums points based on severity factors which are related to both the physicochemical properties and the toxicological information in the nanoform as well as the bulk form. Of the maximum 100 points, a maximum of 70 points are designated for nanoform properties, while the other remaining 30 points are for the bulk material properties. Every set of severity factors contains a questionnaire-type questions which, depending on the answer, will result in points that will be accumulated for the hazard banding. When a property is unknown, 75% of the maximum points for that property will be allocated.
LICARA Nanoscan has a different characterization approach. It provides risk benefit/analysis but not a definite risk categorization. The risks score is shown on a scale with 0–0.33 being low risk, 0.33–0.67 being medium risk, and 0.67–1 being high risk. LICARA Nanoscan assumes the worst-case scenario when a question is not answered or the detail is unknown.
Finally, the NanoSafer approach for hazard assessment first takes into account whether the nanomaterial has a high aspect ratio, in which case the highest hazard is attributed. Other factors, such as the surface modification and the OEL for the analogous material, also contribute to the designation of a hazard factor that will be later used in the calculation of the hazard score. Finally, additional input physicochemical information asked by NanoSafer includes the dimensions, the specific density, the specific surface area, powder dustiness, and, most importantly, the hazard sentences. The hazard assessment of NanoSafer incorporates accumulative sum of the hazard score from the hazard sentences found on the safety data sheet of the nanomaterial.
4.2. Exposure banding
The exposure characterization for the ISO tool also follows a tiered approach which results in a decision tree. However, unlike hazard banding, there are several decision trees available, and one must select the most relevant one depending on the physical state of the NPs (embedded in a solid matrix, dispersed in liquid suspension or as nanopowders) or based on the manufacturing process. The endpoints will be given in exposure bands 1–4, where 4 represents the highest exposure probability. Similarly, the banding of the emission potential for ANSES tool depends largely on the physical state of the nanosubstance where aerosols would result in the highest emission potential.
The exposure banding for the Stoffenmanager Nano comprises different factors, each with its own reference table. The factors taken into account for the exposure include information about the substance, handling, location of the emission (near field or far field), local controls for the emission source, dispersion/transmission conditions, receptors (present of personal enclosure and/or protection equipment), background exposure, duration, and frequency. Stoffenmanager Nano requires, by far, the most extensive input parameters in order to determine the exposure band, specifically 26 inputs in total [90].
For the exposure estimation of the Imec tool takes several factors into account, including the localization (far or near field) and duration of the manipulation involving the ENM and the amount used. The exposure banding for the CB Nanotool assigns scores based on different probability factors related to the manipulation and scenario which involves the nanomaterial of interest. A maximum probability score of 100 can be summed based on the answers given to the questions pertaining to the probability factors. An unknown answer will result in a 75% allocation of the maximum point for that probability factor.
The exposure characterization for NanoSafer is calculated using the emission rate, the default activity energy factor, and the mass flow/amount used in the process. Both the convection and the rate of ventilation are taken into account for the near-field and far-field model calculation [85].
4.3. Control banding
The output of a control banding tool is a recommended set of measures which reduce the potential of exposure. For example, the ISO standard provides the following groups:
Control Level 1. Natural or mechanical ventilation.
Control Level 2. Local ventilation—extractor hood, table hood, etc.
Control Level 3. Enclosed ventilation—fume hood, biosafety cabinet, ventilated booth, etc.
Control Level 4. Full containment (continuously closed systems).
Control Level 5. Full containment and review by a safety specialist.
Some tools, for example, LICARA Nanoscan, only provide a decision support scheme (whether to continue with this nano-product or not) or, such as Stoffenmanager Nano, only give prioritization on the task of concern.
4.4. Comparison of the input parameters of used control banding tools
The hazard parameters of so-described tools are summarized in Table 5. All control banding tools required the primary particle diameter of the NP, solubility in water, and the fibrocity/aspect ratio. Most tools demand the CMR and toxicity information but differ in whether this information should be taken from the the nano- or the bulk form. This highlights the fact that risk assessment is a very dynamic process that can always change depending on the availability of data and that different control banding tools should be compared for the process of interest to have a well-rounded risk assessment.
NSM, Stoffenmanager Nano; ISO, ISO Technical Standard ISO/TS 12901-2:2014 “Nanotechnologies—Occupational risk management applied to engineered nanomaterials”; CMR, carcinogenic, mutagentic, and reprotoxic.
The number of hazard parameters required to completed the ISO tool is less than those of the approach of Imec and the CB Nanotool but still more than those of ANSES and Stoffenmanager Nano. The total number of hazard parameters required is the same for the ISO tool as for NanoSafer and LICARA Nanoscan.
Among all control banding tools presented here, the approach of Imec took into account the most physicochemical properties in order to assign hazard bands with a total of nine physicochemical parameters as inputs. On the other hand, the ISO standard recommends collection of much more parameters for future use. In view of the information presented so far, this can be considered as a shortcoming since most of the prescribed parameters are not readily available in the material specifications and safety data sheets.
For the case of toxicological information, no single property is shared by all control banding approach. The CB Nanotool required most toxicological information with a total of up to 12 input parameters, while the ANSES control banding approach required just one. Interestingly, not all CB tools agree on the question of whether toxicological information is needed from the nanoform or from the bulk form. The ISO standard and the CB Nanotool required both the nanoform and the bulk material toxicological information in order to assign a hazard band. This is unrealistic for the state of the art at present.
The Stoffenmanager Nano and LICARA Nanoscan only require the nanoform toxicological information, while the Imec approach, NanoSafer,and the ANSES CB tool only require toxicological profile of the parent form. According to the 2016 evaluation report of OECD, the CMR properties as well as the acute, subacute, chronic, or specific organ toxicity are rarely known for the nanoforms [41]. Therefore, this implies that users will be more likely to take the unknown penalty while completing the control banding approaches that require nanoform toxicological information which can differ in the degree of conservativeness from tool to tool. For instance, the CB Nanotool assigns 75% of the severity score for unknown information, while LICARA Nanoscan assumes the worst-case scenario in the case where a question is left unanswered.
In conclusion, different CB tools emphasize differently on the parameters taken into account for the hazard characterization. The CB Nanotool requires extensive toxicological information of the nano- and the bulk form, while the Imec approach focuses more on the physicochemical properties of the nanomaterial for the hazard banding assessment.
4.5. The NanoStreeM’s tiered risk assessment framework
The NanoStreeM consortium derived a list of activities that can potentially cause the release of nanoparticles [91]. Described activities include, among others, processes from the operation and cleaning and maintenance of certain processing tools. Based on this survey, the consortium further developed a guidance for performing nano-risk assessment for the semiconductor industry (Deliverables 3.1, [4]). The framework proposed a tiered approach, based on the principles of prior OECD work, to identify specific scenarios or tasks that warrant further detailed risk assessment. According to the guidance prior to the start of the risk assessment, characterization information of the substance, the toxicological information, and the use scenario should be well described. On the other hand, performing complete physicochemical characterization and toxicological studies of the nanomaterial is not always feasible or desirable since the results are not likely to be applicable in other contexts or settings as well as being costly and time-consuming. Therefore, there is a need for flexible frameworks that can give the user a focusing point onto which task or use scenario most urgently requires further hazard and exposure characterization.
The initial tiered approach framework can be further generalized (Figure 1) as to include future versions of so-described risk assessment tools or even novel sector-specific tools. As the amount and quality of information improve, the risk assessment can gradually proceed from control bands to NRV and finally regulatory relevant nano-OELs. This can be achieved following the precautionary principle without compromising the necessary safety measures even if the hazard characterization information is uncertain.
Figure 1.
Generalized tiered risk assessment approach.
The three tiered risk assessment methodologies can be described as follows:
Tier 0 gives an overall screening of the situation including hazard and exposure assessment. The output is a categorical ranking of prioritization for the subsequent Tiers 1 and 2. As Tier 0 method, the consortium has identified the ISO Technical Standard.
Tier 1 gives a semiquantitative result for the exposure and the hazard assessment to further elucidate the hotspots. Tier 1 consists of application of a risk model, providing refinement of the Tier 0 result in the case of an identified concern. The outcome of this tier is an indicative estimate of the expected exposure (i.e., a NRV) and a prescription on how the exposure can be controlled.
Tier 3 requires the use of actual exposure measurement or toxicological data for risk assessment. Tier 2 consists of designating of specific monitoring and control strategies for the exposure or emission of nanomaterials, which validates or refutes the estimate of Tier 1 and also refines the identified control strategies.
5. Conclusions
This chapter provides an overview of several control banding tools for risk assessment of ENM. Their application to semiconductor production processes has been presented as a preliminary use case in view of the information collected in the NanoStreeM project. While the page count limitations do not allow for thorough overview of nanoparticle toxicology, identified gaps in the state of the art demonstrate the main advantages and limitations of the different control banding tools. Substantial knowledge gaps can be identified for even widely used by the industry ENM, such as CeO2 and Al2O3 nanoparticles. The situation is even worse for materials with promising nanoelectronic applications, such as CNTs and graphenes. Furthermore, it was found that the ISO Technical Standard ISO/TS 12901-2:2014 needs further clarification in order to improve its usability. The presented NanoStreeeM generalized tiered risk assessment approach allows for the use of different, possibly even sector-specific tools, in combination with emission or exposure measurement field studies.
Acknowledgments
Authors declare no conflict of interest. The work is supported by the NanoStreeM project, funded under H2020 grant agreement 688194 of the European Commission. The authors would like to acknowledge the helpful remarks of Dr. Lieve Geerts and Dr. Maaike Le Feber.
List of acronyms
CB
control canding
CNT
carbon nanotube
CMOS
complementary metal-oxide-semiconductor
CMP
chemical mechanical planarization, chemical mechanical polish
SWCNTs
single-walled carbon nanotubes
DWCNTs
double-walled carbon nanotubes
MWCNTs
multiwalled carbon nanotubes
ENM
engineered nanomaterials
NP
nanoparticle
GO
graphene oxide
CMR
carcinogenic, mutagentic, and reprotoxic
QD
quantum dots
ROS
reactive oxidative species, reactive oxygen species
OEL
occupational exposure limit
OECD
Organization for Economic Co-operation and Development
NRV
nano-reference value
\n',keywords:"nanosafety, nanomaterials, nanotechnology, semiconductor",chapterPDFUrl:"https://cdn.intechopen.com/pdfs/61139.pdf",chapterXML:"https://mts.intechopen.com/source/xml/61139.xml",downloadPdfUrl:"/chapter/pdf-download/61139",previewPdfUrl:"/chapter/pdf-preview/61139",totalDownloads:899,totalViews:168,totalCrossrefCites:2,totalDimensionsCites:2,totalAltmetricsMentions:0,impactScore:1,impactScorePercentile:66,impactScoreQuartile:3,hasAltmetrics:0,dateSubmitted:"January 24th 2018",dateReviewed:"March 17th 2018",datePrePublished:"November 5th 2018",datePublished:"July 18th 2018",dateFinished:"April 30th 2018",readingETA:"0",abstract:"Engineered nanomaterials (ENM) are used in a wide variety of applications: from cosmetics and paints to sportswear and semiconductor chips. While for chemicals there are established regulatory frameworks dealing with the risk for the consumers, workers, and the environment, this is not the case for nanomaterials. This is precisely why ENMs are used—the properties of matter change at the nanoscale and become dependent on the particle morphology and size. Our understanding on how such nano-systems react with biological matter, such as cells and tissues, is far from complete, and this brings about an increasing level of uncertainty in the research and development process. This chapter will give an overview of several materials, which are either used or have potential applications in nanoelectronics. While silicon dioxide and metal oxide nanoparticles are used in semiconductor processing in standard polishing steps, applications of carbon materials may be more disruptive. As promising materials with broad applications, we focus on carbon nanotubes and graphene. So-identified materials are used to illustrate the use of different risk assessment tools in the occupational setting of nanoelectronics. The application of such tools in itself is also a growing area of research efforts supported by international stakeholders, such as the European Commission.",reviewType:"peer-reviewed",bibtexUrl:"/chapter/bibtex/61139",risUrl:"/chapter/ris/61139",book:{id:"6480",slug:"occupational-health-and-safety-a-multi-regional-perspective"},signatures:"Ponnapat Watjanatepin and Dimiter Prodanov",authors:[{id:"109518",title:"Dr.",name:"Dimiter",middleName:null,surname:"Prodanov",fullName:"Dimiter Prodanov",slug:"dimiter-prodanov",email:"dimiter.prodanov@imec.be",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",institution:{name:"Imec",institutionURL:null,country:{name:"Netherlands"}}},{id:"242413",title:"Mr.",name:"Ponnapat",middleName:null,surname:"Watjanatepin",fullName:"Ponnapat Watjanatepin",slug:"ponnapat-watjanatepin",email:"ponnapatwatjanatepin@gmail.com",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",institution:null}],sections:[{id:"sec_1",title:"1. Introduction",level:"1"},{id:"sec_2",title:"2. Applications",level:"1"},{id:"sec_2_2",title:"2.1. Nanoelectronics as a case study",level:"2"},{id:"sec_3_2",title:"2.2. Metal oxides NPs and silica",level:"2"},{id:"sec_4_2",title:"2.3. Carbon nanotubes",level:"2"},{id:"sec_5_2",title:"2.4. Graphene",level:"2"},{id:"sec_7",title:"3. Nanotoxicology",level:"1"},{id:"sec_7_2",title:"3.1. Nanotoxicology of silica",level:"2"},{id:"sec_8_2",title:"3.2. Nanotoxicology of CeO2",level:"2"},{id:"sec_9_2",title:"3.3. Nanotoxicology of Al2O3",level:"2"},{id:"sec_10_2",title:"3.4. Nanotoxicology of CNTs",level:"2"},{id:"sec_11_2",title:"3.5. Nanotoxicology of graphene",level:"2"},{id:"sec_12_2",title:"3.6. Overview of the nanotoxicological properties of studied ENM",level:"2"},{id:"sec_14",title:"4. Elements of nanomaterial risk assessment",level:"1"},{id:"sec_14_2",title:"4.1. Hazard banding",level:"2"},{id:"sec_15_2",title:"4.2. Exposure banding",level:"2"},{id:"sec_16_2",title:"4.3. Control banding",level:"2"},{id:"sec_17_2",title:"4.4. Comparison of the input parameters of used control banding tools",level:"2"},{id:"sec_18_2",title:"4.5. The NanoStreeM’s tiered risk assessment framework",level:"2"},{id:"sec_20",title:"5. Conclusions",level:"1"},{id:"sec_21",title:"Acknowledgments",level:"1"},{id:"sec_21",title:"List of acronyms",level:"1"}],chapterReferences:[{id:"B1",body:'Schulte PA, Geraci CL, Hodson LL, Zumwalde RD, Kuempel ED, Murashov V, Martinez KF, Heidel DS. Overview of risk management for engineered nanomaterials. Journal of Physics: Conference Series. 2013;429(1):012062'},{id:"B2",body:'Bystrzejewska-Piotrowska G, Golimowski J, Urban P. Nanoparticles: Their potential toxicity, waste and environmental management. Waste management (New York N.Y.). 2009;29:2587-2595'},{id:"B3",body:'Vargas Ferreira F, De Simone Cividanes L, Sales Brito F, Rossi Canuto de Menezes B, Franceschi W, Nunes Simonetti E, Patrocnio Thim G. Functionalizing Graphene and Carbon Nanotubes. Switzerland AG: Springer International Publishing; 2016'},{id:"B4",body:'Lehman S, Morris A, Mueller P, Salem A, Grassian V, Larsen S. Silica nanoparticle-generated ROS as a predictor of cellular toxicity: Mechanistic insights and safety by design. Environmental Science: Nano. 2016;3(1):56-66'},{id:"B5",body:'Speed D, Westerhoff P, Sierra-Alvarez R, Draper R, Pantano P, Aravamudhan S, Loon Chen K, Hristovski K, Herckes P, Bi X, Yang Y, Zeng C, Otero-Gonzalez L, Mikoryak C, Wilson B, Kosaraju K, Tarannum M, Crawford S, Yi P, Liu X, Babu SV, Moinpour M, Ranville J, Montano M, Corredor C, Posner J, Shadman F. Physical, chemical, and in vitro toxicological characterization of nanoparticles in chemical mechanical planarization suspensions used in the semiconductor industry: Towards environmental health and safety assessments. Environmental Science: Nano. 2015;2(3):227-244'},{id:"B6",body:'Buzea C, Pacheco I, Robbie K. Nanomaterials and nanoparticles: Sources and toxicity. Biointerphases. 2007;2(4):MR17-MR71'},{id:"B7",body:'Oberdörster G. Safety assessment for nanotechnology and nanomedicine: Concepts of nanotoxicology. Journal of Internal Medicine. 2010;267(1):89-105'},{id:"B8",body:'Luyts K, Napierska D, Nemery B, Hoet PHM. How physico-chemical characteristics of nanoparticles cause their toxicity: Complex and unresolved interrelations. Environmental Science: Processes & Impacts. 2013;15(1):23-38'},{id:"B9",body:'Shepard MN, Brenner S. An occupational exposure assessment for engineered nanoparticles used in semiconductor fabrication. The Annals of Occupational Hygiene. 2013;58(2):251-265'},{id:"B10",body:'Forsberg M, Olsson J. Chemical mechanical polishing for surface smoothing. Physica Scripta. 2002;T101:200-202'},{id:"B11",body:'Zantye P, Kumar A, Sikder A. Chemical mechanical planarization for microelectronics applications. Materials Science and Engineering: R: Reports. 2004;45(3–6):89-220'},{id:"B12",body:'Singh R, Lee SM, Choi K-S, Basim G, Choi W, Chen Z, Moudgil B. Fundamentals of slurry design for CMP of metal and dielectric materials. MRS Bulletin. 2002;27(10):752-760'},{id:"B13",body:'Dekkers S, Oomen A, Bleeker E, Vandebriel R, Micheletti C, Cabellos J, Janer G, Fuentes N, Vázquez-Campos S, Borges T, João Silva M, Prina-Mello A, Movia D, Nesslany F, Ribeiro A, Leite PE, Groenewold M, Cassee F, Sips A, Dijkzeul A, van Teunenbroek T, Wijnhoven SWP. Towards a nanospecific approach for risk assessment. Regulatory Toxicology and Pharmacology. 2016;80:46-59'},{id:"B14",body:'Schnorr J, Swager T. Emerging applications of carbon nanotubes. Chemistry of Materials. 2011;23(3):646-657'},{id:"B15",body:'Zhao J, Buldum A, Han J, Ping Lu J. First-principles study of li-intercalated carbon nanotube ropes. Physical Review Letters. 2000;85(8):1706-1709'},{id:"B16",body:'Nguyen KT, Zhao Y. Integrated graphene/nanoparticle hybrids for biological and electronic applications. Nanoscale. 2014;6(12):6245-6266'},{id:"B17",body:'Peng L-M, Zhang Z, Wang S. Carbon nanotube electronics: Recent advances. Materials Today. 2014;17(9):433-442'},{id:"B18",body:'Chiang IW, Brinson BE, Huang AY, Willis PA, Bronikowski MJ, Margrave JL, Smalley RE, Hauge RH. Purification and characterization of single-wall carbon nanotubes (SWNTs) obtained from the gas-phase decomposition of CO (HiPco process). The Journal of Physical Chemistry B. 2001;105(35):8297-8301'},{id:"B19",body:'Liu Y, Zhao Y, Sun B, Chen C. Understanding the toxicity of carbon nanotubes. Accounts of Chemical Research. 2012;46(3):702-713'},{id:"B20",body:'Ng S-H, Wang J, Wexler D, Konstantinov K, Guo Z-P, Liu H-K. Highly reversible lithium storage in spheroidal carbon-coated silicon nanocomposites as anodes for lithium-ion batteries. Angewandte Chemie International Edition. 2006;45(41):6896-6899'},{id:"B21",body:'Yin P, Kim T-H, Choi J-W, Lee K-B. Prospects for graphene-nanoparticle-based hybrid sensors. Physical Chemistry Chemical Physics. 2013;15(31):12785'},{id:"B22",body:'Brownson D, Kampouris D, Banks C. An overview of graphene in energy production and storage applications. Journal of Power Sources. 2011;196(11):4873-4885'},{id:"B23",body:'Gopal Sahoo N, Pan Y, Li L, Hwa Chan S. Graphene-based materials for energy conversion. Advanced Materials. 2012;24(30):4203-4210'},{id:"B24",body:'Hirst SM, Karakoti AS, Tyler RD, Sriranganathan N, Seal S, Reilly CM. Anti-inflammatory properties of cerium oxide nanoparticles. Small. 2009;5(24):2848-2856'},{id:"B25",body:'Murugadoss S, Lison D, Godderis L, Van Den Brule S, Mast J, Brassinne F, Sebaihi N, Hoet PH. Toxicology of silica nanoparticles: An update. Archives of Toxicology. 2017;91:2967-3010'},{id:"B26",body:'Napierska D, Thomassen L, Lison D, Martens J, Hoet P. The nanosilica hazard: Another variable entity. Particle and Fibre Toxicology. 2010;7(1):39'},{id:"B27",body:'Rasmussen K, González M, Kearns P, Riego Sintes J, Rossi F, Sayre P. Review of achievements of the OECD working party on manufactured nanomaterials testing and assessment programme. From exploratory testing to test guidelines. Regulatory Toxicology and Pharmacology. 2016;74:147-160'},{id:"B28",body:'ISO. Nanotechnologies – Health and Safety Practices in Occupational Settings Relevant to Nanotechnologies. iso/tr12885. Technical report, ISO; 2008'},{id:"B29",body:'Kosk-Bienko J, editor. Workplace Exposure to Nanoparticles. Luxembourg: EU-OSHA; 2009'},{id:"B30",body:'NIOSH, editor. Approaches to Safe Nanotechnology. USA: DHHS (NIOSH) Publication; 2006'},{id:"B31",body:'Abdal Dayem A, Hossain M, Lee S, Kim K, Saha S, Yang G-M, Choi H, Cho S-G. The role of reactive oxygen species (ROS) in the biological activities of metallic nanoparticles. International Journal of Molecular Sciences. 2017;18(12):120'},{id:"B32",body:'Fu C, Liu T, Li L, Liu H, Liang Q, Meng X. Effects of graphene oxide on the development of offspring mice in lactation period. Biomaterials. 2015;40:23-31'},{id:"B33",body:'Fu P, Xia Q, Hwang H-M, Ray P, Yu H. Mechanisms of nanotoxicity: Generation of reactive oxygen species. Journal of Food and Drug Analysis. 2014;22(1):64-75'},{id:"B34",body:'Kim K-A, Kim Y-H, Seok Seo M, Kyu Lee W, Won Kim S, Kim H, Lee K-H, Shin I-C, Han J-S, Joong Kim H, Lim Y. Mechanism of silica-induced ROS generation in rat2 fibroblast cells. Toxicology Letters. 2002;135(3):185-191'},{id:"B35",body:'Le Feber M, Prodanov D, Zimmermann E. Identification of the most appropriate risk assessment methodologies for use in the semiconductor industry; 2017'},{id:"B36",body:'Fubini B, Hubbard A. Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflammation and fibrosis. Free Radical Biology and Medicine. 2003;34(12):1507-1516'},{id:"B37",body:'Hu X, Cook S, Wang P, Hwang H-M. In vitro evaluation of cytotoxicity of engineered metal oxide nanoparticles. Science of the Total Environment. 2009;407(8):3070-3072'},{id:"B38",body:'Akhtar M, Ahamed M, Kumar S, Siddiqui H, Patil G, Ashquin M, Ahmad I. Nanotoxicity of pure silica mediated through oxidant generation rather than glutathione depletion in human lung epithelial cells. Toxicology. 2010;276(2):95-102'},{id:"B39",body:'Eom H-J, Choi J. Oxidative stress of silica nanoparticles in human bronchial epithelial cell, beas-2b. Toxicology in Vitro. 2009;23(7):1326-1332'},{id:"B40",body:'Hashimoto M, Imazato S. Cytotoxic and genotoxic characterization of aluminum and silicon oxide nanoparticles in macrophages. Dental Materials. 2015;31(5):556-564'},{id:"B41",body:'OECD. Physical-Chemical Properties of Nanomaterials Evaluation of Methods Applied in the OECD-WPMN Testing Programme. France: OECD Paris; 2016'},{id:"B42",body:'Kumari M, Indu Kumari S, Kamal S, Grover P. Genotoxicity assessment of cerium oxide nanoparticles in female wistar rats after acute oral exposure. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 2014;775-776:7-19'},{id:"B43",body:'van Broekhuizen P, van Veelen W, Streekstra W-H, Schulte P, Reijnders L. Exposure limits for nanoparticles: Report of an international workshop on nano reference values. The Annals of Occupational Hygiene. 2012;56:515-524'},{id:"B44",body:'Gagnon J, Fromm K. Toxicity and protective effects of cerium oxide nanoparticles (nanoceria) depending on their preparation method, particle size, cell type, and exposure route. European Journal of Inorganic Chemistry. 2015;2015(27):4510-4517'},{id:"B45",body:'Liguori B, Foss Hansen S, Baun A, Jensen KA. Control banding tools for occupational exposure assessment of nanomaterials – ready for use in a regulatory context? NanoImpact. 2016;2:1-17'},{id:"B46",body:'ANSES. Assessnment of the Risk Associated with Nanomaterials: Issues and Update of Current Knowledge. Maisons-Alfort, France: ANSES; 2014'},{id:"B47",body:'Korsvik C, Patil S, Seal S, Self WT. Superoxide dismutase mimetic properties exhibited by vacancy engineered ceria nanoparticles. Chemical Communications. 2007;10:1056'},{id:"B48",body:'Van Hoornick N, Prodanov D, Pardon A. Banding approach for engineered nanomaterial risk assessment and control. Journal of Physics: Conference Series. 2017;838:012017'},{id:"B49",body:'Yokel R, Unrine J, Wu P, Wang B, Grulke E. Nanoceria biodistribution and retention in the rat after its intravenous administration are not greatly influenced by dosing schedule, dose, or particle shape. Environmental Science: Nano. 2014;1(6):549-560'},{id:"B50",body:'Kumar A, Dhawan A. Genotoxic and carcinogenic potential of engineered nanoparticles: An update. Archives of Toxicology. 2013;87(11):1883-1900'},{id:"B51",body:'Park E-J, Lee G-H, Yoon C, Jeong U, Kim Y, Cho M-H, Kim D-W. Biodistribution and toxicity of spherical aluminum oxide nanoparticles. Journal of Applied Toxicology. 2015;36(3):424-433'},{id:"B52",body:'Brouwer D. Control banding approaches for nanomaterials. The Annals of Occupational Hygiene. 2012;56(5):506-514'},{id:"B53",body:'Kuhlbusch T, Asbach C, Fissan H, Göler D, Stintz M. Nanoparticle exposure at nanotechnology workplaces: A review. Particle and Fibre Toxicology. 2011;8(1):22'},{id:"B54",body:'Haynes WM, editor. CRC Handbook of Chemistry and Physics. 92nd ed. Boca Raton: CRC Press; 2011'},{id:"B55",body:'Yang H, Wu Q, Tang M, Kong L, Lu Z. Cell membrane injury induced by silica nanoparticles in mouse macrophage. Journal of Biomedical Nanotechnology. 2009;5:528-535'},{id:"B56",body:'Radziun E, Dudkiewicz Wilczyńska J, Książek I, Nowak K, Anuszewska EL, Kunicki A, Olszyna A, Ząbkowski T. Assessment of the cytotoxicity of aluminium oxide nanoparticles on selected mammalian cells. Toxicology in Vitro. 2011;25(8):1694-1700'},{id:"B57",body:'Sadiq R, Mahmood Khan Q, Mobeen A, Hashmat AJ. Vitrotoxicological assessment of iron oxide, aluminium oxide and copper nanoparticles in prokaryotic and eukaryotic cell types. Drug and Chemical Toxicology. 2014;38(2):152-161'},{id:"B58",body:'Braydich-Stolle L, Speshock J, Castle A, Smith M, Murdock R, Hussain S. Nanosized aluminum altered immune function. ACS Nano. 2010;4(7):3661-3670'},{id:"B59",body:'Lam C-W. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicological Sciences. 2003;77(1):126-134'},{id:"B60",body:'Li Y, Zhang X, Luo J, Huang W, Cheng J, Luo Z, Li T, Liu F, Xu G, Ke X, Li L, Geise H. Purification of CVD synthesized single-wall carbon nanotubes by different acid oxidation treatments. Nanotechnology. 2004;15(11):1645-1649'},{id:"B61",body:'Yazdan Madani S, Mandel A, Seifalian AM. A concise review of carbon nanotube’s toxicology. Nano Reviews. 2013;4(1):21521'},{id:"B62",body:'Poland CA, Duffin R, Kinloch I, Maynard A, Wallace WAH, Seaton A, Stone V, Brown S, MacNee W, Donaldson K. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nature Nanotechnology. 2008;3(7):423-428'},{id:"B63",body:'Xu J, Futakuchi M, Shimizu H, Alexander D, Yanagihara K, Fukamachi K, Suzui M, Kanno J, Hirose A, Ogata A, Sakamoto Y, Nakae D, Omori T, Tsuda H. Multi-walled carbon nanotubes translocate into the pleural cavity and induce visceral mesothelial proliferation in rats. Cancer Science. 2012;103(12):2045-2050'},{id:"B64",body:'Muller J, Huaux F, Moreau N, Misson P, Heilier J-F, Delos M, Arras M, Fonseca A, Nagy J, Lison D. Respiratory toxicity of multi-wall carbon nanotubes. Toxicology and Applied Pharmacology. 2005;207(3):221-231'},{id:"B65",body:'Jastrzebska A-M, Kurtycz P, Olszyna A-R. Recent advances in graphene family materials toxicity investigations. Journal of Nanoparticle Research. 2012;14(12):1320'},{id:"B66",body:'Lalwani G, D’Agati M, Mahmud Khan A, Sitharaman B. Toxicology of graphene-based nanomaterials. Advanced Drug Delivery Reviews. 2016;105:109-144'},{id:"B67",body:'Seabra AB, Paula AJ, de Lima R, Alves OL, Durán N. Nanotoxicity of graphene and graphene oxide. Chemical Research in Toxicology. 2014;27(2):159-168'},{id:"B68",body:'Yang K, Li Y, Tan X, Peng R, Liu Z. Behavior and toxicity of graphene and its functionalized derivatives in biological systems. Small. 2012;9(9–10):1492-1503'},{id:"B69",body:'Zhang X, Yin J, Peng C, Hu W, Zhu Z, Li W, Fan C, Huang Q. Distribution and biocompatibility studies of graphene oxide in mice after intravenous administration. Carbon. 2011;49(3):986-995'},{id:"B70",body:'Singh SK, Singh MK, Kulkarni PP, Sonkar VK, Grácio JJA, Dash D. Amine-modified graphene: Thrombo-protective safer alternative to graphene oxide for biomedical applications. ACS Nano. 2012;6(3):2731-2740'},{id:"B71",body:'Singh SK, Singh MK, Nayak MK, Kumari S, Shrivastava S, Grácio JJA, Dash D. Thrombus inducing property of atomically thin graphene oxide sheets. ACS Nano. 2011;5(6):4987-4996'},{id:"B72",body:'Bengtson S, Knudsen KB, Kyjovska ZO, Berthing T, Skaug V, Levin M, Koponen IK, Shivayogimath A, Booth TJ, Alonso B, Pesquera A, Zurutuza A, Thomsen BL, Troelsen JT, Jacobsen NR, Vogel U. Differences in inflammation and acute phase response but similar genotoxicity in mice following pulmonary exposure to graphene oxide and reduced graphene oxide. Plos One. 2017;12(6):e0178355'},{id:"B73",body:'Ivask A, Voelcker NH, Seabrook SA, Hor M, Kirby JK, Fenech M, Davis TP, Ke PC. DNA melting and genotoxicity induced by silver nanoparticles and graphene. Chemical Research in Toxicology. 2015;28(5):1023-1035'},{id:"B74",body:'Pietroiusti A, Stockmann-Juvala H, Lucaroni F, Savolainen K. Nanomaterial exposure, toxicity, and impact on human health. Nanomedicine and Nanobiotechnology, Wiley-Blackwell. 2018;65(2):171-173, e1513'},{id:"B75",body:'Bouillard J, Vignes A. Nano-evaluris: An inhalation and explosion risk evaluation method for nanoparticle use. Part I: Description of the methodology. Journal of Nanoparticle Research. 2014;16:2149. https://doi.org/10.1007/s11051-013-2149-5'},{id:"B76",body:'Hristozov D, Malsch I. Hazards and risks of engineered nanoparticles for the environment and human health. Sustainability. 2009;1(4):1161-1194'},{id:"B77",body:'van Broekhuizen P, van Broekhuizen F, Cornelissen R, Reijnders L. Workplace exposure to nanoparticles and the application of provisional nanoreference values in times of uncertain risks. Journal of Nanoparticle Research. 2012;14(4):1-25'},{id:"B78",body:'De Volder M, Tawfick S, Baughman R, Hart J. Carbon nanotubes: Present and future commercial applications. Science (New York N.Y.). 2013;339:535-539'},{id:"B79",body:'FrÃűhlich E. Cellular targets and mechanisms in the cytotoxic action of non-biodegradable engineered nanoparticles. Current Drug Metabolism. 2013;14:976-988'},{id:"B80",body:'ANSES. Development of a Specific Control Banding Tool for Nanomaterials. France: ANSES; 2010'},{id:"B81",body:'Paik S, Zalk D, Swuste P. Application of a pilot control banding tool for risk level assessment and control of nanoparticle exposures. The Annals of Occupational Hygiene. 2008;52:419-428'},{id:"B82",body:'ISO. Nanotechnologies – Occupational Risk Management Applied to Engineered Nanomaterials. Part 2: Use of the Control Banding Approach. ISO/TS12901-2. Switzerland: ISO; 2014'},{id:"B83",body:'Hristozov D, Gottardo S, Semenzin E, Oomen A, Bos P, Peijnenburg W, van Tongeren M, Nowack B, Hunt N, Brunelli A, Scott-Fordsmand J, Tran L, Marcomini A. Frameworks and tools for risk assessment of manufactured nanomaterials. Environment International. 2016;95:36-53'},{id:"B84",body:'TNO. Stoffenmanager Nano: Description of the conceptual control banding model. Zeist, The Netherlands: TNO; 2011'},{id:"B85",body:'Jensen KA, Saber AT, Kristensen HV, Liguori B, Jensen AC, Koponen IK, Wallin H. Nanosafer Vs. 1.1 Nanomaterial Risk Assessment Using First Order Modeling. Poster session presented at Topical Scientific Workshop on Regulatory Challenges in Risk Assessment of Nanomaterials. Finland: Helsinki; 2014'},{id:"B86",body:'Prodanov D. Management of health risks related to the use of nanomaterials. An analogy with biosafety. Biomedical Reviews. 2018;28:104-109'},{id:"B87",body:'Afshari A, Matson U, Ekberg LE. Characterization of indoor sources of fine and ultrafine particles: A study conducted in a full-scale chamber. Indoor Air. 2005;15:141-150'},{id:"B88",body:'Zalk DM, Nelson DI. History and evolution of control banding: A review. Journal of Occupational and Environmental Hygiene. 2008;5(5):330-346'},{id:"B89",body:'Brouwer D, van Duuren-Stuurman B, Berges M, Jankowska E, Bard D, Mark D. From workplace air measurement results toward estimates of exposure? Development of a strategy to assess exposure to manufactured nano-objects. Journal of Nanoparticle Research. 2009;11(8):1867-1881'},{id:"B90",body:'Li Y, Li P, Yu H, Bian Y. Recent advances (2010–2015) in studies of cerium oxide nanoparticles’ health effects. Environmental Toxicology and Pharmacology. 2016;44:25-29'},{id:"B91",body:'Belde P, Maillet J-C, Moclair F, Morelli A, Prodanov D, Roquet P. A list of associated tasks, activities and operations where exposure might occur. 2016. DOI: 10.5281/zenodo.804442'}],footnotes:[],contributors:[{corresp:null,contributorFullName:"Ponnapat Watjanatepin",address:null,affiliation:'
'}],corrections:null},book:{id:"6480",type:"book",title:"Occupational Health and Safety",subtitle:"A Multi-Regional Perspective",fullTitle:"Occupational Health and Safety - A Multi-Regional Perspective",slug:"occupational-health-and-safety-a-multi-regional-perspective",publishedDate:"July 18th 2018",bookSignature:"Manikam Pillay and Michael Tuck",coverURL:"https://cdn.intechopen.com/books/images_new/6480.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",isbn:"978-1-78923-411-4",printIsbn:"978-1-78923-410-7",pdfIsbn:"978-1-83881-489-2",reviewType:"peer-reviewed",numberOfWosCitations:2,isAvailableForWebshopOrdering:!0,editors:[{id:"199145",title:"Dr.",name:"Manikam",middleName:null,surname:"Pillay",slug:"manikam-pillay",fullName:"Manikam Pillay"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,coeditorOne:{id:"222477",title:"Dr.",name:"Michael",middleName:"Andrew",surname:"Tuck",slug:"michael-tuck",fullName:"Michael Tuck"},coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"1133"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"60395",type:"chapter",title:"Bed Size, Quality Sleep and Occupational Safety: An Investigation of Students at Slovak Universities",slug:"bed-size-quality-sleep-and-occupational-safety-an-investigation-of-students-at-slovak-universities",totalDownloads:1077,totalCrossrefCites:0,signatures:"Miloš Hitka, Pavol Joščák, Silvia Lorincová and Žaneta Balážová",reviewType:"peer-reviewed",authors:[{id:"198736",title:"Associate Prof.",name:"Miloš",middleName:null,surname:"Hitka",fullName:"Miloš Hitka",slug:"milos-hitka"},{id:"198745",title:"Mrs.",name:"Žaneta",middleName:null,surname:"Balážová",fullName:"Žaneta Balážová",slug:"zaneta-balazova"},{id:"199928",title:"Dr.",name:"Silvia",middleName:null,surname:"Lorincová",fullName:"Silvia Lorincová",slug:"silvia-lorincova"},{id:"238932",title:"Dr.",name:"Pavol",middleName:null,surname:"Joščák",fullName:"Pavol Joščák",slug:"pavol-joscak"}]},{id:"61528",type:"chapter",title:"Preventive Measures of Heat Disorder in the Workplace",slug:"preventive-measures-of-heat-disorder-in-the-workplace",totalDownloads:1078,totalCrossrefCites:0,signatures:"Ivan Uher, Iveta Cimboláková and David Kaško",reviewType:"peer-reviewed",authors:[{id:"227237",title:"Associate Prof.",name:"Ivan",middleName:null,surname:"Uher",fullName:"Ivan Uher",slug:"ivan-uher"},{id:"266374",title:"Dr.",name:"Iveta",middleName:null,surname:"Cimboláková",fullName:"Iveta Cimboláková",slug:"iveta-cimbolakova"},{id:"266375",title:"M.Sc.",name:"Dávid",middleName:null,surname:"Kaško",fullName:"Dávid Kaško",slug:"david-kasko"}]},{id:"61139",type:"chapter",title:"Tools for Assessment of Occupational Health Risks of some Engineered Nanoparticles and Carbon Materials Used in Semiconductor Applications",slug:"tools-for-assessment-of-occupational-health-risks-of-some-engineered-nanoparticles-and-carbon-materi",totalDownloads:899,totalCrossrefCites:2,signatures:"Ponnapat Watjanatepin and Dimiter Prodanov",reviewType:"peer-reviewed",authors:[{id:"109518",title:"Dr.",name:"Dimiter",middleName:null,surname:"Prodanov",fullName:"Dimiter Prodanov",slug:"dimiter-prodanov"},{id:"242413",title:"Mr.",name:"Ponnapat",middleName:null,surname:"Watjanatepin",fullName:"Ponnapat Watjanatepin",slug:"ponnapat-watjanatepin"}]},{id:"61180",type:"chapter",title:"Impact of Intervention on the Psychological Well-Being of Injured Workers",slug:"impact-of-intervention-on-the-psychological-well-being-of-injured-workers",totalDownloads:847,totalCrossrefCites:0,signatures:"Halimah Awang and Tan Lih Yoong",reviewType:"peer-reviewed",authors:[{id:"238511",title:"Ph.D.",name:"Halimah",middleName:null,surname:"Awang",fullName:"Halimah Awang",slug:"halimah-awang"},{id:"238574",title:"Ms.",name:"Lih Yoong",middleName:null,surname:"Tan",fullName:"Lih Yoong Tan",slug:"lih-yoong-tan"}]},{id:"61164",type:"chapter",title:"Socio-Cultural Practices and Health and Safety Behaviors Among Ghanaian Employees",slug:"socio-cultural-practices-and-health-and-safety-behaviors-among-ghanaian-employees",totalDownloads:1310,totalCrossrefCites:0,signatures:"Kwesi Amponsah-Tawiah",reviewType:"peer-reviewed",authors:[{id:"224576",title:"Dr.",name:"Kwesi",middleName:null,surname:"Amponsah-Twiah",fullName:"Kwesi Amponsah-Twiah",slug:"kwesi-amponsah-twiah"}]},{id:"61594",type:"chapter",title:"The Utility of M-31000 for Managing Health and Safety Risks: A Pilot Investigation",slug:"the-utility-of-m-31000-for-managing-health-and-safety-risks-a-pilot-investigation",totalDownloads:938,totalCrossrefCites:0,signatures:"Manikam Pillay",reviewType:"peer-reviewed",authors:[{id:"199145",title:"Dr.",name:"Manikam",middleName:null,surname:"Pillay",fullName:"Manikam Pillay",slug:"manikam-pillay"}]}]},relatedBooks:[{type:"book",id:"2304",title:"The Continuum of Health Risk Assessments",subtitle:null,isOpenForSubmission:!1,hash:"4c7746436d03609a8a8eb805f0a2eef1",slug:"the-continuum-of-health-risk-assessments",bookSignature:"Michael G. Tyshenko",coverURL:"https://cdn.intechopen.com/books/images_new/2304.jpg",editedByType:"Edited by",editors:[{id:"118088",title:"Dr.",name:"Michael G.",surname:"Tyshenko",slug:"michael-g.-tyshenko",fullName:"Michael G. Tyshenko"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"35972",title:"The Risk of Blood-Borne Viral Infection due to Syringe Re-Use",slug:"the-risk-of-blood-borne-viral-infection-due-to-syringe-re-use",signatures:"Tamer Oraby, Susie Elsaadany, Robert Gervais, Mustafa Al-Zoughool, Michael G. Tyshenko, Lynn Johnston, Mel Krajden, Dick Zoutman, Jun Wu and Daniel Krewski",authors:[{id:"118088",title:"Dr.",name:"Michael G.",middleName:null,surname:"Tyshenko",fullName:"Michael G. Tyshenko",slug:"michael-g.-tyshenko"},{id:"118084",title:"Dr.",name:"Tamer",middleName:null,surname:"Oraby",fullName:"Tamer Oraby",slug:"tamer-oraby"},{id:"118155",title:"Dr.",name:"Susie",middleName:null,surname:"ElSaadany",fullName:"Susie ElSaadany",slug:"susie-elsaadany"},{id:"118157",title:"Dr.",name:"Jun",middleName:null,surname:"Wu",fullName:"Jun Wu",slug:"jun-wu"},{id:"118159",title:"Prof.",name:"Daniel",middleName:null,surname:"Krewski",fullName:"Daniel Krewski",slug:"daniel-krewski"},{id:"138824",title:"Dr.",name:"Robert",middleName:null,surname:"Gervais",fullName:"Robert Gervais",slug:"robert-gervais"},{id:"138825",title:"Dr.",name:"Mustafa",middleName:null,surname:"Al-Zoughool",fullName:"Mustafa Al-Zoughool",slug:"mustafa-al-zoughool"},{id:"138826",title:"Dr.",name:"L.",middleName:null,surname:"Johnston",fullName:"L. Johnston",slug:"l.-johnston"},{id:"138827",title:"Dr.",name:"Mel",middleName:null,surname:"Krajden",fullName:"Mel Krajden",slug:"mel-krajden"},{id:"138828",title:"Dr.",name:"D.",middleName:null,surname:"Zoutman",fullName:"D. Zoutman",slug:"d.-zoutman"}]},{id:"35973",title:"Professional Drivers and Psychoactive Substances Consumption: First Results from Medical Surveillance at the Workplace in Italy",slug:"professional-drivers-and-psychoactive-substances-consumption-risk-assessment-at-the-workplace-in-it",signatures:"Gian Luca Rosso, Mauro Feola, Maria Paola Rubinetto, Nicola Petti and Lorenzo Rubinetto",authors:[{id:"116153",title:"Dr.",name:"Gian Luca",middleName:null,surname:"Rosso",fullName:"Gian Luca Rosso",slug:"gian-luca-rosso"}]},{id:"35974",title:"Xenotropic Murine Leukemia Virus-Related Virus as a Case Study: Using a Precautionary Risk Management Approach for Emerging Blood-Borne Pathogens in Canada",slug:"xenotropic-murine-leukemia-virus-related-virus-as-a-case-study-using-a-precautionary-risk-managemen",signatures:"Michael G. Tyshenko, Susie ElSaadany, Tamer Oraby, Marian Laderoute, Jun Wu, Willy Aspinall, Daniel Krewski and Peter R. Ganz",authors:[{id:"118088",title:"Dr.",name:"Michael G.",middleName:null,surname:"Tyshenko",fullName:"Michael G. Tyshenko",slug:"michael-g.-tyshenko"},{id:"118084",title:"Dr.",name:"Tamer",middleName:null,surname:"Oraby",fullName:"Tamer Oraby",slug:"tamer-oraby"},{id:"118155",title:"Dr.",name:"Susie",middleName:null,surname:"ElSaadany",fullName:"Susie ElSaadany",slug:"susie-elsaadany"},{id:"118157",title:"Dr.",name:"Jun",middleName:null,surname:"Wu",fullName:"Jun Wu",slug:"jun-wu"},{id:"118159",title:"Prof.",name:"Daniel",middleName:null,surname:"Krewski",fullName:"Daniel Krewski",slug:"daniel-krewski"},{id:"118156",title:"Dr.",name:"Marian",middleName:null,surname:"Laderoute",fullName:"Marian Laderoute",slug:"marian-laderoute"},{id:"118158",title:"Prof.",name:"Willy",middleName:null,surname:"Aspinall",fullName:"Willy Aspinall",slug:"willy-aspinall"},{id:"139899",title:"Dr.",name:"Peter",middleName:null,surname:"Ganz",fullName:"Peter Ganz",slug:"peter-ganz"}]},{id:"35975",title:"Ultrafine and Fine Aerosol Deposition in the Nasal Airways of a 9-Month-Old Girl, a 5-Year-Old Boy and a 53-Year-Old Male",slug:"ultrafine-and-fine-aerosol-deposition-in-the-nasal-airways-of-a-9-month-old-girl-a-5-year-old-boy-a",signatures:"Jinxiang Xi, JongWon Kim and Xiuhua A. Si",authors:[{id:"115321",title:"Prof.",name:"Jinxiang",middleName:null,surname:"Xi",fullName:"Jinxiang Xi",slug:"jinxiang-xi"},{id:"118423",title:"Prof.",name:"Xiuhua",middleName:null,surname:"Si",fullName:"Xiuhua Si",slug:"xiuhua-si"},{id:"118424",title:"Dr.",name:"JonWon",middleName:null,surname:"Kim",fullName:"JonWon Kim",slug:"jonwon-kim"}]},{id:"35976",title:"Safety, Security and Quality: Lessons from GMO Risk Assessments",slug:"safety-security-and-quality-lessons-from-gmo-s-risk-assessment",signatures:"Alice Benessia and Giuseppe Barbiero",authors:[{id:"119240",title:"Dr.",name:"Giuseppe",middleName:null,surname:"Barbiero",fullName:"Giuseppe Barbiero",slug:"giuseppe-barbiero"},{id:"119297",title:"Dr.",name:"Alice",middleName:null,surname:"Benessia",fullName:"Alice Benessia",slug:"alice-benessia"}]},{id:"35977",title:"Breast Cancer Prognostication and Risk Prediction in the Post-Genomic Era",slug:"breast-cancer-prognostication-and-risk-prediction-in-the-post-genomic-era",signatures:"Xi Zhao, Ole Christian Lingjærde and Anne-Lise Børresen-Dale",authors:[{id:"119031",title:"PhD.",name:"Xi",middleName:null,surname:"Zhao",fullName:"Xi Zhao",slug:"xi-zhao"},{id:"119268",title:"Prof.",name:"Anne-Lise",middleName:null,surname:"Børresen-Dale",fullName:"Anne-Lise Børresen-Dale",slug:"anne-lise-borresen-dale"},{id:"144358",title:"Prof.",name:"Ole Christian",middleName:null,surname:"Lingjærde",fullName:"Ole Christian Lingjærde",slug:"ole-christian-lingjaerde"}]},{id:"35978",title:"Physics of Open Systems: A New Approach to Use Genomics Data in Risk Assessment",slug:"physics-of-open-systems-a-new-approach-to-use-genomics-data-in-risk-assessment",signatures:"Viacheslav Ageev, Boric Fomin, Oleg Fomin, Tamara Kachanova, Chao Chen, Maria Spassova and Leonid Kopylev",authors:[{id:"119524",title:"Dr.",name:"Leonid",middleName:null,surname:"Kopylev",fullName:"Leonid Kopylev",slug:"leonid-kopylev"},{id:"119527",title:"Prof.",name:"Boris",middleName:null,surname:"Fomin",fullName:"Boris Fomin",slug:"boris-fomin"},{id:"119528",title:"Dr.",name:"Chao",middleName:null,surname:"Chen",fullName:"Chao Chen",slug:"chao-chen"},{id:"119529",title:"Dr.",name:"Maria",middleName:null,surname:"Spassova",fullName:"Maria Spassova",slug:"maria-spassova"},{id:"119539",title:"Mr.",name:"Oleg",middleName:null,surname:"Fomin",fullName:"Oleg Fomin",slug:"oleg-fomin"},{id:"119540",title:"Mr.",name:"Viacheslav",middleName:null,surname:"Ageev",fullName:"Viacheslav Ageev",slug:"viacheslav-ageev"},{id:"119594",title:"Dr.",name:"Tamara",middleName:null,surname:"Kachanova",fullName:"Tamara Kachanova",slug:"tamara-kachanova"}]},{id:"35979",title:"New Models for the In Vitro Study of Liver Toxicity: 3D Culture Systems and the Role of Bioreactors",slug:"new-models-for-the-in-vitro-study-of-liver-toxicity-3d-culture-systems-and-the-role-of-bioreactors",signatures:"Giovanna Mazzoleni and Nathalie Steimberg",authors:[{id:"120598",title:"Prof.",name:"Giovanna",middleName:null,surname:"Mazzoleni",fullName:"Giovanna Mazzoleni",slug:"giovanna-mazzoleni"},{id:"120599",title:"Dr.",name:"Nathalie",middleName:null,surname:"Steimberg",fullName:"Nathalie Steimberg",slug:"nathalie-steimberg"}]}]}],publishedBooks:[{type:"book",id:"9563",title:"Current Topics on Military Medicine",subtitle:null,isOpenForSubmission:!1,hash:"6b5c2bf5ae0656aff7775c2980a8b285",slug:"current-topics-on-military-medicine",bookSignature:"Nikolai V. Gorbunov",coverURL:"https://cdn.intechopen.com/books/images_new/9563.jpg",editedByType:"Edited by",editors:[{id:"180960",title:"Dr.",name:"Nikolai",surname:"Gorbunov",slug:"nikolai-gorbunov",fullName:"Nikolai Gorbunov"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7620",title:"Safety and Health for Workers",subtitle:"Research and Practical Perspective",isOpenForSubmission:!1,hash:"1233909d682e2cced428e1042fd40ad4",slug:"safety-and-health-for-workers-research-and-practical-perspective",bookSignature:"Bankole Fasanya",coverURL:"https://cdn.intechopen.com/books/images_new/7620.jpg",editedByType:"Edited by",editors:[{id:"214494",title:"Dr.",name:"Bankole",surname:"Fasanya",slug:"bankole-fasanya",fullName:"Bankole Fasanya"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9532",title:"Occupational Wellbeing",subtitle:null,isOpenForSubmission:!1,hash:"b653470d0eea86ec71dc2b3423db7c36",slug:"occupational-wellbeing",bookSignature:"Kavitha Palaniappan and Pamela McCauley",coverURL:"https://cdn.intechopen.com/books/images_new/9532.jpg",editedByType:"Edited by",editors:[{id:"311189",title:"Dr.",name:"Kavitha",surname:"Palaniappan",slug:"kavitha-palaniappan",fullName:"Kavitha Palaniappan"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8794",title:"Leading Community Based Changes in the Culture of Health in the US",subtitle:"Experiences in Developing the Team and Impacting the Community",isOpenForSubmission:!1,hash:"5044f7244f5d99791ec13482f276a075",slug:"leading-community-based-changes-in-the-culture-of-health-in-the-us-experiences-in-developing-the-team-and-impacting-the-community",bookSignature:"Claudia S. P. Fernandez and Giselle Corbie-Smith",coverURL:"https://cdn.intechopen.com/books/images_new/8794.jpg",editedByType:"Edited by",editors:[{id:"89429",title:"Dr.",name:"Claudia S.P.",surname:"Fernandez",slug:"claudia-s.p.-fernandez",fullName:"Claudia S.P. Fernandez"}],equalEditorOne:{id:"419433",title:"Dr.",name:"Giselle",surname:"Corbie-Smith",slug:"giselle-corbie-smith",fullName:"Giselle Corbie-Smith"},equalEditorTwo:null,equalEditorThree:null,productType:{id:"3",chapterContentType:"chapter",authoredCaption:"Authored by"}},{type:"book",id:"10328",title:"AIDS Updates",subtitle:"Recent Advances and New Perspectives",isOpenForSubmission:!1,hash:"a3eff37a164c0b098d04379946609f12",slug:"aids-updates-recent-advances-and-new-perspectives",bookSignature:"Samuel Ikwaras Okware",coverURL:"https://cdn.intechopen.com/books/images_new/10328.jpg",editedByType:"Edited by",editors:[{id:"178641",title:"Dr.",name:"Samuel Ikwaras",surname:"Okware",slug:"samuel-ikwaras-okware",fullName:"Samuel Ikwaras Okware"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],publishedBooksByAuthor:[{type:"book",id:"975",title:"Molecular Imaging",subtitle:null,isOpenForSubmission:!1,hash:"45c307fa57444bc26d042f1e814cef69",slug:"molecular-imaging",bookSignature:"Bernhard Schaller",coverURL:"https://cdn.intechopen.com/books/images_new/975.jpg",editedByType:"Edited by",editors:[{id:"80887",title:"Prof.",name:"Bernhard",surname:"Schaller",slug:"bernhard-schaller",fullName:"Bernhard Schaller"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8851",title:"Advances in Neural Signal Processing",subtitle:null,isOpenForSubmission:!1,hash:"a44ac118b233b29a3d5b57d61680ec38",slug:"advances-in-neural-signal-processing",bookSignature:"Ramana Vinjamuri",coverURL:"https://cdn.intechopen.com/books/images_new/8851.jpg",editedByType:"Edited by",editors:[{id:"196746",title:"Dr.",name:"Ramana",surname:"Vinjamuri",slug:"ramana-vinjamuri",fullName:"Ramana Vinjamuri"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},onlineFirst:{chapter:{type:"chapter",id:"82063",title:"Evaluating Similarities and Differences between Machine Learning and Traditional Statistical Modeling in Healthcare Analytics",doi:"10.5772/intechopen.105116",slug:"evaluating-similarities-and-differences-between-machine-learning-and-traditional-statistical-modelin",body:'
1. Introduction
In the recent years, machine learning techniques have been utilized to solve problems at hand across multitudes of industries and topics. In the healthcare industry, these techniques are often applied to a variety of healthcare claims and electronic health records data to garner valuable insights into diagnostic and treatment pathways in order to help optimize patient healthcare access and treatment process [1]. Unfortunately, many of these applications resulted in inaccurate or irrelevant research results, as proper research protocols were not fully followed [2]. On the other hand, statistics has been the basis of analysis in healthcare research for decades, especially, in the areas of clinical trials and health economics and outcomes research (HEOR), where the precision and accuracy of analyses have been the primary objectives [3]. Furthermore, the classical statistics methodologies are often preferred in those research areas to ensure the ability to replicate and defend the results and ultimately, the ability to publish the research content in peer-reviewed medical journals [3]. The increased availability of data, including data from wearables, provided the opportunity to apply a variety of analytical techniques and methodologies to identify patterns, often hidden, that could help with optimization of healthcare access as well as diagnostic and treatment process [4].
With the rapid increase in data from the healthcare and many other industries, it is important to consider how to select well - suited statistical and machine learning methodologies that would be best for the problem at hand, the available data type, and the overall research objectives [5]. Machine learning alone or complemented by statistical modeling is becoming, not just a more common, but a desired convergence to take advantage of the best of both approaches for advancing healthcare outcomes [1]. Please note that this book chapter was originally posted on the Cornell University’s research working article website: https://arxiv.org. The book chapter content is mostly the same between the two versions [6].
2. Machine learning foundation is in statistical learning theory
Machine learning (ML) is considered a branch of artificial intelligence and computer science that focuses on mimicking human behaviors through a set of algorithms and methods that use historical values to predict new values [7], without specifically being coded to do so and thereby learning over time [8, 9]. ML is grounded in statistical learning theory (SLT), which provides the constructs used to create prediction functions from data. One of the first examples of SLT was the creation of the support vector machine (SVM), the supervised learning method that can be used as for both classification and regression and has become a standard in modeling how to recognize visual objects [7]. SLT formalizes the model that makes a prediction based on observations (i.e., data) and ML automates the modeling [7].
SLT sets the mathematical and theoretical framework for ML as well as the properties of learning algorithms [7] with the goals of providing mechanisms for studying inference and creating algorithms that become more precise and improved over time [8]. SLT is based multivariate statistics and functional analysis [8]. Functional analysis is the branch of statistics that measures shapes, curves, and surfaces, extending multivariate vector statistics to continuous functions and finding functions that describe data patterns [8]. Inductive inference is the process of generalizing and modeling past observations to make predictions for the future; SLT formalizes the modeling concepts of inductive inference, while ML automates them [8].
For example, pattern recognition is considered a problem of inductive inference and SLT, as it is a curving-fitting problem, and one of the most common applications of ML [7, 8, 9]. Pattern recognition is not suited for traditional computer programming as the inferences needed are not free of assumptions and the patterns are not easily described or labeled programmatically with deterministic functions. The standard mathematics behind SLT makes no assumptions on distributions, uses stochastic functions that can include humans labeling the “right” classification, i.e., training data, and can assume that the probability of the occurrence of one observation is independent of another thereby including the concept of randomness [7, 8, 9]. These tenets are therefore those of ML as well.
SLT also provides the definition of terms often using in ML such as overfitting, underfitting and generalization. Overfitting is when the presence of noise in the data negatively affects training and the ultimate model performance because the noise is being incorporated into the learning process, thereby giving error when the model sees new data [8, 9]. Underfitting is when the noise impacts both performance on training data as well as new and unseen data [9]. In ML, discussion about underfitting and overfitting are often used to describe models that do not generalize the data effectively and might not present the right set of data elements to explain the data patterns and posited hypotheses [9]. Underfitting is often defined when model which is missing features that would be present in the most optimized model, akin to a regression model not fully explaining all of the variance of the dependent variable [9]. In a similar vein, overfitting is when the model contains more features or different features than is optimal, like a regression model with autocorrelation or multicollinearity [9].
The general goal of learning algorithms and therefore ML model optimization is to reduce the dimensions, features, or data variables to the fewest number needed as that reduces noise or the impact of trivial variables that can overfit or unfit [8, 9]. A regularization model can then become generalized to perform not just on the past or the training data, but also on future and yet unseen data [8, 9]. Although true generalization needs both the right modeling criteria as well as strong subject matter knowledge [8].
Often dimension reduction approaches like Principal Component Analysis (PCA) or boot strapping techniques used along with subject matter expertise can help resolve how to refine models, combat fit challenges, as well as improve generalization potential [9, 10]. Furthermore, understanding the studied population and data characteristics can further help define the data to be used, variable selection, and proper model set up [10].
3. Similarities between machine learning and statistical modeling
Statistical modeling is based on SLT and use of mathematical models and statistical assumptions to generate sample data and make predictions about the real world occurrences. A statistical model is often represented as a collection of probability distributions on a set of all possible outcomes. Furthermore, statistical modeling has evolved in the last few decades and shaped the future of business analytics and data science, including the current use and applications of ML algorithms. On the other hand, machine learning does not require many assumptions and interventions when running algorithms in order to accurately predict studied outcomes [7].
There are similarities between ML and statistical modeling that are prevalent across most analytical efforts. Both techniques use historical data as input to predict new output values, but they vary as noted above on the underlying assumptions and the level of analyst intervention and data preparation.
Overall, machine learning foundations are based from statistical learning theory, and it is recommended for the data scientists to apply SLT’s guiding rules during analysis. While it may seem as a statistical background and understanding is not required when analyzing the underlying data, this misconception often leads to data scientist’s inability to set up proper research hypothesis and analysis due to a lack of understanding of the problem and the underlying data assumptions as well as caveats. This issue can in turn result in biased and irrelevant results as well as unfounded conclusions and insights. With that in mind, it is important to evaluate the problem at hand, and consider both statistical modeling and ML as possible methods to be applied. Understanding the underlying assumptions of the data and statistical inference can help support proper technique selection and guide the pathway to solution [11]. In the later sections of the chapter, application of both techniques will be provided and the reasoning for selecting the methods presented to guide future research.
As mentioned above, the similarities between ML and statistical modeling start with the underlying assumption that data or observations from the past can be used to predict the future [7]. The variables included in the analysis generally represent two types: dependent variables, that in ML are called targets, and independent variables, that in ML are called features. The definition of the variables is the same across both techniques [8]. Furthermore, both ML and statistical modeling leverage the available data in a way that allow for generalization of results to larger population [7]. The loss and risk associated with the models accuracy and representation of the real world occurrence is described frequently in terms of mean squared error (MSE). In statistical modeling, MSE is the difference between the predicted value and the actual value and is used to measure loss of the performance of predictions. In the ML, the same MSE concept is presented via a confusion matrix that evaluates a classification problem\'s accuracy [9].
4. Differences between machine learning and statistical modeling
Differences between machine learning and statistical modeling are distinct and based on purposes and needs for the analysis as well as the outcomes. Assumptions and purposes for the analysis and approach can vastly differ. For example, statistics typically assumes that predictors or features are known and additive, models are parametric, and testing of hypotheses and uncertainty are forefront. On the other hand, ML does not make these assumptions [12]. In ML, many models are based on non-parametric approaches where the structure of model is not specified or unknown, additivity is not expected, and assumptions about normal distributions, linearity or residuals, for example, are not needed for modeling [10].
The purpose of ML is predictive performance using general purpose learning algorithms to find patterns that are less known, unrelated, and in complex data without a priori view of underlying structures [10]. Whereas in statistical modeling, consideration for inferences, correlations, and the effects of a small number of variables are drivers [12].
Due to the differences in the methods’ characteristics, it is important to understand the variations in application of the techniques when solving healthcare problems. For example, one typical application of statistics is to analyze whether a population has a particular medical condition. For some diseases such as diabetes, the condition is easily screened for and diagnosed using distinct lab values, such as elevated and increasing HbA1C over time, high glucose levels and low insulin levels, often due to insulin depletion occurring from unmanaged diabetes. Also conditions such as hypertension can easily be detected at home or in the healthcare provider’s office using simple blood pressure measurement and monitoring, and wearables can identify when patients are experiencing atrial fibrillation, abnormal heart rhythms and even increased patient falls (possible syncope). Therefore, analyses of patients with these easily measurable conditions can be done simply by qualifying patients based on lab values or biomarkers falling within or outside of certain ranges. One of the simplest examples is identifying patients with diabetes [13]. This can be accomplished by using A1C levels to group patients as having no diabetes (A1C < 5.7), pre-diabetes (AIC of 5.7–6.4), or diabetes (A1C > 6.4). These ranges are based on American Diabetes Association Diagnosis Guidelines and a very high, medically accepted correlation between AIC levels and the diagnosis of diabetes [14].
On the other hand, if the objective of the research is to predict which pre-diabetic patients are most likely to progress to diabetes, a myriad of factors influence diabetes progression including extent of chronic kidney disease, high blood pressure, insulin levels over time, body mass index/obesity, age, years with diabetes, success of prior therapy, number and types of prior therapies, family history, coronary artery disease, prior cardiovascular events, infections, etc. A complicated combination of comorbidities, risk factors, and patient behavior can lead to differing diabetes complications and varying outcomes makes prediction more challenging and thus it represents a good candidate for the use of machine learning techniques. Classification models such as gradient boosting tree algorithms have been used to successfully predict diabetes progression, especially earlier in the disease. While there any many diabetes risk factors and co-morbidities, these disease characteristics are well studied over many years, thus enabling stable predictive models which perform well over time [14].
Overall, machine learning is highly effective when the model uses more than a handful of independent variables/features [10]. ML is required when the number of features (p) is larger than the number of records or observations (n) – this is called the curse of dimensionality [15, 16], which increases the risk of overfitting, but can be overcome with dimensionality reductive techniques (i.e., PCA), as part of modeling [15] and clinical/expert input on the importance or lack thereof of certain features, is it relates to the disease or its treatment. Additionally, statistical learning theory teaches that learning algorithms increase their ability to translate complex structures from data at a greater and faster rate than the increase of sample size capture can alone provide [8]. Therefore, statistical learning theory and ML offer methods for addressing high-dimensional data or big data (high velocity, volume and variety) and smaller sample sizes [17], such as recursive feature elimination and support vector machines, boosting, or cross validation which can also minimize prediction error [18].
In the healthcare industry, machine learning models are frequently used in cancer prediction, generally in three areas: (1) predicting a patient with a cancer prognosis/diagnosis, (2) predicting cancer progression, and (3) predicting cancer mortality. Of these, predicting whether a patient may have a cancer prognosis/diagnosis can be more or less difficult depending on the tumor type. Certain cancers such as lung cancer, breast cancer, prostate cancer, and skin cancer are evaluated based on specific signs and symptoms, and non-invasive imaging or blood tests. These cancers are easier to predict. Conversely, cancers with non-descript symptoms such fatigue, dizziness, GI pain and distress, and lack of appetite are much more difficult to predict even with machine learning models as these symptoms are associated with multiple tumor types (for example esophageal, stomach, bladder, liver, and pancreatic cancer) and also mimic numerous other conditions [14].
For cancers with vague symptoms, understanding the patient journey is very important to cancer prediction. If a prediction period is too long and does not reflect the time period before diagnosis when symptoms develop, the model may overfit due to spurious variables not related to the condition. If the prediction period is too short, key risk factors from the patient record could be missing. Variable pruning is required in these situations. A multi-disciplinary team including business and clinical experts can help trim unrelated variables and improve model performance [14].
Model validation is an inherent part of the ML process where the data is split into training data and test data, with the larger portion of data used to train the model to learn outputs based on known inputs. This process allows for rapid structure knowledge for primary focus on building the ability to predict future outcomes [15]. Beyond initial validation of the model within the test data set, the model should be further tested in the real world using a large, representative, and more recent sample of data [19]. This can be accomplished by using the model to score the eligible population and using a look forward period to assess incidence or prevalence of the desired outcome. If the model is performing well, probability scores should be directly correlated to incidence/prevalence (the higher the probability score, the higher the incidence/prevalence). Model accuracy, precision, and recall can also be assessed using this approach [20].
Epidemiology studies and prior published machine learning research in related areas of healthcare can help benchmark the performance of the model relative to the baseline prevalent or incident population for the condition to be predicted. Machine learning models created using a few hundred or thousand patients often do not perform as well in the real world. Careful variable pruning, cohort refinement and adjustment of modeling periods can often resolve model performance problems. Newer software can be used to more quickly build, test, and iterate models, allowing users to easily transform and combine features as well as run many models simultaneously and visualize model performance, diagnosis and solve model issues [21].
5. How to choose between machine learning and statistical modeling
Machine learning algorithms are a preferred choice of technique vs. a statistical modeling approach under specific circumstances, data configurations, and outcomes needed.
5.1 Importance of prediction over causal relationships
As noted above, machine learning algorithms are leveraged for prediction of the outcome rather than present the inferential and causal relationship between the outcome and independent variables/data elements [17, 22]. Once a model has been created, statistical analysis can sometime elucidate and validate the importance and relationship between independent and dependent variables.
5.2 Application of wide and big dataset(s)
Machine Learning algorithms are learner algorithms and learn on large amount of data often presented by a large number of data elements, but not necessarily with many observations [23]. Ability of multiple replications of samples, cross validation or application of boot strapping techniques for machine learning allows for wide datasets with many data elements and few observations, which is extremely helpful in predicting rare disease onset [24] as long as the process is accompanied with real world testing to ensure the models are not suffering from overfitting [18, 19]. With the advent of less expensive and more powerful computing power and storage, multialgorithm, ensembled models using larger cohorts can be more efficiently built. Larger modeling samples that are more representative of the overall population can help reduce the likelihood of overfitting or underfitting [25]. A large cohort imposes various issues and of priority is the ability to identify the set of independent variables that are most meaningful and impactful. These significant independent variables provide a predictive and/or inferential model that can be readily acceptable in providing a real-world application. The variables in such instances may also result into more realistic magnitude and direction of the causal relationship between the independent and outcomes variables of interest.
A recent example for a real-world example in healthcare for machine learning algorithm application is to identify the likelihood of hospitalization for high-risk patients diagnosed with Covid 19. The dataset leveraged included over 20,000 independent variables across healthcare claims data for diagnostics and treatment variables. The best optimal ML model consisted of approximately 200 important predictors variables such as age, diagnosis like Type 2 diabetes/CKD/Hypertension, frequency of office visits, Obesity amongst others. None of the variables in this example were ‘new’, however, the magnitude and direction as a result of the ML exercise may illustrate the ‘true’ impact of each independent variable, a feature that is a serious limitation in traditional statistical modeling [26].
Furthermore, as explained above, statistical models tend to not operate well on very large datasets and often require manageable datasets with a fewer number of pre-defined attributes/data elements for analysis [23]. The recommended number of attributes is up to 12 in a statistical model, because these techniques are highly prone to overfitting [25]. This limitation creates a challenge when analyzing large healthcare datasets and require application of dimension reduction techniques or expert guidance in allowing to eliminate the number of independent variables in the study [23].
5.3 Limited data and model assumptions are required
In machine learning algorithms, there are fewer assumptions that need to be made on the dataset and the data elements [5]. However, a good model is usually preceded by profiling of the target and control groups and some knowledge of the domain. Understanding relationships within the data improve outcomes and interpretability [27].
Machine learning algorithms are comparatively more flexible than statistical models, as they do not require making assumptions regarding collinearity, normal distribution of residuals, etc. [5]. Thus, they have a high tolerance for uncertainty in variable performance (e.g., confidence intervals, hypothesis tests [28]. In statistical modeling emphasis is put in uncertainty estimates, furthermore, a variety of assumptions have to be satisfied before the outcome from a statistical model can be trusted and applied [28]. As a result, the statistical models have a low uncertainty tolerance [25].
Machine learning algorithms tend to be preferred over statistical modeling when the outcome to be predicted does not have a strong component of randomness, e.g., in visual pattern recognition an object must be an E or not an E [5], and when the learning algorithm can be trained on an unlimited number of exact replications [29].
ML is also appropriate when the overall prediction is the goal, with less visibility to describe the impact of any one independent variable or the relationships between variables [30], and when estimating uncertainty in forecasts or in effects of selected predictors is not a requirement [28]. However, often data scientists and data analysts leverage regression analytics to understand the estimated impact, including directionality of the relationships between the outcome and data elements, to help with model interpretation, relevance, and validity for the studied [27]. ML is also preferred when the dataset is wide and very large [23] with underlying variables are not fully known and previously described [5].
6. Machine learning extends statistics
Machine learning requires no prior assumptions about the underlying relationships between the data elements. It is generally applied to high dimensional data sets and does not require many observations to create a working model [5]. However, understanding the underlying data will support building representative modeling cohorts, deriving features relevant for the disease state and population of interest, as well as understanding how to interpret modeling results [19, 27].
In contrast, statistical model requires a deeper understanding how the data was collected, statistical properties of the estimator (p-value, unbiased estimators), the underlying distribution of the population, etc. [17]. Statistical modeling techniques are usually applied to low dimensional data sets [25].
7. Machine learning can extend the utility of statistical modeling
Robert Tibshirani, a statistician and machine learning expert at Stanford University, calls machine learning “glorified statistics,” which presents the dependence of machine learning techniques on statistics in a successful execution that not only allows for a high level of prediction, but interpretation of the results to ensure validity and applicability of the results in the healthcare [17]. Understanding the association and knowing their differences enables data scientists and statisticians to expand their knowledge and apply variety of methods outside their domain of expertise. This is the notion of “data science,” which aims to bridge the gap between the areas as well as bring other important to consider aspects of research [5]. Data science is evolving beyond statistics or more simple ML approaches to incorporate self-learning and autonomy with the ability to interpret context, assess and fill in data gaps, and make modeling adjustment over time [31]. While these modeling approaches are not perfect and more difficult to interpret, they provide exciting new options for difficult to solve problems, especially where the underlying data or environment is rapidly changing [27].
Collaboration and communication between not only data scientists and statisticians but also medical and clinical experts, public policy creators, epidemiologists, etc. allows for designing successful research studies that not only provide predictions and insights on relationships between the vast amount of data elements and health outcomes [30], but also allow for valid, interpretable and relevant results that can be applied with confidence to the project objectives and future deployment in the real [30, 32].
Finally, it is important to remember that machine learning foundations are based in statistical theory and learning. It may seem machine learning can be done without a sound statistical background, but this leads to not really understanding the different nuances in the data and presented results [17]. Well written machine learning code does not negate the need for an in-depth understanding of the problem, assumptions, and the importance of interpretation and validation [29].
8. Specific examples in healthcare
As mentioned earlier in the chapter, machine learning algorithms can be leveraged in the healthcare industry to help evaluate a continuum of access, diagnostic and treatment outcomes, including prediction of patient diagnoses, treatment, adverse events, side effects, and improved quality of life as well as lower mortality rates [24].
As shown in Figure 1, often these algorithms can be helpful in predicting a variety of disease conditions and shortening the time from awareness to diagnosis and treatment, especially in rare and underdiagnosed conditions, estimate the ‘true’ market size, predicting disease progression such as identifying fast vs. slow progressing patients as well as determinants of suitable next line change [32]. Finally, the models can be leveraged for patient and physician segmentation and clustering to identify appropriate targets for in-person and non-personal promotion [30].
Figure 1.
Examples of Machine Learning Applications in Healthcare Analytics [22].
There are, however, instances in which machine learning might not be the right tool to leverage, including when the condition or the underlying condition have a few known variables, when the market is mature and has known predetermined diagnostic and treatment algorithm, and when understanding correlations and inference is more important than making prediction [5].
One aspect of the machine learning process is to involve a cross functional team of experts in the healthcare area to ensure that the questions and problem statement along with hypothesis are properly set up [33, 34]. Many therapeutic areas require in-depth understanding of the clinical and medical concepts (i.e., diagnostic process, treatment regimens, potential adverse effects, etc.), which can help with the research design and selection of the proper analytical techniques. If the expert knowledge is not considered or properly captured in the research design, it might lead to irrelevant, invalid, and biased results, and ultimately invalidate the entire research study [33, 34].
9. A practical guide to the predominant approach
Using a real example of a project with the goal of predicting the risk of hypertension due to underlying comorbid conditions or induced by medication, the decision to lead with machine learning vs. statistical modeling can be based on explicit criteria that can be weighed and ranked based on the desired outcome of the work [17, 32]. Please see Figure 2 presenting an example of the approach.
Figure 2.
Criteria for Choosing the Predominant Approach for a Project.
As shown in Figure 2, pending the research objectives, machine learning or statistical modeling or both techniques could be the right method(s) to apply. For example, shifts in market trends, including shifts in patient volume of diagnosis and treatment present a suitable example when a statistical modeling type of analysis should be utilized. On the other hand, trying to predict patients with a high risk for hypertension requires the utilization of ML approaches. Leveraging both methods is best suited when predictive power and explanatory reasoning is needed to understand the important factors driving the outcome and their relative magnitudes and inferences.
10. Conclusions
Machine learning requires fewer assumptions about the underlying relationships between the data elements. It is generally applied to high dimensional data sets and require fewer observations to create a working model [5]. In contrast, statistical model requires an understanding of how the data was collected, statistical properties of the estimator (p-value, unbiased estimators), the underlying distribution of the population, etc. [17]. Statistical modeling techniques are usually applied to low dimensional data sets [25]. Statistical modeling and ML are not at odds but rather complementary approaches that offer choice of techniques based on need and desired outcomes. Data scientists and analysts should not necessarily have to choose between either machine learning or statistical modeling as a mutually exclusive decision tree. Instead, selected approaches from both areas should be considered as both types of methodologies are based on the same mathematical principles but expressed somewhat differently [5, 10].
Note: This book chapter was originally posted on the Cornell University’s research working paper website: https://arxiv.org. The content of the book chapter is mostly the same compared to the version posted on https://arxiv.org [6].
Conflict of interest
The authors declare no conflict of interest.
Funding
Authors work for Symphony Health, ICON plc Organization.
\n',keywords:"machine learning, statistical modeling, data science, healthcare analytics, research design",chapterPDFUrl:"https://cdn.intechopen.com/pdfs/82063.pdf",chapterXML:"https://mts.intechopen.com/source/xml/82063.xml",downloadPdfUrl:"/chapter/pdf-download/82063",previewPdfUrl:"/chapter/pdf-preview/82063",totalDownloads:6,totalViews:0,totalCrossrefCites:0,dateSubmitted:"February 14th 2022",dateReviewed:"May 2nd 2022",datePrePublished:"May 31st 2022",datePublished:null,dateFinished:"May 31st 2022",readingETA:"0",abstract:"Data scientists and statisticians are often at odds when determining the best approaches and choosing between machine learning and statistical modeling to solve their analytical challenges and problem statements across industries. However, machine learning and statistical modeling are actually more closely related to each other rather than being on different sides of an analysis battleground. The decision on which approach to choose is often based on the problem at hand, expected outcome(s), real world application of the results and insights, as well as the availability and granularity of data for the analysis. Overall machine learning and statistical modeling are complementary techniques that are guided on similar mathematical principles, but leverage different tools to arrive at insights. Determining the best approach should consider the problem to be solved, empirical evidence and resulting hypothesis, data sources and their completeness, number of variables/data elements, assumptions, and expected outcomes such as the need for predictions or causality and reasoning. Experienced analysts and data scientists are often well versed in both types of approaches and their applications, hence use best suited tools for their analytical challenges. Due to the importance and relevance of the subject in the current analytics environment, this chapter will present an overview of each approach as well as outline their similarities and differences to provide the needed understanding when selecting the proper technique for problems at hand. Furthermore, the chapter will also provide examples of applications in the healthcare industry and outline how to decide which approach is best when analyzing healthcare data. Understanding of the best suited methodologies can help the healthcare industry to develop and apply advanced analytical tools to speed up the diagnostic and treatment processes as well as improve the quality of life for their patients.",reviewType:"peer-reviewed",bibtexUrl:"/chapter/bibtex/82063",risUrl:"/chapter/ris/82063",signatures:"Michele Bennett, Ewa J. Kleczyk, Karin Hayes and Rajesh Mehta",book:{id:"11422",type:"book",title:"Machine Learning and Data Mining - Annual Volume 2022",subtitle:null,fullTitle:"Machine Learning and Data Mining - Annual Volume 2022",slug:null,publishedDate:null,bookSignature:"Dr. Marco Antonio Aceves Fernandez",coverURL:"https://cdn.intechopen.com/books/images_new/11422.jpg",licenceType:"CC BY 3.0",editedByType:null,isbn:"978-1-80355-289-7",printIsbn:"978-1-80355-288-0",pdfIsbn:"978-1-80355-290-3",isAvailableForWebshopOrdering:!0,editors:[{id:"24555",title:"Dr.",name:"Marco Antonio",middleName:null,surname:"Aceves Fernandez",slug:"marco-antonio-aceves-fernandez",fullName:"Marco Antonio Aceves Fernandez"}],productType:{id:"5",title:"Annual Volume",chapterContentType:"chapter",authoredCaption:"Authored by"}},authors:null,sections:[{id:"sec_1",title:"1. Introduction",level:"1"},{id:"sec_2",title:"2. Machine learning foundation is in statistical learning theory",level:"1"},{id:"sec_3",title:"3. Similarities between machine learning and statistical modeling",level:"1"},{id:"sec_4",title:"4. Differences between machine learning and statistical modeling",level:"1"},{id:"sec_5",title:"5. How to choose between machine learning and statistical modeling",level:"1"},{id:"sec_5_2",title:"5.1 Importance of prediction over causal relationships",level:"2"},{id:"sec_6_2",title:"5.2 Application of wide and big dataset(s)",level:"2"},{id:"sec_7_2",title:"5.3 Limited data and model assumptions are required",level:"2"},{id:"sec_9",title:"6. Machine learning extends statistics",level:"1"},{id:"sec_10",title:"7. Machine learning can extend the utility of statistical modeling",level:"1"},{id:"sec_11",title:"8. Specific examples in healthcare",level:"1"},{id:"sec_12",title:"9. A practical guide to the predominant approach",level:"1"},{id:"sec_13",title:"10. Conclusions",level:"1"},{id:"sec_18",title:"Conflict of interest",level:"1"},{id:"sec_14",title:"Funding",level:"1"}],chapterReferences:[{id:"B1",body:'Beam AL, Kohane IS. Big data and machine learning in health care. JAMA. 2018;19(13):1317-1318. DOI: 10.1001/jama.2017.18391'},{id:"B2",body:'Shelmerdine et al. Review of study reporting guidelines for clinical studies using artificial intelligence in healthcare. BMJ Health & Care Informatics. 2021;28(1):e100385. DOI: 10.1136/bmjhci-2021-100385'},{id:"B3",body:'Romano R, Gambale E. Statistics and medicine: The indispensable know-how of the researcher. Translational Medicine @UniSa. 2013;5:28-31'},{id:"B4",body:'Razzak et al. Big data analytics for preventive medicine. Neural Computing and Application. 2020;32:4417-4451. DOI: 10.1007/s00521-019-04095-y'},{id:"B5",body:'Bzdok D, Altman N, Krzywiniski M. Statistics versus machine learning. Nature Methods. 2018;15(4):233-234. DOI: 0.1038/nmeth.4642'},{id:"B6",body:'Bennett M, Hayes K, Kleczyk EJ, Mehta R. Analytics in healthcare: Similarities and differences between machine learning and traditional advanced statistical modeling. Cornell University. 2022:1-16. Available from: https://arxiv.org/abs/2201.02469'},{id:"B7",body:'Von Luxburg U, Scholkopf B. Inductive logic. In: Handbook and History of Logic. Vol. 10. New York: Elsevier; 2011'},{id:"B8",body:'Bousquet et al. Introduction to Statistical Learning. 2003. Available from: http://www.econ.upf.edu/~lugosi/mlss_slt.pdf'},{id:"B9",body:'Field A. Discovering Statistics Using R. London: Sage; 2012'},{id:"B10",body:'Carmichael I, Marron JS. Data science vs. statistics: Two cultures? Japanese Journal of Statistics and Data Science. 2018;1(1):117-138'},{id:"B11",body:'Cahn A, Shoshan A, Sagiv T, Yesharim R, Goshen R, Shalev V, et al. Prediction of progression from pre-diabetes to diabetes: Development and validation of a machine learning model. Diabetes/Metabolism Research and Reviews. 2020;36(2):e3252. DOI: 10.1002/dmrr.3252 Epub 2020 Jan 14'},{id:"B12",body:'Breiman L. Statistical modeling: The two cultures (with comments and a rejoinder by the author). Statistical Science. 2001;16(3):199-231'},{id:"B13",body:'Mehta R, Uppunuthula S. Use of machine learning techniques to identify the likelihood of hospitalization for high-risk patients diagnosed with COVID-19. In: ISPOR Conference; Washington DC. 2022'},{id:"B14",body:'American Diabetes Association. Understanding A1C Diagnosis. 2022. Available from: https://www.diabetes.org/diabetes/a1c/diagnosis#:~:text=Diabetes%20is%20diagnosed%20at%20fasting,equal%20to%20126%20mg%2Fdl'},{id:"B15",body:'Bzdok et al. Machine learning: A primer. Nature Methods. 2017;14(12):1119-1120. DOI: 10.1038/nmeth.4526'},{id:"B16",body:'Bellman RE. Adaptive Control Processes. Princeton, NJ: Princeton University Press; 1961'},{id:"B17",body:'Hastie T, Tibshirani R, Friedman J. The Elements of Statistical Learning: Data Mining, Inference, and Prediction (2ed). Stanford, CA: Springer; 2016'},{id:"B18",body:'Chapman et al. Statistical learning theory for high dimensional prediction: Application to criterion-keyed scale development. Psychology Methods. 2016;21(4):603-620. DOI: 10.1037/met0000088'},{id:"B19",body:'Argent et al. The importance of real-world validation of machine learning systems in wearable exercise biofeedback platforms: A case study. Sensors (Basel). 2021;21(7):2346. DOI: 10.3390/s21072346'},{id:"B20",body:'Parikh et al. Understanding and using sensitivity, specificity and predictive values. Indian Journal of Ophthalmology. 2008;56(1):45-50. DOI: 10.4103/0301-4738.37595'},{id:"B21",body:'Mendis A. Statistical Modeling vs. Machine Learning. 2019. Available from: https://www.kdnuggets.com/2019/08/statistical-modelling-vs-machine-learning.html'},{id:"B22",body:'Hayes K, Rajabathar R, Balasubramaniam V. Uncovering the machine learning “Black Box”: Discoveringlatent patient insights using text mining & machine learning. In: Conference Paper Presented at Innovation in Analytics via Machine Learning & AI; Las Vegas, NV. 2019 Available from: https://www.pmsa.org/other-events/past-symposia'},{id:"B23",body:'Belabbas M, Wolfe PJ. Spectral methods in machine learning and new strategies for very large datasets. Proceedings of the National Academy of Sciences. 2009;106(2):369-374. DOI: 10.1073/pnas.0810600105'},{id:"B24",body:'Kempa-Liehr et al. Healthcare pathway discovery and probabilistic machine learning. International Journal of Medical Informatics. 2020;137:104087. DOI: 10.1016/j.ijmedinf.2020.104087'},{id:"B25",body:'Wasserman L. Rise of the machines. In: Past, Present, and Future of Statistical Science. Chapman and Hall; 2013. pp. 1-12. DOI: 10.1201/b16720-49'},{id:"B26",body:'Ranjan R. Calibration in machine learning. 2019. Available from: https://medium.com/analytics-vidhya/calibration-in-machine-learning-e7972ac93555'},{id:"B27",body:'Child CM, Washburn NR. Embedding domain knowledge for machine learning of complex material systems. MRS Communications. 2019;9(3):806-820. DOI: 10.1557/mrc.2019.90'},{id:"B28",body:'Hilliermeir E, Waegerman W. Aleatoric and epistemic uncertainty in machine learning: An introduction to concepts and methods. Machine Learning. 2021;110:457-506. DOI: 10.1007/s10994-021-05946-3'},{id:"B29",body:'Goh et al. Evaluating human versus machine learning performance in classifying research abstracts. Scientometrics. 2020;125:1197-1212. DOI: 10.1007/s11192-020-03614-2'},{id:"B30",body:'Chicco D, Jutman G. The advantages of the Matthews correlation coefficient (MCC) over F1 score and accuracy in binary classification evaluation. BMC Genomics. 2020;21(6). DOI: /10.1186/s12864-019-6413-7'},{id:"B31",body:'Ansari et al. Rethinking human-machine learning in Industry 4.0: How does the paradigm shift treat the role of human learning? Procedia Manufacturing. 2018;23:117-122. DOI: 10.1016/j.promfg.2018.04.003'},{id:"B32",body:'Morganstein et al. Predicting population health with machine learning: A scoping review. BMJ Open. 2020;10(10). DOI: 10.1136/bmjopen-2020-037860'},{id:"B33",body:'Terranova et al. Application of machine learning in translational medicine: Current status and future opportunities. The AAPS Journal. 2021;23(74). DOI: 10.1208/s12248-021-00593-x'},{id:"B34",body:'Kleczyk E, Hayes K, Bennett M. Building organization AI and ML acumen during the COVID Era. 2022. In: PMSA Annual Conference. Louisville, KY. 2022'}],footnotes:[],contributors:[{corresp:null,contributorFullName:"Michele Bennett",address:null,affiliation:'
Symphony Health, ICON, plc Organization, USA
Data Science, Computer Science, and Business Analytics, Grand Canyon University, USA
'},{corresp:"yes",contributorFullName:"Ewa J. Kleczyk",address:"ewa.kleczyk@symphonyhealth.com",affiliation:'
Symphony Health, ICON, plc Organization, USA
The School of Economics, The University of Maine, USA
'}],corrections:null},book:{id:"11422",type:"book",title:"Machine Learning and Data Mining - Annual Volume 2022",subtitle:null,fullTitle:"Machine Learning and Data Mining - Annual Volume 2022",slug:null,publishedDate:null,bookSignature:"Dr. Marco Antonio Aceves Fernandez",coverURL:"https://cdn.intechopen.com/books/images_new/11422.jpg",licenceType:"CC BY 3.0",editedByType:null,isbn:"978-1-80355-289-7",printIsbn:"978-1-80355-288-0",pdfIsbn:"978-1-80355-290-3",isAvailableForWebshopOrdering:!0,editors:[{id:"24555",title:"Dr.",name:"Marco Antonio",middleName:null,surname:"Aceves Fernandez",slug:"marco-antonio-aceves-fernandez",fullName:"Marco Antonio Aceves Fernandez"}],productType:{id:"5",title:"Annual Volume",chapterContentType:"chapter",authoredCaption:"Authored by"}}},profile:{item:{id:"215438",title:"Prof.",name:"Seung Jun",middleName:null,surname:"Kwon",email:"jjuni98@hnu.kr",fullName:"Seung Jun Kwon",slug:"seung-jun-kwon",position:null,biography:null,institutionString:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",totalCites:0,totalChapterViews:"0",outsideEditionCount:0,totalAuthoredChapters:"1",totalEditedBooks:"0",personalWebsiteURL:null,twitterURL:null,linkedinURL:null,institution:null},booksEdited:[],chaptersAuthored:[{id:"58232",title:"Corrosion Inhibitors for Reinforced Concrete: A Review",slug:"corrosion-inhibitors-for-reinforced-concrete-a-review",abstract:"The objective of the topic is to review the recent trends in corrosion inhibitors for reinforced concrete and their application in the laboratory and field conditions. Inhibitors are chemical substances which when added to the concrete in small concentrations will inhibit or prolong the time to initiation of corrosion in concrete structures. This chapter focuses on the type of inhibitors used in concrete based upon their mode of action and the way of application. The section deals with anodic, cathodic, mixed inhibitors; performance of admixed inhibitor vs. migrating/surface applied inhibitor and their evaluation studies; and electrochemical injection of corrosion inhibitor (EICI) in concrete and electrochemical chloride extraction techniques has been reviewed.",signatures:"Han-Seung Lee, Velu Saraswathy, Seung-Jun Kwon and Subbiah\nKarthick",authors:[{id:"181893",title:"Dr.",name:"Saraswathy",surname:"V",fullName:"Saraswathy V",slug:"saraswathy-v",email:"corrsaras@gmail.com"},{id:"215347",title:"Prof.",name:"Han Seung",surname:"Lee",fullName:"Han Seung Lee",slug:"han-seung-lee",email:"ercleehs@hanyang.ac.kr"},{id:"215438",title:"Prof.",name:"Seung Jun",surname:"Kwon",fullName:"Seung Jun Kwon",slug:"seung-jun-kwon",email:"jjuni98@hnu.kr"},{id:"215440",title:"MSc.",name:"Subbiah",surname:"Karthick",fullName:"Subbiah Karthick",slug:"subbiah-karthick",email:"karthick.chemistry@gmail.com"}],book:{id:"6402",title:"Corrosion Inhibitors, Principles and Recent Applications",slug:"corrosion-inhibitors-principles-and-recent-applications",productType:{id:"1",title:"Edited Volume"}}}],collaborators:[{id:"181893",title:"Dr.",name:"Saraswathy",surname:"V",slug:"saraswathy-v",fullName:"Saraswathy V",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"National Institute of Technology",institutionURL:null,country:{name:"Norway"}}},{id:"214114",title:"Dr.",name:"Shimaa",surname:"Ali",slug:"shimaa-ali",fullName:"Shimaa Ali",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Taibah University",institutionURL:null,country:{name:"Saudi Arabia"}}},{id:"215347",title:"Prof.",name:"Han Seung",surname:"Lee",slug:"han-seung-lee",fullName:"Han Seung Lee",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"215440",title:"MSc.",name:"Subbiah",surname:"Karthick",slug:"subbiah-karthick",fullName:"Subbiah Karthick",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"216069",title:"Mr.",name:"José",surname:"Andrade Neto",slug:"jose-andrade-neto",fullName:"José Andrade Neto",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Federal University of Bahia",institutionURL:null,country:{name:"Brazil"}}},{id:"216070",title:"Dr.",name:"Daniel",surname:"Ribeiro",slug:"daniel-ribeiro",fullName:"Daniel Ribeiro",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"216073",title:"MSc.",name:"Marianna",surname:"Rivetti",slug:"marianna-rivetti",fullName:"Marianna Rivetti",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Federal University of Bahia",institutionURL:null,country:{name:"Brazil"}}},{id:"216075",title:"Mr.",name:"Nilson",surname:"Amorim Júnior",slug:"nilson-amorim-junior",fullName:"Nilson Amorim Júnior",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"216507",title:"Dr.",name:"Khadijah",surname:"Emran",slug:"khadijah-emran",fullName:"Khadijah Emran",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Taibah University",institutionURL:null,country:{name:"Saudi Arabia"}}},{id:"219604",title:"Mrs.",name:"Hamedh",surname:"Al Lehaibi",slug:"hamedh-al-lehaibi",fullName:"Hamedh Al Lehaibi",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null}]},generic:{page:{slug:"OA-publishing-fees",title:"Open Access Publishing Fees",intro:"
The Open Access model is applied to all of our publications and is designed to eliminate subscriptions and pay-per-view fees. This approach ensures free, immediate access to full text versions of your research.
As a gold Open Access publisher, an Open Access Publishing Fee is payable on acceptance following peer review of the manuscript. In return, we provide high quality publishing services and exclusive benefits for all contributors. IntechOpen is the trusted publishing partner of over 140,000 international scientists and researchers.
\\n\\n
The Open Access Publishing Fee (OAPF) is payable only after your book chapter, monograph or journal article is accepted for publication.
\\n\\n
OAPF Publishing Options
\\n\\n
\\n\\t
1,400 GBP Chapter - Edited Volume
\\n\\t
850 GBP Chapter - Book Series Topic (Annual Volume)
\\n\\t
10,000 GBP Monograph - Long Form
\\n\\t
4,000 GBP Compacts Monograph - Short Form
\\n\\t
850 GBP Journal Article (Across Portfolio)
\\n
\\n\\n
During the launching phase journals do not charge an APC, rather they will be funded by IntechOpen.
\\n\\n
*These prices do not include Value-Added Tax (VAT). Residents of European Union countries need to add VAT based on the specific rate in their country of residence. Institutions and companies registered as VAT taxable entities in their own EU member state will not pay VAT as long as provision of the VAT registration number is made during the application process. This is made possible by the EU reverse charge method.
\\n\\n
Services included are:
\\n\\n
\\n\\t
An online manuscript tracking system to facilitate your work
\\n\\t
Personal contact and support throughout the publishing process from your dedicated Author Service Manager
\\n\\t
Assurance that your manuscript meets the highest publishing standards
\\n\\t
English language copyediting and proofreading, including the correction of grammatical, spelling, and other common errors
\\n\\t
XML Typesetting and pagination - web (PDF, HTML) and print files preparation
\\n\\t
Discoverability - electronic citation and linking via DOI
\\n\\t
Permanent and unrestricted online access to your work
\\n
\\n\\n
What isn't covered by the Open Access Publishing Fee?
\\n\\n
If your manuscript:
\\n\\n
\\n\\t
Exceeds the number of pages defined by the publishing guidelines, an additional fee per page may be required
\\n\\t
If a manuscript requires Heavy Editing or Language Polishing, this will incur additional fees.
\\n
\\n\\n
Your Author Service Manager will inform you of any items not covered by the OAPF and provide exact information regarding those additional costs before proceeding.
\\n\\n
Open Access Funding
\\n\\n
To explore funding opportunities and learn more about how you can finance your IntechOpen publication, go to our Open Access Funding page. IntechOpen offers expert assistance to all of its Authors. We can support you in approaching funding bodies and institutions in relation to publishing fees by providing information about compliance with the Open Access policies of your funder or institution. We can also assist with communicating the benefits of Open Access in order to support and strengthen your funding request and provide personal guidance through your application process. You can contact us at funders@intechopen.com for further details or assistance.
\\n\\n
For Authors who are still unable to obtain funding from their institutions or research funding bodies for individual projects, IntechOpen does offer the possibility of applying for a Waiver to offset some or all processing feed. Details regarding our Waiver Policy can be found here.
\\n\\n
Added Value of Publishing with IntechOpen
\\n\\n
Choosing to publish with IntechOpen ensures the following benefits:
\\n\\n
\\n\\t
Indexing and listing across major repositories, see details ...
\\n\\t
Long-term archiving
\\n\\t
Visibility on the world's strongest OA platform
\\n\\t
Live Performance Metrics to track readership and the impact of your chapter
\\n\\t
Dissemination and Promotion
\\n
\\n\\n
Benefits of Publishing with IntechOpen
\\n\\n
\\n\\t
Proven world leader in Open Access book publishing with over 10 years experience
\\n\\t
+5,700 OA books published
\\n\\t
Most competitive prices in the market
\\n\\t
Fully compliant with OA funding requirements
\\n\\t
Optimized processes that assure your research is made available to the scientific community without delay
\\n\\t
Personal support during every step of the publication process
\\n\\t
+184,650 citations in Web of Science databases
\\n\\t
Currently strongest OA platform with over 175 million downloads
As a gold Open Access publisher, an Open Access Publishing Fee is payable on acceptance following peer review of the manuscript. In return, we provide high quality publishing services and exclusive benefits for all contributors. IntechOpen is the trusted publishing partner of over 140,000 international scientists and researchers.
\n\n
The Open Access Publishing Fee (OAPF) is payable only after your book chapter, monograph or journal article is accepted for publication.
\n\n
OAPF Publishing Options
\n\n
\n\t
1,400 GBP Chapter - Edited Volume
\n\t
850 GBP Chapter - Book Series Topic (Annual Volume)
\n\t
10,000 GBP Monograph - Long Form
\n\t
4,000 GBP Compacts Monograph - Short Form
\n\t
850 GBP Journal Article (Across Portfolio)
\n
\n\n
During the launching phase journals do not charge an APC, rather they will be funded by IntechOpen.
\n\n
*These prices do not include Value-Added Tax (VAT). Residents of European Union countries need to add VAT based on the specific rate in their country of residence. Institutions and companies registered as VAT taxable entities in their own EU member state will not pay VAT as long as provision of the VAT registration number is made during the application process. This is made possible by the EU reverse charge method.
\n\n
Services included are:
\n\n
\n\t
An online manuscript tracking system to facilitate your work
\n\t
Personal contact and support throughout the publishing process from your dedicated Author Service Manager
\n\t
Assurance that your manuscript meets the highest publishing standards
\n\t
English language copyediting and proofreading, including the correction of grammatical, spelling, and other common errors
\n\t
XML Typesetting and pagination - web (PDF, HTML) and print files preparation
\n\t
Discoverability - electronic citation and linking via DOI
\n\t
Permanent and unrestricted online access to your work
\n
\n\n
What isn't covered by the Open Access Publishing Fee?
\n\n
If your manuscript:
\n\n
\n\t
Exceeds the number of pages defined by the publishing guidelines, an additional fee per page may be required
\n\t
If a manuscript requires Heavy Editing or Language Polishing, this will incur additional fees.
\n
\n\n
Your Author Service Manager will inform you of any items not covered by the OAPF and provide exact information regarding those additional costs before proceeding.
\n\n
Open Access Funding
\n\n
To explore funding opportunities and learn more about how you can finance your IntechOpen publication, go to our Open Access Funding page. IntechOpen offers expert assistance to all of its Authors. We can support you in approaching funding bodies and institutions in relation to publishing fees by providing information about compliance with the Open Access policies of your funder or institution. We can also assist with communicating the benefits of Open Access in order to support and strengthen your funding request and provide personal guidance through your application process. You can contact us at funders@intechopen.com for further details or assistance.
\n\n
For Authors who are still unable to obtain funding from their institutions or research funding bodies for individual projects, IntechOpen does offer the possibility of applying for a Waiver to offset some or all processing feed. Details regarding our Waiver Policy can be found here.
\n\n
Added Value of Publishing with IntechOpen
\n\n
Choosing to publish with IntechOpen ensures the following benefits:
\n\n
\n\t
Indexing and listing across major repositories, see details ...
\n\t
Long-term archiving
\n\t
Visibility on the world's strongest OA platform
\n\t
Live Performance Metrics to track readership and the impact of your chapter
\n\t
Dissemination and Promotion
\n
\n\n
Benefits of Publishing with IntechOpen
\n\n
\n\t
Proven world leader in Open Access book publishing with over 10 years experience
\n\t
+5,700 OA books published
\n\t
Most competitive prices in the market
\n\t
Fully compliant with OA funding requirements
\n\t
Optimized processes that assure your research is made available to the scientific community without delay
\n\t
Personal support during every step of the publication process
\n\t
+184,650 citations in Web of Science databases
\n\t
Currently strongest OA platform with over 175 million downloads
\n
\n'}]},successStories:{items:[]},authorsAndEditors:{filterParams:{},profiles:[{id:"396",title:"Dr.",name:"Vedran",middleName:null,surname:"Kordic",slug:"vedran-kordic",fullName:"Vedran Kordic",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/396/images/7281_n.png",biography:"After obtaining his Master's degree in Mechanical Engineering he continued his education at the Vienna University of Technology where he obtained his PhD degree in 2004. He worked as a researcher at the Automation and Control Institute, Faculty of Electrical Engineering, Vienna University of Technology until 2008. His studies in robotics lead him not only to a PhD degree but also inspired him to co-found and build the International Journal of Advanced Robotic Systems - world's first Open Access journal in the field of robotics.",institutionString:null,institution:{name:"TU Wien",country:{name:"Austria"}}},{id:"441",title:"Ph.D.",name:"Jaekyu",middleName:null,surname:"Park",slug:"jaekyu-park",fullName:"Jaekyu Park",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/441/images/1881_n.jpg",biography:null,institutionString:null,institution:{name:"LG Corporation (South Korea)",country:{name:"Korea, South"}}},{id:"465",title:"Dr",name:"Christian",middleName:null,surname:"Martens",slug:"christian-martens",fullName:"Christian Martens",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"479",title:"Dr.",name:"Valentina",middleName:null,surname:"Colla",slug:"valentina-colla",fullName:"Valentina Colla",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/479/images/358_n.jpg",biography:null,institutionString:null,institution:{name:"Sant'Anna School of Advanced Studies",country:{name:"Italy"}}},{id:"494",title:"PhD",name:"Loris",middleName:null,surname:"Nanni",slug:"loris-nanni",fullName:"Loris Nanni",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/494/images/system/494.jpg",biography:"Loris Nanni received his Master Degree cum laude on June-2002 from the University of Bologna, and the April 26th 2006 he received his Ph.D. in Computer Engineering at DEIS, University of Bologna. On September, 29th 2006 he has won a post PhD fellowship from the university of Bologna (from October 2006 to October 2008), at the competitive examination he was ranked first in the industrial engineering area. He extensively served as referee for several international journals. He is author/coauthor of more than 100 research papers. He has been involved in some projects supported by MURST and European Community. His research interests include pattern recognition, bioinformatics, and biometric systems (fingerprint classification and recognition, signature verification, face recognition).",institutionString:null,institution:null},{id:"496",title:"Dr.",name:"Carlos",middleName:null,surname:"Leon",slug:"carlos-leon",fullName:"Carlos Leon",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Seville",country:{name:"Spain"}}},{id:"512",title:"Dr.",name:"Dayang",middleName:null,surname:"Jawawi",slug:"dayang-jawawi",fullName:"Dayang Jawawi",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Technology Malaysia",country:{name:"Malaysia"}}},{id:"528",title:"Dr.",name:"Kresimir",middleName:null,surname:"Delac",slug:"kresimir-delac",fullName:"Kresimir Delac",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/528/images/system/528.jpg",biography:"K. Delac received his B.Sc.E.E. degree in 2003 and is currentlypursuing a Ph.D. degree at the University of Zagreb, Faculty of Electrical Engineering andComputing. His current research interests are digital image analysis, pattern recognition andbiometrics.",institutionString:null,institution:{name:"University of Zagreb",country:{name:"Croatia"}}},{id:"557",title:"Dr.",name:"Andon",middleName:"Venelinov",surname:"Topalov",slug:"andon-topalov",fullName:"Andon Topalov",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/557/images/1927_n.jpg",biography:"Dr. Andon V. Topalov received the MSc degree in Control Engineering from the Faculty of Information Systems, Technologies, and Automation at Moscow State University of Civil Engineering (MGGU) in 1979. He then received his PhD degree in Control Engineering from the Department of Automation and Remote Control at Moscow State Mining University (MGSU), Moscow, in 1984. From 1985 to 1986, he was a Research Fellow in the Research Institute for Electronic Equipment, ZZU AD, Plovdiv, Bulgaria. In 1986, he joined the Department of Control Systems, Technical University of Sofia at the Plovdiv campus, where he is presently a Full Professor. He has held long-term visiting Professor/Scholar positions at various institutions in South Korea, Turkey, Mexico, Greece, Belgium, UK, and Germany. And he has coauthored one book and authored or coauthored more than 80 research papers in conference proceedings and journals. His current research interests are in the fields of intelligent control and robotics.",institutionString:null,institution:{name:"Technical University of Sofia",country:{name:"Bulgaria"}}},{id:"585",title:"Prof.",name:"Munir",middleName:null,surname:"Merdan",slug:"munir-merdan",fullName:"Munir Merdan",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/585/images/system/585.jpg",biography:"Munir Merdan received the M.Sc. degree in mechanical engineering from the Technical University of Sarajevo, Bosnia and Herzegovina, in 2001, and the Ph.D. degree in electrical engineering from the Vienna University of Technology, Vienna, Austria, in 2009.Since 2005, he has been at the Automation and Control Institute, Vienna University of Technology, where he is currently a Senior Researcher. His research interests include the application of agent technology for achieving agile control in the manufacturing environment.",institutionString:null,institution:null},{id:"605",title:"Prof",name:"Dil",middleName:null,surname:"Hussain",slug:"dil-hussain",fullName:"Dil Hussain",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/605/images/system/605.jpg",biography:"Dr. Dil Muhammad Akbar Hussain is a professor of Electronics Engineering & Computer Science at the Department of Energy Technology, Aalborg University Denmark. Professor Akbar has a Master degree in Digital Electronics from Govt. College University, Lahore Pakistan and a P-hD degree in Control Engineering from the School of Engineering and Applied Sciences, University of Sussex United Kingdom. Aalborg University has Two Satellite Campuses, one in Copenhagen (Aalborg University Copenhagen) and the other in Esbjerg (Aalborg University Esbjerg).\n· He is a member of prestigious IEEE (Institute of Electrical and Electronics Engineers), and IAENG (International Association of Engineers) organizations. \n· He is the chief Editor of the Journal of Software Engineering.\n· He is the member of the Editorial Board of International Journal of Computer Science and Software Technology (IJCSST) and International Journal of Computer Engineering and Information Technology. \n· He is also the Editor of Communication in Computer and Information Science CCIS-20 by Springer.\n· Reviewer For Many Conferences\nHe is the lead person in making collaboration agreements between Aalborg University and many universities of Pakistan, for which the MOU’s (Memorandum of Understanding) have been signed.\nProfessor Akbar is working in Academia since 1990, he started his career as a Lab demonstrator/TA at the University of Sussex. After finishing his P. hD degree in 1992, he served in the Industry as a Scientific Officer and continued his academic career as a visiting scholar for a number of educational institutions. In 1996 he joined National University of Science & Technology Pakistan (NUST) as an Associate Professor; NUST is one of the top few universities in Pakistan. In 1999 he joined an International Company Lineo Inc, Canada as Manager Compiler Group, where he headed the group for developing Compiler Tool Chain and Porting of Operating Systems for the BLACKfin processor. The processor development was a joint venture by Intel and Analog Devices. In 2002 Lineo Inc., was taken over by another company, so he joined Aalborg University Denmark as an Assistant Professor.\nProfessor Akbar has truly a multi-disciplined career and he continued his legacy and making progress in many areas of his interests both in teaching and research. He has contributed in stochastic estimation of control area especially, in the Multiple Target Tracking and Interactive Multiple Model (IMM) research, Ball & Beam Control Problem, Robotics, Levitation Control. He has contributed in developing Algorithms for Fingerprint Matching, Computer Vision and Face Recognition. He has been supervising Pattern Recognition, Formal Languages and Distributed Processing projects for several years. He has reviewed many books on Management, Computer Science. Currently, he is an active and permanent reviewer for many international conferences and symposia and the program committee member for many international conferences.\nIn teaching he has taught the core computer science subjects like, Digital Design, Real Time Embedded System Programming, Operating Systems, Software Engineering, Data Structures, Databases, Compiler Construction. In the Engineering side, Digital Signal Processing, Computer Architecture, Electronics Devices, Digital Filtering and Engineering Management.\nApart from his Academic Interest and activities he loves sport especially, Cricket, Football, Snooker and Squash. He plays cricket for Esbjerg city in the second division team as an opener wicket keeper batsman. He is a very good player of squash but has not played squash since his arrival in Denmark.",institutionString:null,institution:null},{id:"611",title:"Prof.",name:"T",middleName:null,surname:"Nagarajan",slug:"t-nagarajan",fullName:"T Nagarajan",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universiti Teknologi Petronas",country:{name:"Malaysia"}}}],filtersByRegion:[{group:"region",caption:"North America",value:1,count:6675},{group:"region",caption:"Middle and South America",value:2,count:5955},{group:"region",caption:"Africa",value:3,count:2460},{group:"region",caption:"Asia",value:4,count:12718},{group:"region",caption:"Australia and Oceania",value:5,count:1018},{group:"region",caption:"Europe",value:6,count:17721}],offset:12,limit:12,total:134203},chapterEmbeded:{data:{}},editorApplication:{success:null,errors:{}},ofsBooks:{filterParams:{hasNoEditors:"1",sort:"dateEndThirdStepPublish",src:"ECM",topicId:"8,9,10,11,14,15,17,20,22,24"},books:[{type:"book",id:"11837",title:"Ecology and Geography of the Mediterranean",subtitle:null,isOpenForSubmission:!0,hash:"bbb25987a982d61da4f47fb13614ba3c",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11837.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11858",title:"Terahertz Radiation",subtitle:null,isOpenForSubmission:!0,hash:"f08ee0bf20cd8b5fa772b4752081f2fe",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11858.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11942",title:"Updates on Spatial Audio",subtitle:null,isOpenForSubmission:!0,hash:"f4ac095defb765e0e9bfebc06dac719e",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11942.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11915",title:"Ontology in Information Science",subtitle:null,isOpenForSubmission:!0,hash:"b52397215f6b5e05a22368f629695704",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11915.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11938",title:"Ballistics",subtitle:null,isOpenForSubmission:!0,hash:"9c64ef67aac55216f08c65a2a179835c",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11938.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12070",title:"Knowledge Graphs",subtitle:null,isOpenForSubmission:!0,hash:"96ef2d3d8ee32501d05e295c61640048",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/12070.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12017",title:"Polynomials",subtitle:null,isOpenForSubmission:!0,hash:"1912acc4811b724cc0a15dba11f5af79",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/12017.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12024",title:"UWB Technology",subtitle:null,isOpenForSubmission:!0,hash:"6158349f714de7cee2337adf57b2617d",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/12024.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12022",title:"Statistical Sampling",subtitle:null,isOpenForSubmission:!0,hash:"d95646776d1cb0b10161dc68c9c07781",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/12022.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12025",title:"Cognitive Radio Systems",subtitle:null,isOpenForSubmission:!0,hash:"75b14778d5efbcfe9c1f51d2e31f6aeb",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/12025.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12026",title:"Induction Motor",subtitle:null,isOpenForSubmission:!0,hash:"0273a4ffd6bc66faed9db00380771240",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/12026.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"12027",title:"Optical Fiber",subtitle:null,isOpenForSubmission:!0,hash:"479f515bddf75aa9857e4f0ccf3e7c74",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/12027.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],filtersByTopic:[{group:"topic",caption:"Agricultural and Biological Sciences",value:5,count:30},{group:"topic",caption:"Biochemistry, Genetics and Molecular Biology",value:6,count:7},{group:"topic",caption:"Business, Management and Economics",value:7,count:4},{group:"topic",caption:"Chemistry",value:8,count:14},{group:"topic",caption:"Computer and Information Science",value:9,count:8},{group:"topic",caption:"Earth and Planetary Sciences",value:10,count:10},{group:"topic",caption:"Engineering",value:11,count:24},{group:"topic",caption:"Environmental Sciences",value:12,count:5},{group:"topic",caption:"Immunology and Microbiology",value:13,count:7},{group:"topic",caption:"Materials Science",value:14,count:9},{group:"topic",caption:"Mathematics",value:15,count:5},{group:"topic",caption:"Medicine",value:16,count:83},{group:"topic",caption:"Neuroscience",value:18,count:5},{group:"topic",caption:"Pharmacology, Toxicology and Pharmaceutical Science",value:19,count:6},{group:"topic",caption:"Physics",value:20,count:1},{group:"topic",caption:"Psychology",value:21,count:4},{group:"topic",caption:"Robotics",value:22,count:2},{group:"topic",caption:"Social Sciences",value:23,count:24},{group:"topic",caption:"Technology",value:24,count:1}],offset:12,limit:12,total:74},popularBooks:{featuredBooks:[{type:"book",id:"10858",title:"MOOC (Massive Open Online Courses)",subtitle:null,isOpenForSubmission:!1,hash:"d32f86793bc72dde32532f509b1ec5b0",slug:"mooc-massive-open-online-courses-",bookSignature:"Dragan Cvetković",coverURL:"https://cdn.intechopen.com/books/images_new/10858.jpg",editors:[{id:"101330",title:"Dr.",name:"Dragan",middleName:"Mladen",surname:"Cvetković",slug:"dragan-cvetkovic",fullName:"Dragan Cvetković"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10195",title:"Serotonin and the CNS",subtitle:"New Developments in Pharmacology and Therapeutics",isOpenForSubmission:!1,hash:"7ed9d96da98233a885bd2869a8056c36",slug:"serotonin-and-the-cns-new-developments-in-pharmacology-and-therapeutics",bookSignature:"Berend Olivier",coverURL:"https://cdn.intechopen.com/books/images_new/10195.jpg",editors:[{id:"71579",title:"Prof.",name:"Berend",middleName:null,surname:"Olivier",slug:"berend-olivier",fullName:"Berend Olivier"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10755",title:"Corporate Governance",subtitle:"Recent Advances and Perspectives",isOpenForSubmission:!1,hash:"ffe06d1d5c4bf0fc2e63511825fe1257",slug:"corporate-governance-recent-advances-and-perspectives",bookSignature:"Okechukwu Lawrence Emeagwali and Feyza Bhatti",coverURL:"https://cdn.intechopen.com/books/images_new/10755.jpg",editors:[{id:"196317",title:"Associate Prof.",name:"Okechukwu Lawrence",middleName:null,surname:"Emeagwali",slug:"okechukwu-lawrence-emeagwali",fullName:"Okechukwu Lawrence Emeagwali"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11120",title:"Environmental Impact and Remediation of Heavy Metals",subtitle:null,isOpenForSubmission:!1,hash:"9e77514288e7394f1e6cd13481af3509",slug:"environmental-impact-and-remediation-of-heavy-metals",bookSignature:"Hosam M. Saleh and Amal I. Hassan",coverURL:"https://cdn.intechopen.com/books/images_new/11120.jpg",editors:[{id:"144691",title:"Prof.",name:"Hosam M.",middleName:null,surname:"Saleh",slug:"hosam-m.-saleh",fullName:"Hosam M. Saleh"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10901",title:"Grapes and Wine",subtitle:null,isOpenForSubmission:!1,hash:"5d7f2aa74874444bc6986e613ccebd7c",slug:"grapes-and-wine",bookSignature:"Antonio Morata, Iris Loira and Carmen González",coverURL:"https://cdn.intechopen.com/books/images_new/10901.jpg",editors:[{id:"180952",title:"Prof.",name:"Antonio",middleName:null,surname:"Morata",slug:"antonio-morata",fullName:"Antonio Morata"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11080",title:"Engineering Principles",subtitle:"Welding and Residual Stresses",isOpenForSubmission:!1,hash:"6c07a13a113bce94174b40096f30fb5e",slug:"engineering-principles-welding-and-residual-stresses",bookSignature:"Kavian Omar Cooke and Ronaldo Câmara Cozza",coverURL:"https://cdn.intechopen.com/books/images_new/11080.jpg",editors:[{id:"138778",title:"Dr.",name:"Kavian",middleName:"Omar",surname:"Cooke",slug:"kavian-cooke",fullName:"Kavian Cooke"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11332",title:"Essential Oils",subtitle:"Advances in Extractions and Biological Applications",isOpenForSubmission:!1,hash:"742e6cae3a35686f975edc8d7f9afa94",slug:"essential-oils-advances-in-extractions-and-biological-applications",bookSignature:"Mozaniel Santana de Oliveira and Eloisa Helena de Aguiar Andrade",coverURL:"https://cdn.intechopen.com/books/images_new/11332.jpg",editors:[{id:"195290",title:"Ph.D.",name:"Mozaniel",middleName:null,surname:"Santana De Oliveira",slug:"mozaniel-santana-de-oliveira",fullName:"Mozaniel Santana De Oliveira"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11029",title:"Hepatitis B",subtitle:null,isOpenForSubmission:!1,hash:"609701f502efc3538c112ff47a2c2119",slug:"hepatitis-b",bookSignature:"Luis Rodrigo",coverURL:"https://cdn.intechopen.com/books/images_new/11029.jpg",editors:[{id:"73208",title:"Prof.",name:"Luis",middleName:null,surname:"Rodrigo",slug:"luis-rodrigo",fullName:"Luis Rodrigo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9537",title:"Human Rights in the Contemporary World",subtitle:null,isOpenForSubmission:!1,hash:"54f05b93812fd434f3962956d6413a6b",slug:"human-rights-in-the-contemporary-world",bookSignature:"Trudy Corrigan",coverURL:"https://cdn.intechopen.com/books/images_new/9537.jpg",editors:[{id:"197557",title:"Dr.",name:"Trudy",middleName:null,surname:"Corrigan",slug:"trudy-corrigan",fullName:"Trudy Corrigan"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11371",title:"Cerebral Circulation",subtitle:"Updates on Models, Diagnostics and Treatments of Related Diseases",isOpenForSubmission:!1,hash:"e2d3335445d2852d0b906bb9750e939f",slug:"cerebral-circulation-updates-on-models-diagnostics-and-treatments-of-related-diseases",bookSignature:"Alba Scerrati, Luca Ricciardi and Flavia Dones",coverURL:"https://cdn.intechopen.com/books/images_new/11371.jpg",editors:[{id:"182614",title:"Dr.",name:"Alba",middleName:null,surname:"Scerrati",slug:"alba-scerrati",fullName:"Alba Scerrati"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11012",title:"Radiopharmaceuticals",subtitle:"Current Research for Better Diagnosis and Therapy",isOpenForSubmission:!1,hash:"f9046d6f96148b285e776f384991120d",slug:"radiopharmaceuticals-current-research-for-better-diagnosis-and-therapy",bookSignature:"Farid A. Badria",coverURL:"https://cdn.intechopen.com/books/images_new/11012.jpg",editors:[{id:"41865",title:"Prof.",name:"Farid A.",middleName:null,surname:"Badria",slug:"farid-a.-badria",fullName:"Farid A. Badria"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9974",title:"E-Learning and Digital Education in the Twenty-First Century",subtitle:null,isOpenForSubmission:!1,hash:"88b58d66e975df20425fc1dfd22d53aa",slug:"e-learning-and-digital-education-in-the-twenty-first-century",bookSignature:"M. Mahruf C. Shohel",coverURL:"https://cdn.intechopen.com/books/images_new/9974.jpg",editors:[{id:"94099",title:"Dr.",name:"M. Mahruf C.",middleName:null,surname:"Shohel",slug:"m.-mahruf-c.-shohel",fullName:"M. Mahruf C. Shohel"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:12,limit:12,total:4433},hotBookTopics:{hotBooks:[],offset:0,limit:12,total:null},publish:{},publishingProposal:{success:null,errors:{}},books:{featuredBooks:[{type:"book",id:"10858",title:"MOOC (Massive Open Online Courses)",subtitle:null,isOpenForSubmission:!1,hash:"d32f86793bc72dde32532f509b1ec5b0",slug:"mooc-massive-open-online-courses-",bookSignature:"Dragan Cvetković",coverURL:"https://cdn.intechopen.com/books/images_new/10858.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:1677,editors:[{id:"101330",title:"Dr.",name:"Dragan",middleName:"Mladen",surname:"Cvetković",slug:"dragan-cvetkovic",fullName:"Dragan Cvetković"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10195",title:"Serotonin and the CNS",subtitle:"New Developments in Pharmacology and Therapeutics",isOpenForSubmission:!1,hash:"7ed9d96da98233a885bd2869a8056c36",slug:"serotonin-and-the-cns-new-developments-in-pharmacology-and-therapeutics",bookSignature:"Berend Olivier",coverURL:"https://cdn.intechopen.com/books/images_new/10195.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:1337,editors:[{id:"71579",title:"Prof.",name:"Berend",middleName:null,surname:"Olivier",slug:"berend-olivier",fullName:"Berend Olivier"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10755",title:"Corporate Governance",subtitle:"Recent Advances and Perspectives",isOpenForSubmission:!1,hash:"ffe06d1d5c4bf0fc2e63511825fe1257",slug:"corporate-governance-recent-advances-and-perspectives",bookSignature:"Okechukwu Lawrence Emeagwali and Feyza Bhatti",coverURL:"https://cdn.intechopen.com/books/images_new/10755.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:1309,editors:[{id:"196317",title:"Associate Prof.",name:"Okechukwu Lawrence",middleName:null,surname:"Emeagwali",slug:"okechukwu-lawrence-emeagwali",fullName:"Okechukwu Lawrence Emeagwali"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11120",title:"Environmental Impact and Remediation of Heavy Metals",subtitle:null,isOpenForSubmission:!1,hash:"9e77514288e7394f1e6cd13481af3509",slug:"environmental-impact-and-remediation-of-heavy-metals",bookSignature:"Hosam M. Saleh and Amal I. Hassan",coverURL:"https://cdn.intechopen.com/books/images_new/11120.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:847,editors:[{id:"144691",title:"Prof.",name:"Hosam M.",middleName:null,surname:"Saleh",slug:"hosam-m.-saleh",fullName:"Hosam M. Saleh"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10901",title:"Grapes and Wine",subtitle:null,isOpenForSubmission:!1,hash:"5d7f2aa74874444bc6986e613ccebd7c",slug:"grapes-and-wine",bookSignature:"Antonio Morata, Iris Loira and Carmen González",coverURL:"https://cdn.intechopen.com/books/images_new/10901.jpg",publishedDate:"June 15th 2022",numberOfDownloads:2273,editors:[{id:"180952",title:"Prof.",name:"Antonio",middleName:null,surname:"Morata",slug:"antonio-morata",fullName:"Antonio Morata"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11080",title:"Engineering Principles",subtitle:"Welding and Residual Stresses",isOpenForSubmission:!1,hash:"6c07a13a113bce94174b40096f30fb5e",slug:"engineering-principles-welding-and-residual-stresses",bookSignature:"Kavian Omar Cooke and Ronaldo Câmara Cozza",coverURL:"https://cdn.intechopen.com/books/images_new/11080.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:591,editors:[{id:"138778",title:"Dr.",name:"Kavian",middleName:"Omar",surname:"Cooke",slug:"kavian-cooke",fullName:"Kavian Cooke"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11332",title:"Essential Oils",subtitle:"Advances in Extractions and Biological Applications",isOpenForSubmission:!1,hash:"742e6cae3a35686f975edc8d7f9afa94",slug:"essential-oils-advances-in-extractions-and-biological-applications",bookSignature:"Mozaniel Santana de Oliveira and Eloisa Helena de Aguiar Andrade",coverURL:"https://cdn.intechopen.com/books/images_new/11332.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:515,editors:[{id:"195290",title:"Ph.D.",name:"Mozaniel",middleName:null,surname:"Santana De Oliveira",slug:"mozaniel-santana-de-oliveira",fullName:"Mozaniel Santana De Oliveira"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11029",title:"Hepatitis B",subtitle:null,isOpenForSubmission:!1,hash:"609701f502efc3538c112ff47a2c2119",slug:"hepatitis-b",bookSignature:"Luis Rodrigo",coverURL:"https://cdn.intechopen.com/books/images_new/11029.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:413,editors:[{id:"73208",title:"Prof.",name:"Luis",middleName:null,surname:"Rodrigo",slug:"luis-rodrigo",fullName:"Luis Rodrigo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9537",title:"Human Rights in the Contemporary World",subtitle:null,isOpenForSubmission:!1,hash:"54f05b93812fd434f3962956d6413a6b",slug:"human-rights-in-the-contemporary-world",bookSignature:"Trudy Corrigan",coverURL:"https://cdn.intechopen.com/books/images_new/9537.jpg",publishedDate:"June 8th 2022",numberOfDownloads:2194,editors:[{id:"197557",title:"Dr.",name:"Trudy",middleName:null,surname:"Corrigan",slug:"trudy-corrigan",fullName:"Trudy Corrigan"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"11371",title:"Cerebral Circulation",subtitle:"Updates on Models, Diagnostics and Treatments of Related Diseases",isOpenForSubmission:!1,hash:"e2d3335445d2852d0b906bb9750e939f",slug:"cerebral-circulation-updates-on-models-diagnostics-and-treatments-of-related-diseases",bookSignature:"Alba Scerrati, Luca Ricciardi and Flavia Dones",coverURL:"https://cdn.intechopen.com/books/images_new/11371.jpg",publishedDate:"June 23rd 2022",numberOfDownloads:341,editors:[{id:"182614",title:"Dr.",name:"Alba",middleName:null,surname:"Scerrati",slug:"alba-scerrati",fullName:"Alba Scerrati"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],latestBooks:[{type:"book",id:"11043",title:"Endometriosis",subtitle:"Recent Advances, New Perspectives and Treatments",isOpenForSubmission:!1,hash:"7baf1c70b11d41400bb9302ae9411ca4",slug:"endometriosis-recent-advances-new-perspectives-and-treatments",bookSignature:"Giovana Ap. Gonçalves",coverURL:"https://cdn.intechopen.com/books/images_new/11043.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"185930",title:"Associate Prof.",name:"Giovana",middleName:null,surname:"Gonçalves",slug:"giovana-goncalves",fullName:"Giovana Gonçalves"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10536",title:"Campylobacter",subtitle:null,isOpenForSubmission:!1,hash:"c4b132b741dd0a2ed539b824ab63965f",slug:"campylobacter",bookSignature:"Guillermo Tellez-Isaias and Saeed El-Ashram",coverURL:"https://cdn.intechopen.com/books/images_new/10536.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"73465",title:"Dr.",name:"Guillermo",middleName:null,surname:"Téllez",slug:"guillermo-tellez",fullName:"Guillermo Téllez"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10798",title:"Starch",subtitle:"Evolution and Recent Advances",isOpenForSubmission:!1,hash:"f197f6062c1574a9a90e50a369271bcf",slug:"starch-evolution-and-recent-advances",bookSignature:"Martins Ochubiojo Emeje",coverURL:"https://cdn.intechopen.com/books/images_new/10798.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"94311",title:"Prof.",name:"Martins",middleName:"Ochubiojo",surname:"Ochubiojo Emeje",slug:"martins-ochubiojo-emeje",fullName:"Martins Ochubiojo Emeje"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11083",title:"Hazardous Waste Management",subtitle:null,isOpenForSubmission:!1,hash:"d553bd4f6f1c4b115ca69bd19faac7dc",slug:"hazardous-waste-management",bookSignature:"Rajesh Banu Jeyakumar, Kavitha Sankarapandian and Yukesh Kannah Ravi",coverURL:"https://cdn.intechopen.com/books/images_new/11083.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"218539",title:"Dr.",name:"Rajesh Banu",middleName:null,surname:"Jeyakumar",slug:"rajesh-banu-jeyakumar",fullName:"Rajesh Banu Jeyakumar"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10848",title:"Tribology of Machine Elements",subtitle:"Fundamentals and Applications",isOpenForSubmission:!1,hash:"3c4ca4c4692ca8d4fa749b4ae81ec1fa",slug:"tribology-of-machine-elements-fundamentals-and-applications",bookSignature:"Giuseppe Pintaude, Tiago Cousseau and Anna Rudawska",coverURL:"https://cdn.intechopen.com/books/images_new/10848.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"18347",title:"Prof.",name:"Giuseppe",middleName:null,surname:"Pintaude",slug:"giuseppe-pintaude",fullName:"Giuseppe Pintaude"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10856",title:"Crude Oil",subtitle:"New Technologies and Recent Approaches",isOpenForSubmission:!1,hash:"8d0a7ca35b3de95b295dc4eab39a087e",slug:"crude-oil-new-technologies-and-recent-approaches",bookSignature:"Manar Elsayed Abdel-Raouf and Mohamed Hasan El-Keshawy",coverURL:"https://cdn.intechopen.com/books/images_new/10856.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"102626",title:"Prof.",name:"Manar",middleName:null,surname:"Elsayed Abdel-Raouf",slug:"manar-elsayed-abdel-raouf",fullName:"Manar Elsayed Abdel-Raouf"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9625",title:"Spinocerebellar Ataxia",subtitle:"Concepts, Particularities and Generalities",isOpenForSubmission:!1,hash:"365a7025fd46eb45de2549bdd9d50b98",slug:"spinocerebellar-ataxia-concepts-particularities-and-generalities",bookSignature:"Patricia Bozzetto Ambrosi",coverURL:"https://cdn.intechopen.com/books/images_new/9625.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"221787",title:"Dr.",name:"Patricia",middleName:null,surname:"Bozzetto Ambrosi",slug:"patricia-bozzetto-ambrosi",fullName:"Patricia Bozzetto Ambrosi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10905",title:"Plant Defense Mechanisms",subtitle:null,isOpenForSubmission:!1,hash:"84ad5b27dde5f01dc76087d0fd6fa834",slug:"plant-defense-mechanisms",bookSignature:"Josphert Ngui Kimatu",coverURL:"https://cdn.intechopen.com/books/images_new/10905.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"224171",title:"Prof.",name:"Josphert N.",middleName:null,surname:"Kimatu",slug:"josphert-n.-kimatu",fullName:"Josphert N. Kimatu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10686",title:"Natural Gas",subtitle:"New Perspectives and Future Developments",isOpenForSubmission:!1,hash:"581763788a6a59e653a9d1d9b5a42d79",slug:"natural-gas-new-perspectives-and-future-developments",bookSignature:"Maryam Takht Ravanchi",coverURL:"https://cdn.intechopen.com/books/images_new/10686.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"2416",title:"Dr.",name:"Maryam",middleName:null,surname:"Takht Ravanchi",slug:"maryam-takht-ravanchi",fullName:"Maryam Takht Ravanchi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10988",title:"Railway Transport Planning and Manageme",subtitle:null,isOpenForSubmission:!1,hash:"5cb54cc53caedad9ec78372563c82e2c",slug:"railway-transport-planning-and-management",bookSignature:"Stefano de Luca, Roberta Di Pace and Chiara Fiori",coverURL:"https://cdn.intechopen.com/books/images_new/10988.jpg",editedByType:"Edited by",publishedDate:"June 28th 2022",editors:[{id:"271061",title:"Prof.",name:"Stefano",middleName:null,surname:"de Luca",slug:"stefano-de-luca",fullName:"Stefano de Luca"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},subject:{topic:{id:"374",title:"Plant Engineering",slug:"plant-engineering",parent:{id:"41",title:"Plant Biology",slug:"agricultural-and-biological-sciences-plant-biology"},numberOfBooks:2,numberOfSeries:0,numberOfAuthorsAndEditors:35,numberOfWosCitations:38,numberOfCrossrefCitations:40,numberOfDimensionsCitations:80,videoUrl:null,fallbackUrl:null,description:null},booksByTopicFilter:{topicId:"374",sort:"-publishedDate",limit:12,offset:0},booksByTopicCollection:[{type:"book",id:"8291",title:"Technological Innovation in the Olive Oil Production Chain",subtitle:null,isOpenForSubmission:!1,hash:"6604d6cd5f4995f6ab303e82ddd5fcd9",slug:"technological-innovation-in-the-olive-oil-production-chain",bookSignature:"Innocenzo Muzzalupo",coverURL:"https://cdn.intechopen.com/books/images_new/8291.jpg",editedByType:"Edited by",editors:[{id:"93139",title:"Dr.",name:"Innocenzo",middleName:null,surname:"Muzzalupo",slug:"innocenzo-muzzalupo",fullName:"Innocenzo Muzzalupo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5772",title:"Plant Engineering",subtitle:null,isOpenForSubmission:!1,hash:"4eae6c6ccd98efec6d8a1a4b6003d0a2",slug:"plant-engineering",bookSignature:"Snježana Jurić",coverURL:"https://cdn.intechopen.com/books/images_new/5772.jpg",editedByType:"Edited by",editors:[{id:"161262",title:"Dr.",name:"Snježana",middleName:null,surname:"Jurić",slug:"snjezana-juric",fullName:"Snježana Jurić"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],booksByTopicTotal:2,seriesByTopicCollection:[],seriesByTopicTotal:0,mostCitedChapters:[{id:"56273",doi:"10.5772/intechopen.69974",title:"The Use of Gamma Irradiation in Plant Mutation Breeding",slug:"the-use-of-gamma-irradiation-in-plant-mutation-breeding",totalDownloads:4162,totalCrossrefCites:15,totalDimensionsCites:36,abstract:"In plant breeding programs, one of the oldest methods is mutation breeding. Currently, mutation breeding has became popular among the breeders and scientists again with its use in plant biotechnology and due to some restrictions on the other techniques such as hybridization, cross breeding, and transgenic plants. Physical mutagens (X-rays, UV light, neutrons-alpha-beta particles, fast and thermal neutrons, especially gamma rays) are used more widely than chemical (ethyl methanesulfonate [EMS]) ones to artificially induce mutations (mutagenesis). However, among the physical mutagens, gamma-rays are widely used. During the irradiation of the seeds with ionizing radiation to generate mutants with desirable traits, reactive oxygen species (ROS) or free radicals can generate in cells. Although, these radicals/species generally can be very dangerous for the cell compartments, they can take an important role as a signal molecule activation of genes of antioxidant enzymes and proline, which are defense systems against these radicals in plant cells. In this chapter, usability of gamma-irradiation to provide the permanent gene expression of antioxidant enzymes and proline through the production of reactive oxygen species (ROS) is discussed.",book:{id:"5772",slug:"plant-engineering",title:"Plant Engineering",fullTitle:"Plant Engineering"},signatures:"Ramazan Beyaz and Mustafa Yildiz",authors:[{id:"203524",title:"Dr.",name:"Ramazan",middleName:null,surname:"Beyaz",slug:"ramazan-beyaz",fullName:"Ramazan Beyaz"}]},{id:"64271",doi:"10.5772/intechopen.81390",title:"Emerging Extraction Technologies in Olive Oil Production",slug:"emerging-extraction-technologies-in-olive-oil-production",totalDownloads:1310,totalCrossrefCites:5,totalDimensionsCites:9,abstract:"In the field of olive oil extraction, current scientific research has focused on improving quality, paying particular attention to optimizing the efficiency of extraction and reducing the duration of the process. Recently, studies have been conducted to improve the traditional malaxation process and obtain positive effects on both oil production and consumption. With these aims, emerging technologies including microwave (MW), pulsed electric field (PEF), and ultrasound (US) have been applied to conventional virgin olive oil extraction process. In this chapter, most recent studies that focused on adaptation of emerging technologies to traditional extraction to increase the yield of olive oil or some minor compounds and bioactive components present in olive oil including tocopherols, chlorophyll, carotenoids, and phenolic compounds have been compiled.",book:{id:"8291",slug:"technological-innovation-in-the-olive-oil-production-chain",title:"Technological Innovation in the Olive Oil Production Chain",fullTitle:"Technological Innovation in the Olive Oil Production Chain"},signatures:"Alev Yüksel Aydar",authors:[{id:"218870",title:"Dr.",name:"Alev Yüksel",middleName:null,surname:"Aydar",slug:"alev-yuksel-aydar",fullName:"Alev Yüksel Aydar"}]},{id:"56451",doi:"10.5772/intechopen.69972",title:"Adaptive Management Framework for Evaluating and Adjusting Microclimate Parameters in Tropical Greenhouse Crop Production Systems",slug:"adaptive-management-framework-for-evaluating-and-adjusting-microclimate-parameters-in-tropical-green",totalDownloads:1884,totalCrossrefCites:7,totalDimensionsCites:8,abstract:"High operational costs of greenhouse production in hot and humid climate condition due to the initial investments on structure, equipment, and energy necessitate practicing advanced techniques for more efficient use of available resources. This chapter describes design and concepts of an adaptive management framework for evaluating and adjusting optimality degrees and comfort ratios of microclimate parameters, as well as predicting the expected yield in greenhouse cultivation of tomato. A systematic approach is presented for automatic data collection and processing with the objective to produce knowledge‐based information in achieving optimum microclimate for high‐quality and high‐yield tomato. Applications of relevant computer models are demonstrated through case‐study examples for use in an iterative way to simulate and compare different scenarios. The presented framework can contribute to future studies for providing best management decisions such as site selection, optimum growing season, scheduling efficiencies, energy management with different climate control systems, and risk assessments associated with each task.",book:{id:"5772",slug:"plant-engineering",title:"Plant Engineering",fullTitle:"Plant Engineering"},signatures:"Redmond R. Shamshiri, Muhammad Razif Mahadi, Kelly R. Thorp,\nWan Ishak Wan Ismail, Desa Ahmad and Hasfalina Che Man",authors:[{id:"203413",title:"Dr.",name:"Redmond R.",middleName:null,surname:"Shamshiri",slug:"redmond-r.-shamshiri",fullName:"Redmond R. Shamshiri"},{id:"206174",title:"Dr.",name:"Muhammad Razif",middleName:null,surname:"Mahadi",slug:"muhammad-razif-mahadi",fullName:"Muhammad Razif Mahadi"},{id:"206175",title:"Prof.",name:"AbdJamil",middleName:null,surname:"Zakaria",slug:"abdjamil-zakaria",fullName:"AbdJamil Zakaria"},{id:"206176",title:"Prof.",name:"Wan Ishak",middleName:null,surname:"Wan Ismail",slug:"wan-ishak-wan-ismail",fullName:"Wan Ishak Wan Ismail"},{id:"206177",title:"Prof.",name:"Desa",middleName:null,surname:"Ahmad",slug:"desa-ahmad",fullName:"Desa Ahmad"},{id:"206179",title:"Prof.",name:"Hasfalina",middleName:null,surname:"Che Man",slug:"hasfalina-che-man",fullName:"Hasfalina Che Man"},{id:"206344",title:"Dr.",name:"Kelly",middleName:null,surname:"Thorp",slug:"kelly-thorp",fullName:"Kelly Thorp"}]},{id:"56511",doi:"10.5772/intechopen.69971",title:"Climate Smart Agriculture: An Option for Changing Climatic Situation",slug:"climate-smart-agriculture-an-option-for-changing-climatic-situation",totalDownloads:2344,totalCrossrefCites:4,totalDimensionsCites:8,abstract:"World population is increasing day by day and at the same time agriculture is threatened due to natural resource degradation and climate change. Production stability, agricultural productivity, income and food security is negatively affected by changing climate. Therefore, agriculture must change according to present situation for meeting the need of food security and also withstanding under changing climatic situation. Projected estimates based on food consumption pattern and population growth show that agriculture production will require enhancing by 65% to meet the need of burgeoning population by 2050. Agriculture is a prominent source as well as a sink of greenhouse gases (GHGs). So there is a need to modify agricultural practices in a more sustainable way to overcome these problems. Developing climate‐resilient agriculture is thus crucial to achieving future food security and climate change goals. It helps the agricultural system to resist damage and recover quickly by adaptation and mitigation strategies. Mitigation strategies reduce the contribution of agriculture system to greenhouse gas emission, and adaptation strategies provide agriculture production under changing scenarios. This chapter explains different mitigation and adaptation strategies, including farming practices and engineering approaches.",book:{id:"5772",slug:"plant-engineering",title:"Plant Engineering",fullTitle:"Plant Engineering"},signatures:"Mona Nagargade, Vishal Tyagi and Manoj Kumar Singh",authors:[{id:"203531",title:"Ph.D. Student",name:"Mona",middleName:null,surname:"Nagargade",slug:"mona-nagargade",fullName:"Mona Nagargade"},{id:"203808",title:"Ms.",name:"Vishal",middleName:null,surname:"Tyagi",slug:"vishal-tyagi",fullName:"Vishal Tyagi"},{id:"203809",title:"Prof.",name:"Manoj Kumar",middleName:null,surname:"Singh",slug:"manoj-kumar-singh",fullName:"Manoj Kumar Singh"}]},{id:"64315",doi:"10.5772/intechopen.81666",title:"Does the Introduction of Ultrasound in Extra-Virgin Olive Oil Extraction Process Improve the Income of the Olive Millers? The First Technology for the Simultaneous Increment of Yield and Quality of the Product",slug:"does-the-introduction-of-ultrasound-in-extra-virgin-olive-oil-extraction-process-improve-the-income-",totalDownloads:1052,totalCrossrefCites:4,totalDimensionsCites:6,abstract:"Olive oil is an important product of the European agro-alimentary sector. The current olive oil extraction process can be further improved in order to overcome the weaknesses of the actual system in terms of non-continuity, reduction of oil in waste, sustainability, and improvement of quality both in the healthy and sensory perspective. Many innovative approaches have been developed to improve the olive oil extraction process. However, not all the proposed innovations have the opportunity to effectively reach a technological level of readiness close to “ready for the market.” An innovator should simultaneously evaluate the aptitude of its invention to turn into a widely used commercial product both under the technological and the marketing perspectives. Under the technological point of view, an innovation should be effective, so, adequate to accomplish a purpose, and efficient, so, able to perform or functioning in the best possible manner with the least waste of time and effort. Under the marketing point of view, an innovation should be able to develop products that accurately and timely respond to customer needs, offering a valuable experience to the customer, exceeding his expectations. The innovative EVOO process based on ultrasound extraction has several advantages useful to improve olive miller income: higher yield extraction, higher polyphenols, and lower bitter and pungent taste than traditional EVOO samples.",book:{id:"8291",slug:"technological-innovation-in-the-olive-oil-production-chain",title:"Technological Innovation in the Olive Oil Production Chain",fullTitle:"Technological Innovation in the Olive Oil Production Chain"},signatures:"Maria Lisa Clodoveo, Filomena Corbo and Riccardo Amirante",authors:[{id:"199763",title:"Dr.",name:"Maria",middleName:"Lisa",surname:"Clodoveo",slug:"maria-clodoveo",fullName:"Maria Clodoveo"}]}],mostDownloadedChaptersLast30Days:[{id:"56273",title:"The Use of Gamma Irradiation in Plant Mutation Breeding",slug:"the-use-of-gamma-irradiation-in-plant-mutation-breeding",totalDownloads:4159,totalCrossrefCites:15,totalDimensionsCites:35,abstract:"In plant breeding programs, one of the oldest methods is mutation breeding. Currently, mutation breeding has became popular among the breeders and scientists again with its use in plant biotechnology and due to some restrictions on the other techniques such as hybridization, cross breeding, and transgenic plants. Physical mutagens (X-rays, UV light, neutrons-alpha-beta particles, fast and thermal neutrons, especially gamma rays) are used more widely than chemical (ethyl methanesulfonate [EMS]) ones to artificially induce mutations (mutagenesis). However, among the physical mutagens, gamma-rays are widely used. During the irradiation of the seeds with ionizing radiation to generate mutants with desirable traits, reactive oxygen species (ROS) or free radicals can generate in cells. Although, these radicals/species generally can be very dangerous for the cell compartments, they can take an important role as a signal molecule activation of genes of antioxidant enzymes and proline, which are defense systems against these radicals in plant cells. In this chapter, usability of gamma-irradiation to provide the permanent gene expression of antioxidant enzymes and proline through the production of reactive oxygen species (ROS) is discussed.",book:{id:"5772",slug:"plant-engineering",title:"Plant Engineering",fullTitle:"Plant Engineering"},signatures:"Ramazan Beyaz and Mustafa Yildiz",authors:[{id:"203524",title:"Dr.",name:"Ramazan",middleName:null,surname:"Beyaz",slug:"ramazan-beyaz",fullName:"Ramazan Beyaz"}]},{id:"64271",title:"Emerging Extraction Technologies in Olive Oil Production",slug:"emerging-extraction-technologies-in-olive-oil-production",totalDownloads:1305,totalCrossrefCites:5,totalDimensionsCites:9,abstract:"In the field of olive oil extraction, current scientific research has focused on improving quality, paying particular attention to optimizing the efficiency of extraction and reducing the duration of the process. Recently, studies have been conducted to improve the traditional malaxation process and obtain positive effects on both oil production and consumption. With these aims, emerging technologies including microwave (MW), pulsed electric field (PEF), and ultrasound (US) have been applied to conventional virgin olive oil extraction process. In this chapter, most recent studies that focused on adaptation of emerging technologies to traditional extraction to increase the yield of olive oil or some minor compounds and bioactive components present in olive oil including tocopherols, chlorophyll, carotenoids, and phenolic compounds have been compiled.",book:{id:"8291",slug:"technological-innovation-in-the-olive-oil-production-chain",title:"Technological Innovation in the Olive Oil Production Chain",fullTitle:"Technological Innovation in the Olive Oil Production Chain"},signatures:"Alev Yüksel Aydar",authors:[{id:"218870",title:"Dr.",name:"Alev Yüksel",middleName:null,surname:"Aydar",slug:"alev-yuksel-aydar",fullName:"Alev Yüksel Aydar"}]},{id:"56511",title:"Climate Smart Agriculture: An Option for Changing Climatic Situation",slug:"climate-smart-agriculture-an-option-for-changing-climatic-situation",totalDownloads:2337,totalCrossrefCites:4,totalDimensionsCites:8,abstract:"World population is increasing day by day and at the same time agriculture is threatened due to natural resource degradation and climate change. Production stability, agricultural productivity, income and food security is negatively affected by changing climate. Therefore, agriculture must change according to present situation for meeting the need of food security and also withstanding under changing climatic situation. Projected estimates based on food consumption pattern and population growth show that agriculture production will require enhancing by 65% to meet the need of burgeoning population by 2050. Agriculture is a prominent source as well as a sink of greenhouse gases (GHGs). So there is a need to modify agricultural practices in a more sustainable way to overcome these problems. Developing climate‐resilient agriculture is thus crucial to achieving future food security and climate change goals. It helps the agricultural system to resist damage and recover quickly by adaptation and mitigation strategies. Mitigation strategies reduce the contribution of agriculture system to greenhouse gas emission, and adaptation strategies provide agriculture production under changing scenarios. This chapter explains different mitigation and adaptation strategies, including farming practices and engineering approaches.",book:{id:"5772",slug:"plant-engineering",title:"Plant Engineering",fullTitle:"Plant Engineering"},signatures:"Mona Nagargade, Vishal Tyagi and Manoj Kumar Singh",authors:[{id:"203531",title:"Ph.D. Student",name:"Mona",middleName:null,surname:"Nagargade",slug:"mona-nagargade",fullName:"Mona Nagargade"},{id:"203808",title:"Ms.",name:"Vishal",middleName:null,surname:"Tyagi",slug:"vishal-tyagi",fullName:"Vishal Tyagi"},{id:"203809",title:"Prof.",name:"Manoj Kumar",middleName:null,surname:"Singh",slug:"manoj-kumar-singh",fullName:"Manoj Kumar Singh"}]},{id:"56106",title:"Vascular Tissue Development and Regeneration in the Model Plant Arabidopsis",slug:"vascular-tissue-development-and-regeneration-in-the-model-plant-arabidopsis",totalDownloads:1600,totalCrossrefCites:0,totalDimensionsCites:1,abstract:"Development of vascular tissue is a remarkable example of intercellular communication and coordinated development involving hormonal signaling and tissue polarity. Thus far, studies on vascular patterning and regeneration have been conducted mainly in trees—woody plants—with a well-developed layer of vascular cambium and secondary tissues. Trees are difficult to use as genetic models, i.e., due to long generation time, unstable environmental conditions, and lack of available mutants and transgenic lines. Therefore, the use of the main genetic model plant Arabidopsis thaliana (L.) Heynh., with a wealth of available marker and transgenic lines, provides a unique opportunity to address molecular mechanism of vascular tissue formation and regeneration. With specific treatments, the tiny weed Arabidopsis can serve as a model to understand the growth of mighty trees and interconnect a tree physiology with molecular genetics and cell biology of Arabidopsis.",book:{id:"5772",slug:"plant-engineering",title:"Plant Engineering",fullTitle:"Plant Engineering"},signatures:"Ewa Mazur and Jiří Friml",authors:[{id:"114092",title:"MSc.",name:"Ewa",middleName:null,surname:"Mazur",slug:"ewa-mazur",fullName:"Ewa Mazur"},{id:"204352",title:"Prof.",name:"Jiri",middleName:null,surname:"Friml",slug:"jiri-friml",fullName:"Jiri Friml"}]},{id:"64315",title:"Does the Introduction of Ultrasound in Extra-Virgin Olive Oil Extraction Process Improve the Income of the Olive Millers? The First Technology for the Simultaneous Increment of Yield and Quality of the Product",slug:"does-the-introduction-of-ultrasound-in-extra-virgin-olive-oil-extraction-process-improve-the-income-",totalDownloads:1050,totalCrossrefCites:4,totalDimensionsCites:6,abstract:"Olive oil is an important product of the European agro-alimentary sector. The current olive oil extraction process can be further improved in order to overcome the weaknesses of the actual system in terms of non-continuity, reduction of oil in waste, sustainability, and improvement of quality both in the healthy and sensory perspective. Many innovative approaches have been developed to improve the olive oil extraction process. However, not all the proposed innovations have the opportunity to effectively reach a technological level of readiness close to “ready for the market.” An innovator should simultaneously evaluate the aptitude of its invention to turn into a widely used commercial product both under the technological and the marketing perspectives. Under the technological point of view, an innovation should be effective, so, adequate to accomplish a purpose, and efficient, so, able to perform or functioning in the best possible manner with the least waste of time and effort. Under the marketing point of view, an innovation should be able to develop products that accurately and timely respond to customer needs, offering a valuable experience to the customer, exceeding his expectations. The innovative EVOO process based on ultrasound extraction has several advantages useful to improve olive miller income: higher yield extraction, higher polyphenols, and lower bitter and pungent taste than traditional EVOO samples.",book:{id:"8291",slug:"technological-innovation-in-the-olive-oil-production-chain",title:"Technological Innovation in the Olive Oil Production Chain",fullTitle:"Technological Innovation in the Olive Oil Production Chain"},signatures:"Maria Lisa Clodoveo, Filomena Corbo and Riccardo Amirante",authors:[{id:"199763",title:"Dr.",name:"Maria",middleName:"Lisa",surname:"Clodoveo",slug:"maria-clodoveo",fullName:"Maria Clodoveo"}]}],onlineFirstChaptersFilter:{topicId:"374",limit:6,offset:0},onlineFirstChaptersCollection:[],onlineFirstChaptersTotal:0},preDownload:{success:null,errors:{}},subscriptionForm:{success:null,errors:{}},aboutIntechopen:{},privacyPolicy:{},peerReviewing:{},howOpenAccessPublishingWithIntechopenWorks:{},sponsorshipBooks:{sponsorshipBooks:[],offset:8,limit:8,total:0},allSeries:{pteSeriesList:[{id:"14",title:"Artificial Intelligence",numberOfPublishedBooks:9,numberOfPublishedChapters:90,numberOfOpenTopics:6,numberOfUpcomingTopics:0,issn:"2633-1403",doi:"10.5772/intechopen.79920",isOpenForSubmission:!0},{id:"7",title:"Biomedical Engineering",numberOfPublishedBooks:12,numberOfPublishedChapters:104,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2631-5343",doi:"10.5772/intechopen.71985",isOpenForSubmission:!0}],lsSeriesList:[{id:"11",title:"Biochemistry",numberOfPublishedBooks:32,numberOfPublishedChapters:319,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2632-0983",doi:"10.5772/intechopen.72877",isOpenForSubmission:!0},{id:"25",title:"Environmental Sciences",numberOfPublishedBooks:1,numberOfPublishedChapters:12,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2754-6713",doi:"10.5772/intechopen.100362",isOpenForSubmission:!0},{id:"10",title:"Physiology",numberOfPublishedBooks:11,numberOfPublishedChapters:141,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2631-8261",doi:"10.5772/intechopen.72796",isOpenForSubmission:!0}],hsSeriesList:[{id:"3",title:"Dentistry",numberOfPublishedBooks:8,numberOfPublishedChapters:133,numberOfOpenTopics:2,numberOfUpcomingTopics:0,issn:"2631-6218",doi:"10.5772/intechopen.71199",isOpenForSubmission:!0},{id:"6",title:"Infectious Diseases",numberOfPublishedBooks:13,numberOfPublishedChapters:113,numberOfOpenTopics:3,numberOfUpcomingTopics:1,issn:"2631-6188",doi:"10.5772/intechopen.71852",isOpenForSubmission:!0},{id:"13",title:"Veterinary Medicine and Science",numberOfPublishedBooks:11,numberOfPublishedChapters:107,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2632-0517",doi:"10.5772/intechopen.73681",isOpenForSubmission:!0}],sshSeriesList:[{id:"22",title:"Business, Management and Economics",numberOfPublishedBooks:1,numberOfPublishedChapters:19,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2753-894X",doi:"10.5772/intechopen.100359",isOpenForSubmission:!0},{id:"23",title:"Education and Human Development",numberOfPublishedBooks:0,numberOfPublishedChapters:5,numberOfOpenTopics:1,numberOfUpcomingTopics:1,issn:null,doi:"10.5772/intechopen.100360",isOpenForSubmission:!0},{id:"24",title:"Sustainable Development",numberOfPublishedBooks:0,numberOfPublishedChapters:16,numberOfOpenTopics:5,numberOfUpcomingTopics:0,issn:null,doi:"10.5772/intechopen.100361",isOpenForSubmission:!0}],testimonialsList:[{id:"6",text:"It is great to work with the IntechOpen to produce a worthwhile collection of research that also becomes a great educational resource and guide for future research endeavors.",author:{id:"259298",name:"Edward",surname:"Narayan",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/259298/images/system/259298.jpeg",slug:"edward-narayan",institution:{id:"3",name:"University of Queensland",country:{id:null,name:"Australia"}}}},{id:"13",text:"The collaboration with and support of the technical staff of IntechOpen is fantastic. The whole process of submitting an article and editing of the submitted article goes extremely smooth and fast, the number of reads and downloads of chapters is high, and the contributions are also frequently cited.",author:{id:"55578",name:"Antonio",surname:"Jurado-Navas",institutionString:null,profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRisIQAS/Profile_Picture_1626166543950",slug:"antonio-jurado-navas",institution:{id:"720",name:"University of Malaga",country:{id:null,name:"Spain"}}}}]},series:{item:{id:"7",title:"Biomedical Engineering",doi:"10.5772/intechopen.71985",issn:"2631-5343",scope:"Biomedical Engineering is one of the fastest-growing interdisciplinary branches of science and industry. The combination of electronics and computer science with biology and medicine has improved patient diagnosis, reduced rehabilitation time, and helped to facilitate a better quality of life. Nowadays, all medical imaging devices, medical instruments, or new laboratory techniques result from the cooperation of specialists in various fields. The series of Biomedical Engineering books covers such areas of knowledge as chemistry, physics, electronics, medicine, and biology. This series is intended for doctors, engineers, and scientists involved in biomedical engineering or those wanting to start working in this field.",coverUrl:"https://cdn.intechopen.com/series/covers/7.jpg",latestPublicationDate:"June 25th, 2022",hasOnlineFirst:!0,numberOfPublishedBooks:12,editor:{id:"50150",title:"Prof.",name:"Robert",middleName:null,surname:"Koprowski",slug:"robert-koprowski",fullName:"Robert Koprowski",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002aYTYNQA4/Profile_Picture_1630478535317",biography:"Robert Koprowski, MD (1997), PhD (2003), Habilitation (2015), is an employee of the University of Silesia, Poland, Institute of Computer Science, Department of Biomedical Computer Systems. For 20 years, he has studied the analysis and processing of biomedical images, emphasizing the full automation of measurement for a large inter-individual variability of patients. Dr. Koprowski has authored more than a hundred research papers with dozens in impact factor (IF) journals and has authored or co-authored six books. Additionally, he is the author of several national and international patents in the field of biomedical devices and imaging. Since 2011, he has been a reviewer of grants and projects (including EU projects) in biomedical engineering.",institutionString:null,institution:{name:"University of Silesia",institutionURL:null,country:{name:"Poland"}}},editorTwo:null,editorThree:null},subseries:{paginationCount:7,paginationItems:[{id:"7",title:"Bioinformatics and Medical Informatics",coverUrl:"https://cdn.intechopen.com/series_topics/covers/7.jpg",editor:{id:"351533",title:"Dr.",name:"Slawomir",middleName:null,surname:"Wilczynski",slug:"slawomir-wilczynski",fullName:"Slawomir Wilczynski",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y000035U1loQAC/Profile_Picture_1630074514792",biography:"Professor Sławomir Wilczyński, Head of the Chair of Department of Basic Biomedical Sciences, Faculty of Pharmaceutical Sciences, Medical University of Silesia in Katowice, Poland. His research interests are focused on modern imaging methods used in medicine and pharmacy, including in particular hyperspectral imaging, dynamic thermovision analysis, high-resolution ultrasound, as well as other techniques such as EPR, NMR and hemispheric directional reflectance. Author of over 100 scientific works, patents and industrial designs. Expert of the Polish National Center for Research and Development, Member of the Investment Committee in the Bridge Alfa NCBiR program, expert of the Polish Ministry of Funds and Regional Policy, Polish Medical Research Agency. Editor-in-chief of the journal in the field of aesthetic medicine and dermatology - Aesthetica.",institutionString:null,institution:{name:"Medical University of Silesia",institutionURL:null,country:{name:"Poland"}}},editorTwo:null,editorThree:null,editorialBoard:[{id:"5886",title:"Dr.",name:"Alexandros",middleName:"T.",surname:"Tzallas",slug:"alexandros-tzallas",fullName:"Alexandros Tzallas",profilePictureURL:"https://mts.intechopen.com/storage/users/5886/images/system/5886.png",institutionString:"University of Ioannina, Greece & Imperial College London",institution:{name:"University of Ioannina",institutionURL:null,country:{name:"Greece"}}},{id:"257388",title:"Distinguished Prof.",name:"Lulu",middleName:null,surname:"Wang",slug:"lulu-wang",fullName:"Lulu Wang",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRX6kQAG/Profile_Picture_1630329584194",institutionString:"Shenzhen Technology University",institution:{name:"Shenzhen Technology University",institutionURL:null,country:{name:"China"}}},{id:"225387",title:"Prof.",name:"Reda R.",middleName:"R.",surname:"Gharieb",slug:"reda-r.-gharieb",fullName:"Reda R. Gharieb",profilePictureURL:"https://mts.intechopen.com/storage/users/225387/images/system/225387.jpg",institutionString:"Assiut University",institution:{name:"Assiut University",institutionURL:null,country:{name:"Egypt"}}}]},{id:"8",title:"Bioinspired Technology and Biomechanics",coverUrl:"https://cdn.intechopen.com/series_topics/covers/8.jpg",editor:{id:"144937",title:"Prof.",name:"Adriano",middleName:"De Oliveira",surname:"Andrade",slug:"adriano-andrade",fullName:"Adriano Andrade",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRC8QQAW/Profile_Picture_1625219101815",biography:"Dr. Adriano de Oliveira Andrade graduated in Electrical Engineering at the Federal University of Goiás (Brazil) in 1997. He received his MSc and PhD in Biomedical Engineering respectively from the Federal University of Uberlândia (UFU, Brazil) in 2000 and from the University of Reading (UK) in 2005. He completed a one-year Post-Doctoral Fellowship awarded by the DFAIT (Foreign Affairs and International Trade Canada) at the Institute of Biomedical Engineering of the University of New Brunswick (Canada) in 2010. Currently, he is Professor in the Faculty of Electrical Engineering (UFU). He has authored and co-authored more than 200 peer-reviewed publications in Biomedical Engineering. He has been a researcher of The National Council for Scientific and Technological Development (CNPq-Brazil) since 2009. He has served as an ad-hoc consultant for CNPq, CAPES (Coordination for the Improvement of Higher Education Personnel), FINEP (Brazilian Innovation Agency), and other funding bodies on several occasions. He was the Secretary of the Brazilian Society of Biomedical Engineering (SBEB) from 2015 to 2016, President of SBEB (2017-2018) and Vice-President of SBEB (2019-2020). He was the head of the undergraduate program in Biomedical Engineering of the Federal University of Uberlândia (2015 - June/2019) and the head of the Centre for Innovation and Technology Assessment in Health (NIATS/UFU) since 2010. He is the head of the Postgraduate Program in Biomedical Engineering (UFU, July/2019 - to date). He was the secretary of the Parkinson's Disease Association of Uberlândia (2018-2019). Dr. Andrade's primary area of research is focused towards getting information from the neuromuscular system to understand its strategies of organization, adaptation and controlling in the context of motor neuron diseases. His research interests include Biomedical Signal Processing and Modelling, Assistive Technology, Rehabilitation Engineering, Neuroengineering and Parkinson's Disease.",institutionString:null,institution:{name:"Federal University of Uberlândia",institutionURL:null,country:{name:"Brazil"}}},editorTwo:null,editorThree:null,editorialBoard:[{id:"49517",title:"Prof.",name:"Hitoshi",middleName:null,surname:"Tsunashima",slug:"hitoshi-tsunashima",fullName:"Hitoshi Tsunashima",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002aYTP4QAO/Profile_Picture_1625819726528",institutionString:null,institution:{name:"Nihon University",institutionURL:null,country:{name:"Japan"}}},{id:"425354",title:"Dr.",name:"Marcus",middleName:"Fraga",surname:"Vieira",slug:"marcus-vieira",fullName:"Marcus Vieira",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y00003BJSgIQAX/Profile_Picture_1627904687309",institutionString:null,institution:{name:"Universidade Federal de Goiás",institutionURL:null,country:{name:"Brazil"}}},{id:"196746",title:"Dr.",name:"Ramana",middleName:null,surname:"Vinjamuri",slug:"ramana-vinjamuri",fullName:"Ramana Vinjamuri",profilePictureURL:"https://mts.intechopen.com/storage/users/196746/images/system/196746.jpeg",institutionString:"University of Maryland, Baltimore County",institution:{name:"University of Maryland, Baltimore County",institutionURL:null,country:{name:"United States of America"}}}]},{id:"9",title:"Biotechnology - Biosensors, Biomaterials and Tissue Engineering",coverUrl:"https://cdn.intechopen.com/series_topics/covers/9.jpg",editor:{id:"126286",title:"Dr.",name:"Luis",middleName:"Jesús",surname:"Villarreal-Gómez",slug:"luis-villarreal-gomez",fullName:"Luis Villarreal-Gómez",profilePictureURL:"https://mts.intechopen.com/storage/users/126286/images/system/126286.jpg",biography:"Dr. Luis Villarreal is a research professor from the Facultad de Ciencias de la Ingeniería y Tecnología, Universidad Autónoma de Baja California, Tijuana, Baja California, México. Dr. Villarreal is the editor in chief and founder of the Revista de Ciencias Tecnológicas (RECIT) (https://recit.uabc.mx/) and is a member of several editorial and reviewer boards for numerous international journals. He has published more than thirty international papers and reviewed more than ninety-two manuscripts. His research interests include biomaterials, nanomaterials, bioengineering, biosensors, drug delivery systems, and tissue engineering.",institutionString:null,institution:{name:"Autonomous University of Baja California",institutionURL:null,country:{name:"Mexico"}}},editorTwo:null,editorThree:null,editorialBoard:[{id:"35539",title:"Dr.",name:"Cecilia",middleName:null,surname:"Cristea",slug:"cecilia-cristea",fullName:"Cecilia Cristea",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002aYQ65QAG/Profile_Picture_1621007741527",institutionString:null,institution:{name:"Iuliu Hațieganu University of Medicine and Pharmacy",institutionURL:null,country:{name:"Romania"}}},{id:"40735",title:"Dr.",name:"Gil",middleName:"Alberto Batista",surname:"Gonçalves",slug:"gil-goncalves",fullName:"Gil Gonçalves",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002aYRLGQA4/Profile_Picture_1628492612759",institutionString:null,institution:{name:"University of Aveiro",institutionURL:null,country:{name:"Portugal"}}},{id:"211725",title:"Associate Prof.",name:"Johann F.",middleName:null,surname:"Osma",slug:"johann-f.-osma",fullName:"Johann F. Osma",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bSDv7QAG/Profile_Picture_1626602531691",institutionString:null,institution:{name:"Universidad de Los Andes",institutionURL:null,country:{name:"Colombia"}}},{id:"69697",title:"Dr.",name:"Mani T.",middleName:null,surname:"Valarmathi",slug:"mani-t.-valarmathi",fullName:"Mani T. Valarmathi",profilePictureURL:"https://mts.intechopen.com/storage/users/69697/images/system/69697.jpg",institutionString:"Religen Inc. | A Life Science Company, United States of America",institution:null},{id:"205081",title:"Dr.",name:"Marco",middleName:"Vinícius",surname:"Chaud",slug:"marco-chaud",fullName:"Marco Chaud",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bSDGeQAO/Profile_Picture_1622624307737",institutionString:null,institution:{name:"Universidade de Sorocaba",institutionURL:null,country:{name:"Brazil"}}}]}]},overviewPageOFChapters:{paginationCount:8,paginationItems:[{id:"82289",title:"Consumer Culture and Abundance of Choices: Having More, Feeling Blue",doi:"10.5772/intechopen.105607",signatures:"Ondřej Roubal",slug:"consumer-culture-and-abundance-of-choices-having-more-feeling-blue",totalDownloads:2,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"A New Era of Consumer Behavior - Beyond the Pandemic",coverURL:"https://cdn.intechopen.com/books/images_new/11581.jpg",subseries:{id:"88",title:"Marketing"}}},{id:"82405",title:"Does Board Structure Matter in CSR Spending of Commercial Banks? Empirical Evidence from an Emerging Economy",doi:"10.5772/intechopen.105589",signatures:"Bishnu Kumar Adhikary and Ranjan Kumar Mitra",slug:"does-board-structure-matter-in-csr-spending-of-commercial-banks-empirical-evidence-from-an-emerging-",totalDownloads:8,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Corporate Social Responsibility",coverURL:"https://cdn.intechopen.com/books/images_new/11602.jpg",subseries:{id:"86",title:"Business and Management"}}},{id:"82395",title:"Toward a Better Understanding of Green Human Resource Management’s Impact on Green Competitive Advantage: A Conceptual Model",doi:"10.5772/intechopen.105528",signatures:"Hosna Hossari and Kaoutar Elfahli",slug:"toward-a-better-understanding-of-green-human-resource-management-s-impact-on-green-competitive-advan",totalDownloads:12,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Corporate Social Responsibility",coverURL:"https://cdn.intechopen.com/books/images_new/11602.jpg",subseries:{id:"86",title:"Business and Management"}}},{id:"82269",title:"CSR Reporting and Blockchain Technology",doi:"10.5772/intechopen.105512",signatures:"Pattarake Sarajoti, Pattanaporn Chatjuthamard, Suwongrat Papangkorn and Piyachart Phiromswad",slug:"csr-reporting-and-blockchain-technology",totalDownloads:9,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Corporate Social Responsibility",coverURL:"https://cdn.intechopen.com/books/images_new/11602.jpg",subseries:{id:"86",title:"Business and Management"}}}]},overviewPagePublishedBooks:{paginationCount:1,paginationItems:[{type:"book",id:"11392",title:"Leadership in a Changing World",subtitle:"A Multidimensional Perspective",coverURL:"https://cdn.intechopen.com/books/images_new/11392.jpg",slug:"leadership-in-a-changing-world-a-multidimensional-perspective",publishedDate:"May 11th 2022",editedByType:"Edited by",bookSignature:"Muhammad Mohiuddin, Bilal Khalid, Md. Samim Al Azad and Slimane Ed-dafali",hash:"86a6d33cf601587e591064ce92effc02",volumeInSeries:1,fullTitle:"Leadership in a Changing World - A Multidimensional Perspective",editors:[{id:"418514",title:"Dr.",name:"Muhammad",middleName:null,surname:"Mohiuddin",slug:"muhammad-mohiuddin",fullName:"Muhammad Mohiuddin",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y000038UqSfQAK/Profile_Picture_2022-05-13T10:39:03.jpg",biography:"Dr. Muhammad Mohiuddin is an Associate Professor of International Business at Laval University, Canada. He has taught at Thompson Rivers University, Canada; University of Paris-Est, France; Osnabruck University of Applied Science, Germany; and Shanghai Institute of Technology and Tianjin University of Technology, China. He has published research in Research Policy, Applied Economics, Review of Economic Philosophy, Strategic Change, International Journal of Logistics, Sustainability, Journal of Environmental Management, Journal of Global Information Management, Journal of Cleaner Production, M@N@GEMENT, and more. He is a member of CEDIMES Institut (France), Academy of International Business (AIB), Strategic Management Society (SMS), Academy of Management (AOM), Administrative Science Association of Canada (ASAC), and Canadian council of small business and entrepreneurship (CCSBE). He is currently the director of the Research Group on Contemporary Asia (GERAC) at Laval University. He is also co-managing editor of Transnational Corporations Review and a guest editor for Electronic Commerce Research and Journal of Internet Technology.",institutionString:"Université Laval",institution:{name:"Université Laval",institutionURL:null,country:{name:"Canada"}}}]}]},openForSubmissionBooks:{paginationCount:3,paginationItems:[{id:"11601",title:"Econometrics - Recent Advances and Applications",coverURL:"https://cdn.intechopen.com/books/images_new/11601.jpg",hash:"bc8ab49e2cf436c217a49ca8c12a22eb",secondStepPassed:!0,currentStepOfPublishingProcess:3,submissionDeadline:"May 13th 2022",isOpenForSubmission:!0,editors:[{id:"452331",title:"Dr.",name:"Brian",surname:"Sloboda",slug:"brian-sloboda",fullName:"Brian Sloboda"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{id:"12141",title:"Leadership - Advancing Great Leadership Practices and Good Leaders",coverURL:"https://cdn.intechopen.com/books/images_new/12141.jpg",hash:"85f77453916f1d80d80d88ee4fd2f2d1",secondStepPassed:!0,currentStepOfPublishingProcess:3,submissionDeadline:"July 1st 2022",isOpenForSubmission:!0,editors:[{id:"420133",title:"Dr.",name:"Joseph",surname:"Crawford",slug:"joseph-crawford",fullName:"Joseph Crawford"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{id:"12139",title:"Global Market and Trade",coverURL:"https://cdn.intechopen.com/books/images_new/12139.jpg",hash:"fa34af07c3a9657fa670404202f8cba5",secondStepPassed:!1,currentStepOfPublishingProcess:2,submissionDeadline:"July 21st 2022",isOpenForSubmission:!0,editors:[{id:"243649",title:"Dr.Ing.",name:"Ireneusz",surname:"Miciuła",slug:"ireneusz-miciula",fullName:"Ireneusz Miciuła"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null}]},onlineFirstChapters:{paginationCount:8,paginationItems:[{id:"82289",title:"Consumer Culture and Abundance of Choices: Having More, Feeling Blue",doi:"10.5772/intechopen.105607",signatures:"Ondřej Roubal",slug:"consumer-culture-and-abundance-of-choices-having-more-feeling-blue",totalDownloads:2,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"A New Era of Consumer Behavior - Beyond the Pandemic",coverURL:"https://cdn.intechopen.com/books/images_new/11581.jpg",subseries:{id:"88",title:"Marketing"}}},{id:"82405",title:"Does Board Structure Matter in CSR Spending of Commercial Banks? Empirical Evidence from an Emerging Economy",doi:"10.5772/intechopen.105589",signatures:"Bishnu Kumar Adhikary and Ranjan Kumar Mitra",slug:"does-board-structure-matter-in-csr-spending-of-commercial-banks-empirical-evidence-from-an-emerging-",totalDownloads:8,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Corporate Social Responsibility",coverURL:"https://cdn.intechopen.com/books/images_new/11602.jpg",subseries:{id:"86",title:"Business and Management"}}},{id:"82395",title:"Toward a Better Understanding of Green Human Resource Management’s Impact on Green Competitive Advantage: A Conceptual Model",doi:"10.5772/intechopen.105528",signatures:"Hosna Hossari and Kaoutar Elfahli",slug:"toward-a-better-understanding-of-green-human-resource-management-s-impact-on-green-competitive-advan",totalDownloads:12,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Corporate Social Responsibility",coverURL:"https://cdn.intechopen.com/books/images_new/11602.jpg",subseries:{id:"86",title:"Business and Management"}}},{id:"82269",title:"CSR Reporting and Blockchain Technology",doi:"10.5772/intechopen.105512",signatures:"Pattarake Sarajoti, Pattanaporn Chatjuthamard, Suwongrat Papangkorn and Piyachart Phiromswad",slug:"csr-reporting-and-blockchain-technology",totalDownloads:9,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Corporate Social Responsibility",coverURL:"https://cdn.intechopen.com/books/images_new/11602.jpg",subseries:{id:"86",title:"Business and Management"}}},{id:"82270",title:"From Corporate Social Opportunity to Corporate Social Responsibility",doi:"10.5772/intechopen.105445",signatures:"Brian Bolton",slug:"from-corporate-social-opportunity-to-corporate-social-responsibility",totalDownloads:6,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Corporate Social Responsibility",coverURL:"https://cdn.intechopen.com/books/images_new/11602.jpg",subseries:{id:"86",title:"Business and Management"}}},{id:"82339",title:"Green Human Resource Management: An Exploratory Study from Moroccan ISO 14001 Certified Companies",doi:"10.5772/intechopen.105565",signatures:"Hosna Hossari and Kaoutar Elfahli",slug:"green-human-resource-management-an-exploratory-study-from-moroccan-iso-14001-certified-companies",totalDownloads:10,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Corporate Social Responsibility",coverURL:"https://cdn.intechopen.com/books/images_new/11602.jpg",subseries:{id:"86",title:"Business and Management"}}},{id:"82194",title:"CSR and Female Directors: A Review and Future Research Agenda",doi:"10.5772/intechopen.105112",signatures:"Pattarake Sarajoti, Pattanaporn Chatjuthamard, Suwongrat Papangkorn and Sirimon Treepongkaruna",slug:"csr-and-female-directors-a-review-and-future-research-agenda",totalDownloads:11,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Corporate Social Responsibility",coverURL:"https://cdn.intechopen.com/books/images_new/11602.jpg",subseries:{id:"86",title:"Business and Management"}}},{id:"81831",title:"Deep Network Model and Regression Analysis using OLS Method for Predicting Lung Vital Capacity",doi:"10.5772/intechopen.104737",signatures:"Harun Sümbül",slug:"deep-network-model-and-regression-analysis-using-ols-method-for-predicting-lung-vital-capacity",totalDownloads:12,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Decision Science - Recent Advances and Applications",coverURL:"https://cdn.intechopen.com/books/images_new/11604.jpg",subseries:{id:"86",title:"Business and Management"}}}]},subseriesFiltersForOFChapters:[{caption:"Marketing",value:88,count:1,group:"subseries"},{caption:"Business and Management",value:86,count:7,group:"subseries"}],publishedBooks:{paginationCount:32,paginationItems:[{type:"book",id:"10798",title:"Starch",subtitle:"Evolution and Recent Advances",coverURL:"https://cdn.intechopen.com/books/images_new/10798.jpg",slug:"starch-evolution-and-recent-advances",publishedDate:"June 28th 2022",editedByType:"Edited by",bookSignature:"Martins Ochubiojo Emeje",hash:"f197f6062c1574a9a90e50a369271bcf",volumeInSeries:33,fullTitle:"Starch - Evolution and Recent Advances",editors:[{id:"94311",title:"Prof.",name:"Martins",middleName:"Ochubiojo",surname:"Ochubiojo Emeje",slug:"martins-ochubiojo-emeje",fullName:"Martins Ochubiojo Emeje",profilePictureURL:"https://mts.intechopen.com/storage/users/94311/images/system/94311.jpeg",institutionString:"National Institute for Pharmaceutical Research and Development",institution:{name:"National Institute for Pharmaceutical Research and Development",institutionURL:null,country:{name:"Nigeria"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"11332",title:"Essential Oils",subtitle:"Advances in Extractions and Biological Applications",coverURL:"https://cdn.intechopen.com/books/images_new/11332.jpg",slug:"essential-oils-advances-in-extractions-and-biological-applications",publishedDate:"June 23rd 2022",editedByType:"Edited by",bookSignature:"Mozaniel Santana de Oliveira and Eloisa Helena de Aguiar Andrade",hash:"742e6cae3a35686f975edc8d7f9afa94",volumeInSeries:32,fullTitle:"Essential Oils - Advances in Extractions and Biological Applications",editors:[{id:"195290",title:"Ph.D.",name:"Mozaniel",middleName:null,surname:"Santana De Oliveira",slug:"mozaniel-santana-de-oliveira",fullName:"Mozaniel Santana De Oliveira",profilePictureURL:"https://mts.intechopen.com/storage/users/195290/images/system/195290.png",institutionString:"Museu Paraense Emílio Goeldi",institution:{name:"Museu Paraense Emílio Goeldi",institutionURL:null,country:{name:"Brazil"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"10839",title:"Protein Detection",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/10839.jpg",slug:"protein-detection",publishedDate:"June 23rd 2022",editedByType:"Edited by",bookSignature:"Yusuf Tutar and Lütfi Tutar",hash:"2f1c0e4e0207fc45c936e7d22a5369c4",volumeInSeries:31,fullTitle:"Protein Detection",editors:[{id:"158492",title:"Prof.",name:"Yusuf",middleName:null,surname:"Tutar",slug:"yusuf-tutar",fullName:"Yusuf Tutar",profilePictureURL:"https://mts.intechopen.com/storage/users/158492/images/system/158492.jpeg",institutionString:"University of Health Sciences",institution:null}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"10797",title:"Cell Culture",subtitle:"Advanced Technology and Applications in Medical and Life Sciences",coverURL:"https://cdn.intechopen.com/books/images_new/10797.jpg",slug:"cell-culture-advanced-technology-and-applications-in-medical-and-life-sciences",publishedDate:"June 15th 2022",editedByType:"Edited by",bookSignature:"Xianquan Zhan",hash:"2c628f4757f9639a4450728d839a7842",volumeInSeries:30,fullTitle:"Cell Culture - Advanced Technology and Applications in Medical and Life Sciences",editors:[{id:"223233",title:"Prof.",name:"Xianquan",middleName:null,surname:"Zhan",slug:"xianquan-zhan",fullName:"Xianquan Zhan",profilePictureURL:"https://mts.intechopen.com/storage/users/223233/images/system/223233.png",institutionString:"Shandong First Medical University",institution:{name:"Affiliated Hospital of Shandong Academy of Medical Sciences",institutionURL:null,country:{name:"China"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"10841",title:"Hydrolases",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/10841.jpg",slug:"hydrolases",publishedDate:"June 15th 2022",editedByType:"Edited by",bookSignature:"Sajjad Haider, Adnan Haider and Angel Catalá",hash:"4e868cde273d65a7ff54b1817d640629",volumeInSeries:29,fullTitle:"Hydrolases",editors:[{id:"110708",title:"Dr.",name:"Sajjad",middleName:null,surname:"Haider",slug:"sajjad-haider",fullName:"Sajjad Haider",profilePictureURL:"https://mts.intechopen.com/storage/users/110708/images/system/110708.png",institutionString:"King Saud University",institution:{name:"King Saud University",institutionURL:null,country:{name:"Saudi Arabia"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"10803",title:"Reactive Oxygen Species",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/10803.jpg",slug:"reactive-oxygen-species",publishedDate:"April 28th 2022",editedByType:"Edited by",bookSignature:"Rizwan Ahmad",hash:"176adcf090fdd1f93cb8ce3146e79ca1",volumeInSeries:28,fullTitle:"Reactive Oxygen Species",editors:[{id:"40482",title:null,name:"Rizwan",middleName:null,surname:"Ahmad",slug:"rizwan-ahmad",fullName:"Rizwan Ahmad",profilePictureURL:"https://mts.intechopen.com/storage/users/40482/images/system/40482.jpeg",institutionString:"Imam Abdulrahman Bin Faisal University",institution:{name:"Imam Abdulrahman Bin Faisal University",institutionURL:null,country:{name:"Saudi Arabia"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"9008",title:"Vitamin K",subtitle:"Recent Topics on the Biology and Chemistry",coverURL:"https://cdn.intechopen.com/books/images_new/9008.jpg",slug:"vitamin-k-recent-topics-on-the-biology-and-chemistry",publishedDate:"March 23rd 2022",editedByType:"Edited by",bookSignature:"Hiroyuki Kagechika and Hitoshi Shirakawa",hash:"8b43add5389ba85743e0a9491e4b9943",volumeInSeries:27,fullTitle:"Vitamin K - Recent Topics on the Biology and Chemistry",editors:[{id:"180528",title:"Dr.",name:"Hiroyuki",middleName:null,surname:"Kagechika",slug:"hiroyuki-kagechika",fullName:"Hiroyuki Kagechika",profilePictureURL:"https://mts.intechopen.com/storage/users/180528/images/system/180528.jpg",institutionString:"Tokyo Medical and Dental University",institution:{name:"Tokyo Medical and Dental University",institutionURL:null,country:{name:"Japan"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"10799",title:"Phenolic Compounds",subtitle:"Chemistry, Synthesis, Diversity, Non-Conventional Industrial, Pharmaceutical and Therapeutic Applications",coverURL:"https://cdn.intechopen.com/books/images_new/10799.jpg",slug:"phenolic-compounds-chemistry-synthesis-diversity-non-conventional-industrial-pharmaceutical-and-therapeutic-applications",publishedDate:"February 23rd 2022",editedByType:"Edited by",bookSignature:"Farid A. Badria",hash:"339199f254d2987ef3167eef74fb8a38",volumeInSeries:26,fullTitle:"Phenolic Compounds - Chemistry, Synthesis, Diversity, Non-Conventional Industrial, Pharmaceutical and Therapeutic Applications",editors:[{id:"41865",title:"Prof.",name:"Farid A.",middleName:null,surname:"Badria",slug:"farid-a.-badria",fullName:"Farid A. Badria",profilePictureURL:"https://mts.intechopen.com/storage/users/41865/images/system/41865.jpg",institutionString:"Mansoura University",institution:{name:"Mansoura University",institutionURL:null,country:{name:"Egypt"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"9659",title:"Fibroblasts",subtitle:"Advances in Inflammation, Autoimmunity and Cancer",coverURL:"https://cdn.intechopen.com/books/images_new/9659.jpg",slug:"fibroblasts-advances-in-inflammation-autoimmunity-and-cancer",publishedDate:"December 22nd 2021",editedByType:"Edited by",bookSignature:"Mojca Frank Bertoncelj and Katja Lakota",hash:"926fa6446f6befbd363fc74971a56de2",volumeInSeries:25,fullTitle:"Fibroblasts - Advances in Inflammation, Autoimmunity and Cancer",editors:[{id:"328755",title:"Ph.D.",name:"Mojca",middleName:null,surname:"Frank Bertoncelj",slug:"mojca-frank-bertoncelj",fullName:"Mojca Frank Bertoncelj",profilePictureURL:"https://mts.intechopen.com/storage/users/328755/images/system/328755.jpg",institutionString:"BioMed X Institute",institution:{name:"University Hospital of Zurich",institutionURL:null,country:{name:"Switzerland"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8977",title:"Protein Kinases",subtitle:"Promising Targets for Anticancer Drug Research",coverURL:"https://cdn.intechopen.com/books/images_new/8977.jpg",slug:"protein-kinases-promising-targets-for-anticancer-drug-research",publishedDate:"December 8th 2021",editedByType:"Edited by",bookSignature:"Rajesh Kumar Singh",hash:"6d200cc031706a565b554fdb1c478901",volumeInSeries:24,fullTitle:"Protein Kinases - Promising Targets for Anticancer Drug Research",editors:[{id:"329385",title:"Dr.",name:"Rajesh K.",middleName:"Kumar",surname:"Singh",slug:"rajesh-k.-singh",fullName:"Rajesh K. Singh",profilePictureURL:"https://mts.intechopen.com/storage/users/329385/images/system/329385.png",institutionString:"Punjab Technical University",institution:{name:"Punjab Technical University",institutionURL:null,country:{name:"India"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8018",title:"Extracellular Matrix",subtitle:"Developments and Therapeutics",coverURL:"https://cdn.intechopen.com/books/images_new/8018.jpg",slug:"extracellular-matrix-developments-and-therapeutics",publishedDate:"October 27th 2021",editedByType:"Edited by",bookSignature:"Rama Sashank Madhurapantula, Joseph Orgel P.R.O. and Zvi Loewy",hash:"c85e82851e80b40282ff9be99ddf2046",volumeInSeries:23,fullTitle:"Extracellular Matrix - Developments and Therapeutics",editors:[{id:"212416",title:"Dr.",name:"Rama Sashank",middleName:null,surname:"Madhurapantula",slug:"rama-sashank-madhurapantula",fullName:"Rama Sashank Madhurapantula",profilePictureURL:"https://mts.intechopen.com/storage/users/212416/images/system/212416.jpg",institutionString:"Illinois Institute of Technology",institution:{name:"Illinois Institute of Technology",institutionURL:null,country:{name:"United States of America"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"9759",title:"Vitamin E in Health and Disease",subtitle:"Interactions, Diseases and Health Aspects",coverURL:"https://cdn.intechopen.com/books/images_new/9759.jpg",slug:"vitamin-e-in-health-and-disease-interactions-diseases-and-health-aspects",publishedDate:"October 6th 2021",editedByType:"Edited by",bookSignature:"Pınar Erkekoglu and Júlia Scherer Santos",hash:"6c3ddcc13626110de289b57f2516ac8f",volumeInSeries:22,fullTitle:"Vitamin E in Health and Disease - Interactions, Diseases and Health Aspects",editors:[{id:"109978",title:"Prof.",name:"Pınar",middleName:null,surname:"Erkekoğlu",slug:"pinar-erkekoglu",fullName:"Pınar Erkekoğlu",profilePictureURL:"https://mts.intechopen.com/storage/users/109978/images/system/109978.jpg",institutionString:"Hacettepe University",institution:{name:"Hacettepe University",institutionURL:null,country:{name:"Turkey"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null}]},subseriesFiltersForPublishedBooks:[{group:"subseries",caption:"Proteomics",value:18,count:4},{group:"subseries",caption:"Metabolism",value:17,count:6},{group:"subseries",caption:"Cell and Molecular Biology",value:14,count:9},{group:"subseries",caption:"Chemical Biology",value:15,count:13}],publicationYearFilters:[{group:"publicationYear",caption:"2022",value:2022,count:8},{group:"publicationYear",caption:"2021",value:2021,count:7},{group:"publicationYear",caption:"2020",value:2020,count:12},{group:"publicationYear",caption:"2019",value:2019,count:3},{group:"publicationYear",caption:"2018",value:2018,count:2}],authors:{paginationCount:25,paginationItems:[{id:"429683",title:"Dr.",name:"Bilal",middleName:null,surname:"Khalid",slug:"bilal-khalid",fullName:"Bilal Khalid",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/429683/images/system/429683.png",biography:"Dr. Bilal Khalid received a Ph.D. in Industrial Business Administration from KMITL Business School, Bangkok, in 2021, and a master’s in International Business Management from Stamford International University, Bangkok, in 2017. Dr. Khalid\\'s research interests include leadership and negotiations, digital transformations, gamification, eLearning, blockchain, Big Data, and management of information technology. Dr. Bilal Khalid also serves as an academic editor at Education Research International and a reviewer for international journals.",institutionString:"KMITL Business School",institution:{name:"King Mongkut's Institute of Technology Ladkrabang",country:{name:"Thailand"}}},{id:"418514",title:"Dr.",name:"Muhammad",middleName:null,surname:"Mohiuddin",slug:"muhammad-mohiuddin",fullName:"Muhammad Mohiuddin",position:null,profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y000038UqSfQAK/Profile_Picture_2022-05-13T10:39:03.jpg",biography:"Dr. Muhammad Mohiuddin is an Associate Professor of International Business at Laval University, Canada. He has taught at Thompson Rivers University, Canada; University of Paris-Est, France; Osnabruck University of Applied Science, Germany; and Shanghai Institute of Technology and Tianjin University of Technology, China. He has published research in Research Policy, Applied Economics, Review of Economic Philosophy, Strategic Change, International Journal of Logistics, Sustainability, Journal of Environmental Management, Journal of Global Information Management, Journal of Cleaner Production, M@N@GEMENT, and more. He is a member of CEDIMES Institut (France), Academy of International Business (AIB), Strategic Management Society (SMS), Academy of Management (AOM), Administrative Science Association of Canada (ASAC), and Canadian council of small business and entrepreneurship (CCSBE). He is currently the director of the Research Group on Contemporary Asia (GERAC) at Laval University. He is also co-managing editor of Transnational Corporations Review and a guest editor for Electronic Commerce Research and Journal of Internet Technology.",institutionString:"Université Laval",institution:{name:"Université Laval",country:{name:"Canada"}}},{id:"189147",title:"Dr.",name:"Hailan",middleName:null,surname:"Salamun",slug:"hailan-salamun",fullName:"Hailan Salamun",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/189147/images/19274_n.jpeg",biography:"Hailan Salamun, (Dr.) was born in Selangor, Malaysia and graduated from Tunku Ampuan Jamaah Religious High School at Shah Alam. Obtained a degree from the International Islamic University (UIA), Gombak in the field of Islamic Revealed Knowledge and Heritage. Next, I furthered my studies to the professional level to obtain a Diploma in Education at UIA. After serving for several years in school, I furthered my studies to the Master of Dakwah and Leadership at Universiti Kebangsaan Malaysia (UKM), Bangi. I graduated with a Doctor of Philosophy in Principalship Leadership from the University of Malaya (UM) in 2010. I am currently a senior lecturer in the Department of Nationalism and Civilization, Center for Basic and Continuing Education, Universiti Malaysia Terengganu. Prior to that, I had served in several educational institutions such as schools, the Institute of Teacher Education (IPG), and also the University of Malaya. I am also actively involved in paper presentation, writing and publishing. My research interests are focused on leadership, education, society and Islamic civilization. This area of research requires a detailed understanding of Islamic studies and research studies in leadership. Another research interest that I have explored recently is the politics of the Malay community and also the leadership of the mosque.",institutionString:null,institution:{name:"Universiti Malaysia Terengganu",country:{name:"Malaysia"}}},{id:"442081",title:"Dr.",name:"Audrey",middleName:null,surname:"Addy",slug:"audrey-addy",fullName:"Audrey Addy",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Kwame Nkrumah University of Science and Technology",country:{name:"Ghana"}}},{id:"437993",title:"Mr.",name:"Job",middleName:null,surname:"Jackson",slug:"job-jackson",fullName:"Job Jackson",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Management College of Southern Africa",country:{name:"South Africa"}}},{id:"428495",title:"Prof.",name:"Asyraf",middleName:null,surname:"Ab Rahman",slug:"asyraf-ab-rahman",fullName:"Asyraf Ab Rahman",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universiti Malaysia Terengganu",country:{name:"Malaysia"}}},{id:"429650",title:"Dr.",name:"Jacqueline",middleName:null,surname:"Kareem",slug:"jacqueline-kareem",fullName:"Jacqueline Kareem",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Christ University",country:{name:"India"}}},{id:"421041",title:"Dr.",name:"Sunil",middleName:null,surname:"Kumar Ramdas",slug:"sunil-kumar-ramdas",fullName:"Sunil Kumar Ramdas",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Jain University",country:{name:"India"}}},{id:"421833",title:"Mr.",name:"Eugene",middleName:null,surname:"Owusu-Acheampong",slug:"eugene-owusu-acheampong",fullName:"Eugene Owusu-Acheampong",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Ghana",country:{name:"Ghana"}}},{id:"239876",title:"Ph.D.",name:"Luciana",middleName:null,surname:"Mourão",slug:"luciana-mourao",fullName:"Luciana Mourão",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universidade Salgado de Oliveira",country:{name:"Brazil"}}},{id:"421735",title:"Dr.",name:"elizabeth",middleName:null,surname:"addy",slug:"elizabeth-addy",fullName:"elizabeth addy",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"442083",title:"Dr.",name:"James",middleName:null,surname:"Addy",slug:"james-addy",fullName:"James Addy",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"437991",title:"Prof.",name:"Muhammad",middleName:null,surname:"Hoque",slug:"muhammad-hoque",fullName:"Muhammad Hoque",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"421006",title:"Dr.",name:"Anna",middleName:null,surname:"Uster",slug:"anna-uster",fullName:"Anna Uster",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"470243",title:"Dr.",name:"Md Samim",middleName:null,surname:"Al Azad",slug:"md-samim-al-azad",fullName:"Md Samim Al Azad",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"470244",title:"Dr.",name:"Slimane",middleName:null,surname:"Ed-dafali",slug:"slimane-ed-dafali",fullName:"Slimane Ed-dafali",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"421011",title:"Dr.",name:"Afatakpa",middleName:null,surname:"Fortune",slug:"afatakpa-fortune",fullName:"Afatakpa Fortune",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"446057",title:"Mr.",name:"Okedare",middleName:null,surname:"David Olubukunmi",slug:"okedare-david-olubukunmi",fullName:"Okedare David Olubukunmi",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"421778",title:"Dr.",name:"Fatimah",middleName:"Saeed",surname:"AlAhmari",slug:"fatimah-alahmari",fullName:"Fatimah AlAhmari",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"421024",title:"Prof.",name:"Harold Andrew",middleName:null,surname:"Patrick",slug:"harold-andrew-patrick",fullName:"Harold Andrew Patrick",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"421065",title:"Ms.",name:"Euzália",middleName:null,surname:"do Rosário Botelho Tomé",slug:"euzalia-do-rosario-botelho-tome",fullName:"Euzália do Rosário Botelho Tomé",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"421053",title:"Associate Prof.",name:"Ken",middleName:null,surname:"Kalala Ndalamba",slug:"ken-kalala-ndalamba",fullName:"Ken Kalala Ndalamba",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"421826",title:"Dr.",name:"Inusah",middleName:null,surname:"Salifu",slug:"inusah-salifu",fullName:"Inusah Salifu",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"420823",title:"Prof.",name:"Gardênia da Silva",middleName:null,surname:"Abbad",slug:"gardenia-da-silva-abbad",fullName:"Gardênia da Silva Abbad",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"437613",title:"MSc.",name:"Juliana",middleName:null,surname:"Legentil",slug:"juliana-legentil",fullName:"Juliana Legentil",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null}]}},subseries:{item:{id:"28",type:"subseries",title:"Animal Reproductive Biology and Technology",keywords:"Animal Reproduction, Artificial Insemination, Embryos, Cryopreservation, Conservation, Breeding, Epigenetics",scope:"The advances of knowledge on animal reproductive biology and technologies revolutionized livestock production. Artificial insemination, for example, was the first technology applied on a large scale, initially in dairy cattle and afterward applied to other species. Nowadays, embryo production and transfer are used commercially along with other technologies to modulate epigenetic regulation. Gene editing is also emerging as an innovative tool. This topic will discuss the potential use of these techniques, novel strategies, and lines of research in progress in the fields mentioned above.",coverUrl:"https://cdn.intechopen.com/series_topics/covers/28.jpg",hasOnlineFirst:!1,hasPublishedBooks:!0,annualVolume:11417,editor:{id:"177225",title:"Prof.",name:"Rosa Maria Lino Neto",middleName:null,surname:"Pereira",slug:"rosa-maria-lino-neto-pereira",fullName:"Rosa Maria Lino Neto Pereira",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bS9wkQAC/Profile_Picture_1624519982291",biography:"Rosa Maria Lino Neto Pereira (DVM, MsC, PhD and) is currently a researcher at the Genetic Resources and Biotechnology Unit of the National Institute of Agrarian and Veterinarian Research (INIAV, Portugal). She is the head of the Reproduction and Embryology Laboratories and was lecturer of Reproduction and Reproductive Biotechnologies at Veterinary Medicine Faculty. She has over 25 years of experience working in reproductive biology and biotechnology areas with a special emphasis on embryo and gamete cryopreservation, for research and animal genetic resources conservation, leading research projects with several peer-reviewed papers. Rosa Pereira is member of the ERFP-FAO Ex situ Working Group and of the Management Commission of the Portuguese Animal Germplasm Bank.",institutionString:"The National Institute for Agricultural and Veterinary Research. Portugal",institution:null},editorTwo:null,editorThree:null,series:{id:"13",title:"Veterinary Medicine and Science",doi:"10.5772/intechopen.73681",issn:"2632-0517"},editorialBoard:[{id:"90066",title:"Dr.",name:"Alexandre",middleName:"Rodrigues",surname:"Silva",slug:"alexandre-silva",fullName:"Alexandre Silva",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRt8pQAC/Profile_Picture_1622531020756",institutionString:null,institution:{name:"Universidade Federal Rural do Semi-Árido",institutionURL:null,country:{name:"Brazil"}}},{id:"176987",title:"Ph.D.",name:"María-José",middleName:"Carrascosa",surname:"Argente",slug:"maria-jose-argente",fullName:"María-José Argente",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bS9vOQAS/Profile_Picture_1630330499537",institutionString:null,institution:{name:"Miguel Hernandez University",institutionURL:null,country:{name:"Spain"}}},{id:"321396",title:"Prof.",name:"Muhammad Subhan",middleName:null,surname:"Qureshi",slug:"muhammad-subhan-qureshi",fullName:"Muhammad Subhan Qureshi",profilePictureURL:"https://mts.intechopen.com/storage/users/321396/images/system/321396.jpg",institutionString:null,institution:{name:"University of Agriculture",institutionURL:null,country:{name:"Pakistan"}}},{id:"183723",title:"Dr.",name:"Xiaojun",middleName:null,surname:"Liu",slug:"xiaojun-liu",fullName:"Xiaojun Liu",profilePictureURL:"https://mts.intechopen.com/storage/users/183723/images/system/183723.jpg",institutionString:null,institution:null}]},onlineFirstChapters:{paginationCount:6,paginationItems:[{id:"82291",title:"The Role of Oxidative Stress in the Onset and Development of Age-Related Macular Degeneration",doi:"10.5772/intechopen.105599",signatures:"Emina Čolak, Lepša Žorić, Miloš Mirković, Jana Mirković, Ilija Dragojević, Dijana Mirić, Bojana Kisić and Ljubinka Nikolić",slug:"the-role-of-oxidative-stress-in-the-onset-and-development-of-age-related-macular-degeneration",totalDownloads:0,totalCrossrefCites:null,totalDimensionsCites:null,authors:null,book:{title:"Importance of Oxidative Stress and Antioxidant System in Health and Disease",coverURL:"https://cdn.intechopen.com/books/images_new/11671.jpg",subseries:{id:"15",title:"Chemical Biology"}}},{id:"82029",title:"Synthesis, Characterization and Antimicrobial Properties of Novel Benzimidazole Amide Derivatives Bearing Thiophene Moiety",doi:"10.5772/intechopen.104908",signatures:"Vinayak Adimule, Pravin Kendrekar and Sheetal Batakurki",slug:"synthesis-characterization-and-antimicrobial-properties-of-novel-benzimidazole-amide-derivatives-bea",totalDownloads:6,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Benzimidazole",coverURL:"https://cdn.intechopen.com/books/images_new/10840.jpg",subseries:{id:"15",title:"Chemical Biology"}}},{id:"80168",title:"Benzimidazole: Pharmacological Profile",doi:"10.5772/intechopen.102091",signatures:"Mahender Thatikayala, Anil Kumar Garige and Hemalatha Gadegoni",slug:"benzimidazole-pharmacological-profile",totalDownloads:84,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Benzimidazole",coverURL:"https://cdn.intechopen.com/books/images_new/10840.jpg",subseries:{id:"15",title:"Chemical Biology"}}},{id:"80130",title:"Exploring the Versatility of Benzimidazole Scaffolds as Medicinal Agents: A Brief Update",doi:"10.5772/intechopen.101942",signatures:"Gopakumar Kavya and Akhil Sivan",slug:"exploring-the-versatility-of-benzimidazole-scaffolds-as-medicinal-agents-a-brief-update",totalDownloads:62,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Benzimidazole",coverURL:"https://cdn.intechopen.com/books/images_new/10840.jpg",subseries:{id:"15",title:"Chemical Biology"}}},{id:"79964",title:"The Anticancer Profile of Benzimidazolium Salts and Their Metal Complexes",doi:"10.5772/intechopen.101729",signatures:"Imran Ahmad Khan, Noor ul Amin Mohsin, Sana Aslam and Matloob Ahmad",slug:"the-anticancer-profile-of-benzimidazolium-salts-and-their-metal-complexes",totalDownloads:95,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Benzimidazole",coverURL:"https://cdn.intechopen.com/books/images_new/10840.jpg",subseries:{id:"15",title:"Chemical Biology"}}},{id:"79835",title:"Advances of Benzimidazole Derivatives as Anticancer Agents: Bench to Bedside",doi:"10.5772/intechopen.101702",signatures:"Kashif Haider and Mohammad Shahar Yar",slug:"advances-of-benzimidazole-derivatives-as-anticancer-agents-bench-to-bedside",totalDownloads:128,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Benzimidazole",coverURL:"https://cdn.intechopen.com/books/images_new/10840.jpg",subseries:{id:"15",title:"Chemical Biology"}}}]},publishedBooks:{paginationCount:4,paginationItems:[{type:"book",id:"9869",title:"Self-Driving Vehicles and Enabling Technologies",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/9869.jpg",slug:"self-driving-vehicles-and-enabling-technologies",publishedDate:"September 22nd 2021",editedByType:"Edited by",bookSignature:"Marian Găiceanu",hash:"fd451ca2e4785ef098e04b7d695a18d9",volumeInSeries:6,fullTitle:"Self-Driving Vehicles and Enabling Technologies",editors:[{id:"169608",title:"Prof.",name:"Marian",middleName:null,surname:"Găiceanu",slug:"marian-gaiceanu",fullName:"Marian Găiceanu",profilePictureURL:"https://mts.intechopen.com/storage/users/169608/images/system/169608.png",institutionString:'"Dunarea de Jos" University of Galati',institution:{name:'"Dunarea de Jos" University of Galati',institutionURL:null,country:{name:"Romania"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"9958",title:"Artificial Intelligence",subtitle:"Latest Advances, New Paradigms and Novel Applications",coverURL:"https://cdn.intechopen.com/books/images_new/9958.jpg",slug:"artificial-intelligence-latest-advances-new-paradigms-and-novel-applications",publishedDate:"September 1st 2021",editedByType:"Edited by",bookSignature:"Eneko Osaba, Esther Villar, Jesús L. Lobo and Ibai Laña",hash:"39648fbfdaa11385097d62b1f13aad54",volumeInSeries:5,fullTitle:"Artificial Intelligence - Latest Advances, New Paradigms and Novel Applications",editors:[{id:"221364",title:"Dr.",name:"Eneko",middleName:null,surname:"Osaba",slug:"eneko-osaba",fullName:"Eneko Osaba",profilePictureURL:"https://mts.intechopen.com/storage/users/221364/images/system/221364.jpg",institutionString:"TECNALIA Research & Innovation",institution:{name:"Tecnalia",institutionURL:null,country:{name:"Spain"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"7656",title:"Fuzzy Logic",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/7656.jpg",slug:"fuzzy-logic",publishedDate:"February 5th 2020",editedByType:"Edited by",bookSignature:"Constantin Volosencu",hash:"54f092d4ffe0abf5e4172a80025019bc",volumeInSeries:3,fullTitle:"Fuzzy Logic",editors:[{id:"1063",title:"Prof.",name:"Constantin",middleName:null,surname:"Volosencu",slug:"constantin-volosencu",fullName:"Constantin Volosencu",profilePictureURL:"https://mts.intechopen.com/storage/users/1063/images/system/1063.png",institutionString:"Polytechnic University of Timişoara",institution:{name:"Polytechnic University of Timişoara",institutionURL:null,country:{name:"Romania"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"7723",title:"Artificial Intelligence",subtitle:"Applications in Medicine and Biology",coverURL:"https://cdn.intechopen.com/books/images_new/7723.jpg",slug:"artificial-intelligence-applications-in-medicine-and-biology",publishedDate:"July 31st 2019",editedByType:"Edited by",bookSignature:"Marco Antonio Aceves-Fernandez",hash:"a3852659e727f95c98c740ed98146011",volumeInSeries:1,fullTitle:"Artificial Intelligence - Applications in Medicine and Biology",editors:[{id:"24555",title:"Dr.",name:"Marco Antonio",middleName:null,surname:"Aceves Fernandez",slug:"marco-antonio-aceves-fernandez",fullName:"Marco Antonio Aceves Fernandez",profilePictureURL:"https://mts.intechopen.com/storage/users/24555/images/system/24555.jpg",institutionString:"Universidad Autonoma de Queretaro",institution:{name:"Autonomous University of Queretaro",institutionURL:null,country:{name:"Mexico"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null}]},testimonialsList:[{id:"18",text:"It was great publishing with IntechOpen, the process was straightforward and I had support all along.",author:{id:"71579",name:"Berend",surname:"Olivier",institutionString:"Utrecht University",profilePictureURL:"https://mts.intechopen.com/storage/users/71579/images/system/71579.png",slug:"berend-olivier",institution:{id:"253",name:"Utrecht University",country:{id:null,name:"Netherlands"}}}},{id:"27",text:"The opportunity to work with a prestigious publisher allows for the possibility to collaborate with more research groups interested in animal nutrition, leading to the development of new feeding strategies and food valuation while being more sustainable with the environment, allowing more readers to learn about the subject.",author:{id:"175967",name:"Manuel",surname:"Gonzalez Ronquillo",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/175967/images/system/175967.png",slug:"manuel-gonzalez-ronquillo",institution:{id:"6221",name:"Universidad Autónoma del Estado de México",country:{id:null,name:"Mexico"}}}},{id:"8",text:"I work with IntechOpen for a number of reasons: their professionalism, their mission in support of Open Access publishing, and the quality of their peer-reviewed publications, but also because they believe in equality.",author:{id:"202192",name:"Catrin",surname:"Rutland",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/202192/images/system/202192.png",slug:"catrin-rutland",institution:{id:"134",name:"University of Nottingham",country:{id:null,name:"United Kingdom"}}}}]},submityourwork:{pteSeriesList:[{id:"14",title:"Artificial Intelligence",numberOfPublishedBooks:9,numberOfPublishedChapters:90,numberOfOpenTopics:6,numberOfUpcomingTopics:0,issn:"2633-1403",doi:"10.5772/intechopen.79920",isOpenForSubmission:!0},{id:"7",title:"Biomedical Engineering",numberOfPublishedBooks:12,numberOfPublishedChapters:104,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2631-5343",doi:"10.5772/intechopen.71985",isOpenForSubmission:!0}],lsSeriesList:[{id:"11",title:"Biochemistry",numberOfPublishedBooks:32,numberOfPublishedChapters:319,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2632-0983",doi:"10.5772/intechopen.72877",isOpenForSubmission:!0},{id:"25",title:"Environmental Sciences",numberOfPublishedBooks:1,numberOfPublishedChapters:12,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2754-6713",doi:"10.5772/intechopen.100362",isOpenForSubmission:!0},{id:"10",title:"Physiology",numberOfPublishedBooks:11,numberOfPublishedChapters:141,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2631-8261",doi:"10.5772/intechopen.72796",isOpenForSubmission:!0}],hsSeriesList:[{id:"3",title:"Dentistry",numberOfPublishedBooks:8,numberOfPublishedChapters:133,numberOfOpenTopics:2,numberOfUpcomingTopics:0,issn:"2631-6218",doi:"10.5772/intechopen.71199",isOpenForSubmission:!0},{id:"6",title:"Infectious Diseases",numberOfPublishedBooks:13,numberOfPublishedChapters:113,numberOfOpenTopics:3,numberOfUpcomingTopics:1,issn:"2631-6188",doi:"10.5772/intechopen.71852",isOpenForSubmission:!0},{id:"13",title:"Veterinary Medicine and Science",numberOfPublishedBooks:11,numberOfPublishedChapters:107,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2632-0517",doi:"10.5772/intechopen.73681",isOpenForSubmission:!0}],sshSeriesList:[{id:"22",title:"Business, Management and Economics",numberOfPublishedBooks:1,numberOfPublishedChapters:19,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2753-894X",doi:"10.5772/intechopen.100359",isOpenForSubmission:!0},{id:"23",title:"Education and Human Development",numberOfPublishedBooks:0,numberOfPublishedChapters:5,numberOfOpenTopics:1,numberOfUpcomingTopics:1,issn:null,doi:"10.5772/intechopen.100360",isOpenForSubmission:!0},{id:"24",title:"Sustainable Development",numberOfPublishedBooks:0,numberOfPublishedChapters:16,numberOfOpenTopics:5,numberOfUpcomingTopics:0,issn:null,doi:"10.5772/intechopen.100361",isOpenForSubmission:!0}],subseriesList:[{id:"4",title:"Fungal Infectious Diseases",scope:"Fungi are ubiquitous and there are almost no non-pathogenic fungi. Fungal infectious illness prevalence and prognosis are determined by the exposure between fungi and host, host immunological state, fungal virulence, and early and accurate diagnosis and treatment. \r\nPatients with both congenital and acquired immunodeficiency are more likely to be infected with opportunistic mycosis. Fungal infectious disease outbreaks are common during the post- disaster rebuilding era, which is characterised by high population density, migration, and poor health and medical conditions.\r\nSystemic or local fungal infection is mainly associated with the fungi directly inhaled or inoculated in the environment during the disaster. The most common fungal infection pathways are human to human (anthropophilic), animal to human (zoophilic), and environment to human (soilophile). Diseases are common as a result of widespread exposure to pathogenic fungus dispersed into the environment. \r\nFungi that are both common and emerging are intertwined. In Southeast Asia, for example, Talaromyces marneffei is an important pathogenic thermally dimorphic fungus that causes systemic mycosis. Widespread fungal infections with complicated and variable clinical manifestations, such as Candida auris infection resistant to several antifungal medicines, Covid-19 associated with Trichoderma, and terbinafine resistant dermatophytosis in India, are among the most serious disorders. \r\nInappropriate local or systemic use of glucocorticoids, as well as their immunosuppressive effects, may lead to changes in fungal infection spectrum and clinical characteristics. Hematogenous candidiasis is a worrisome issue that affects people all over the world, particularly ICU patients. CARD9 deficiency and fungal infection have been major issues in recent years. Invasive aspergillosis is associated with a significant death rate. Special attention should be given to endemic fungal infections, identification of important clinical fungal infections advanced in yeasts, filamentous fungal infections, skin mycobiome and fungal genomes, and immunity to fungal infections.\r\nIn addition, endemic fungal diseases or uncommon fungal infections caused by Mucor irregularis, dermatophytosis, Malassezia, cryptococcosis, chromoblastomycosis, coccidiosis, blastomycosis, histoplasmosis, sporotrichosis, and other fungi, should be monitored. \r\nThis topic includes the research progress on the etiology and pathogenesis of fungal infections, new methods of isolation and identification, rapid detection, drug sensitivity testing, new antifungal drugs, schemes and case series reports. It will provide significant opportunities and support for scientists, clinical doctors, mycologists, antifungal drug researchers, public health practitioners, and epidemiologists from all over the world to share new research, ideas and solutions to promote the development and progress of medical mycology.",coverUrl:"https://cdn.intechopen.com/series_topics/covers/4.jpg",keywords:"Emerging Fungal Pathogens, Invasive Infections, Epidemiology, Cell Membrane, Fungal Virulence, Diagnosis, Treatment"},{id:"5",title:"Parasitic Infectious Diseases",scope:"Parasitic diseases have evolved alongside their human hosts. In many cases, these diseases have adapted so well that they have developed efficient resilience methods in the human host and can live in the host for years. Others, particularly some blood parasites, can cause very acute diseases and are responsible for millions of deaths yearly. Many parasitic diseases are classified as neglected tropical diseases because they have received minimal funding over recent years and, in many cases, are under-reported despite the critical role they play in morbidity and mortality among human and animal hosts. The current topic, Parasitic Infectious Diseases, in the Infectious Diseases Series aims to publish studies on the systematics, epidemiology, molecular biology, genomics, pathogenesis, genetics, and clinical significance of parasitic diseases from blood borne to intestinal parasites as well as zoonotic parasites. We hope to cover all aspects of parasitic diseases to provide current and relevant research data on these very important diseases. In the current atmosphere of the Coronavirus pandemic, communities around the world, particularly those in different underdeveloped areas, are faced with the growing challenges of the high burden of parasitic diseases. At the same time, they are faced with the Covid-19 pandemic leading to what some authors have called potential syndemics that might worsen the outcome of such infections. Therefore, it is important to conduct studies that examine parasitic infections in the context of the coronavirus pandemic for the benefit of all communities to help foster more informed decisions for the betterment of human and animal health.",coverUrl:"https://cdn.intechopen.com/series_topics/covers/5.jpg",keywords:"Blood Borne Parasites, Intestinal Parasites, Protozoa, Helminths, Arthropods, Water Born Parasites, Epidemiology, Molecular Biology, Systematics, Genomics, Proteomics, Ecology"},{id:"6",title:"Viral Infectious Diseases",scope:"The Viral Infectious Diseases Book Series aims to provide a comprehensive overview of recent research trends and discoveries in various viral infectious diseases emerging around the globe. The emergence of any viral disease is hard to anticipate, which often contributes to death. A viral disease can be defined as an infectious disease that has recently appeared within a population or exists in nature with the rapid expansion of incident or geographic range. This series will focus on various crucial factors related to emerging viral infectious diseases, including epidemiology, pathogenesis, host immune response, clinical manifestations, diagnosis, treatment, and clinical recommendations for managing viral infectious diseases, highlighting the recent issues with future directions for effective therapeutic strategies.",coverUrl:"https://cdn.intechopen.com/series_topics/covers/6.jpg",keywords:"Novel Viruses, Virus Transmission, Virus Evolution, Molecular Virology, Control and Prevention, Virus-host Interaction"}],annualVolumeBook:{},thematicCollection:[{type:"book",id:"11672",title:"Chemokines Updates",subtitle:null,isOpenForSubmission:!0,hash:"c00855833476a514d37abf7c846e16e9",slug:null,bookSignature:"Prof. Murat Şentürk",coverURL:"https://cdn.intechopen.com/books/images_new/11672.jpg",editedByType:null,submissionDeadline:"May 6th 2022",editors:[{id:"14794",title:"Prof.",name:"Murat",middleName:null,surname:"Şentürk",slug:"murat-senturk",fullName:"Murat Şentürk",profilePictureURL:"https://mts.intechopen.com/storage/users/14794/images/system/14794.jpeg",biography:"Dr. Murat Şentürk obtained a baccalaureate degree in Chemistry in 2002, a master’s degree in Biochemistry in 2006, and a doctorate degree in Biochemistry in 2009 from Atatürk University, Turkey. Dr. Şentürk currently works as an professor of Biochemistry in the Department of Basic Pharmacy Sciences, Faculty of Pharmacy, Ağri Ibrahim Cecen University, Turkey. \nDr. Şentürk published over 120 scientific papers, reviews, and book chapters and presented several conferences to scientists. \nHis research interests span enzyme inhibitor or activator, protein expression, purification and characterization, drug design and synthesis, toxicology, and pharmacology. \nHis research work has focused on neurodegenerative diseases and cancer treatment. Dr. Şentürk serves as the editorial board member of several international journals.",institutionString:"Ağrı İbrahim Çeçen University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"2",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"Ağrı İbrahim Çeçen University",institutionURL:null,country:{name:"Turkey"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null}],selectedSeries:null,selectedSubseries:null},seriesLanding:{item:{id:"11",title:"Biochemistry",doi:"10.5772/intechopen.72877",issn:"2632-0983",scope:"Biochemistry, the study of chemical transformations occurring within living organisms, impacts all areas of life sciences, from molecular crystallography and genetics to ecology, medicine, and population biology. Biochemistry examines macromolecules - proteins, nucleic acids, carbohydrates, and lipids – and their building blocks, structures, functions, and interactions. Much of biochemistry is devoted to enzymes, proteins that catalyze chemical reactions, enzyme structures, mechanisms of action and their roles within cells. Biochemistry also studies small signaling molecules, coenzymes, inhibitors, vitamins, and hormones, which play roles in life processes. Biochemical experimentation, besides coopting classical chemistry methods, e.g., chromatography, adopted new techniques, e.g., X-ray diffraction, electron microscopy, NMR, radioisotopes, and developed sophisticated microbial genetic tools, e.g., auxotroph mutants and their revertants, fermentation, etc. More recently, biochemistry embraced the ‘big data’ omics systems. Initial biochemical studies have been exclusively analytic: dissecting, purifying, and examining individual components of a biological system; in the apt words of Efraim Racker (1913 –1991), “Don’t waste clean thinking on dirty enzymes.” Today, however, biochemistry is becoming more agglomerative and comprehensive, setting out to integrate and describe entirely particular biological systems. The ‘big data’ metabolomics can define the complement of small molecules, e.g., in a soil or biofilm sample; proteomics can distinguish all the comprising proteins, e.g., serum; metagenomics can identify all the genes in a complex environment, e.g., the bovine rumen. This Biochemistry Series will address the current research on biomolecules and the emerging trends with great promise.",coverUrl:"https://cdn.intechopen.com/series/covers/11.jpg",latestPublicationDate:"July 5th, 2022",hasOnlineFirst:!0,numberOfOpenTopics:4,numberOfPublishedChapters:319,numberOfPublishedBooks:32,editor:{id:"31610",title:"Dr.",name:"Miroslav",middleName:null,surname:"Blumenberg",fullName:"Miroslav Blumenberg",profilePictureURL:"https://mts.intechopen.com/storage/users/31610/images/system/31610.jpg",biography:"Miroslav Blumenberg, Ph.D., was born in Subotica and received his BSc in Belgrade, Yugoslavia. He completed his Ph.D. at MIT in Organic Chemistry; he followed up his Ph.D. with two postdoctoral study periods at Stanford University. Since 1983, he has been a faculty member of the RO Perelman Department of Dermatology, NYU School of Medicine, where he is codirector of a training grant in cutaneous biology. Dr. Blumenberg’s research is focused on the epidermis, expression of keratin genes, transcription profiling, keratinocyte differentiation, inflammatory diseases and cancers, and most recently the effects of the microbiome on the skin. He has published more than 100 peer-reviewed research articles and graduated numerous Ph.D. and postdoctoral students.",institutionString:null,institution:{name:"New York University Langone Medical Center",institutionURL:null,country:{name:"United States of America"}}},subseries:[{id:"14",title:"Cell and Molecular Biology",keywords:"Omics (Transcriptomics; Proteomics; Metabolomics), Molecular Biology, Cell Biology, Signal Transduction and Regulation, Cell Growth and Differentiation, Apoptosis, Necroptosis, Ferroptosis, Autophagy, Cell Cycle, Macromolecules and Complexes, Gene Expression",scope:"The Cell and Molecular Biology topic within the IntechOpen Biochemistry Series aims to rapidly publish contributions on all aspects of cell and molecular biology, including aspects related to biochemical and genetic research (not only in humans but all living beings). We encourage the submission of manuscripts that provide novel and mechanistic insights that report significant advances in the fields. Topics include, but are not limited to: Advanced techniques of cellular and molecular biology (Molecular methodologies, imaging techniques, and bioinformatics); Biological activities at the molecular level; Biological processes of cell functions, cell division, senescence, maintenance, and cell death; Biomolecules interactions; Cancer; Cell biology; Chemical biology; Computational biology; Cytochemistry; Developmental biology; Disease mechanisms and therapeutics; DNA, and RNA metabolism; Gene functions, genetics, and genomics; Genetics; Immunology; Medical microbiology; Molecular biology; Molecular genetics; Molecular processes of cell and organelle dynamics; Neuroscience; Protein biosynthesis, degradation, and functions; Regulation of molecular interactions in a cell; Signalling networks and system biology; Structural biology; Virology and microbiology.",annualVolume:11410,isOpenForSubmission:!0,coverUrl:"https://cdn.intechopen.com/series_topics/covers/14.jpg",editor:{id:"165627",title:"Dr.",name:"Rosa María",middleName:null,surname:"Martínez-Espinosa",fullName:"Rosa María Martínez-Espinosa",profilePictureURL:"https://mts.intechopen.com/storage/users/165627/images/system/165627.jpeg",institutionString:null,institution:{name:"University of Alicante",institutionURL:null,country:{name:"Spain"}}},editorTwo:null,editorThree:null,editorialBoard:[{id:"79367",title:"Dr.",name:"Ana Isabel",middleName:null,surname:"Flores",fullName:"Ana Isabel Flores",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRpIOQA0/Profile_Picture_1632418099564",institutionString:null,institution:{name:"Hospital Universitario 12 De Octubre",institutionURL:null,country:{name:"Spain"}}},{id:"328234",title:"Ph.D.",name:"Christian",middleName:null,surname:"Palavecino",fullName:"Christian Palavecino",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y000030DhEhQAK/Profile_Picture_1628835318625",institutionString:null,institution:{name:"Central University of Chile",institutionURL:null,country:{name:"Chile"}}},{id:"186585",title:"Dr.",name:"Francisco Javier",middleName:null,surname:"Martin-Romero",fullName:"Francisco Javier Martin-Romero",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bSB3HQAW/Profile_Picture_1631258137641",institutionString:null,institution:{name:"University of Extremadura",institutionURL:null,country:{name:"Spain"}}}]},{id:"15",title:"Chemical Biology",keywords:"Phenolic Compounds, Essential Oils, Modification of Biomolecules, Glycobiology, Combinatorial Chemistry, Therapeutic peptides, Enzyme Inhibitors",scope:"Chemical biology spans the fields of chemistry and biology involving the application of biological and chemical molecules and techniques. In recent years, the application of chemistry to biological molecules has gained significant interest in medicinal and pharmacological studies. This topic will be devoted to understanding the interplay between biomolecules and chemical compounds, their structure and function, and their potential applications in related fields. Being a part of the biochemistry discipline, the ideas and concepts that have emerged from Chemical Biology have affected other related areas. This topic will closely deal with all emerging trends in this discipline.",annualVolume:11411,isOpenForSubmission:!0,coverUrl:"https://cdn.intechopen.com/series_topics/covers/15.jpg",editor:{id:"441442",title:"Dr.",name:"Şükrü",middleName:null,surname:"Beydemir",fullName:"Şükrü Beydemir",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y00003GsUoIQAV/Profile_Picture_1634557147521",institutionString:null,institution:{name:"Anadolu University",institutionURL:null,country:{name:"Turkey"}}},editorTwo:{id:"13652",title:"Prof.",name:"Deniz",middleName:null,surname:"Ekinci",fullName:"Deniz Ekinci",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002aYLT1QAO/Profile_Picture_1634557223079",institutionString:null,institution:{name:"Ondokuz Mayıs University",institutionURL:null,country:{name:"Turkey"}}},editorThree:null,editorialBoard:[{id:"219081",title:"Dr.",name:"Abdulsamed",middleName:null,surname:"Kükürt",fullName:"Abdulsamed Kükürt",profilePictureURL:"https://mts.intechopen.com/storage/users/219081/images/system/219081.png",institutionString:null,institution:{name:"Kafkas University",institutionURL:null,country:{name:"Turkey"}}},{id:"241413",title:"Dr.",name:"Azhar",middleName:null,surname:"Rasul",fullName:"Azhar Rasul",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRT1oQAG/Profile_Picture_1635251978933",institutionString:null,institution:{name:"Government College University, Faisalabad",institutionURL:null,country:{name:"Pakistan"}}},{id:"178316",title:"Ph.D.",name:"Sergey",middleName:null,surname:"Sedykh",fullName:"Sergey Sedykh",profilePictureURL:"https://mts.intechopen.com/storage/users/178316/images/system/178316.jfif",institutionString:null,institution:{name:"Novosibirsk State University",institutionURL:null,country:{name:"Russia"}}}]},{id:"17",title:"Metabolism",keywords:"Biomolecules Metabolism, Energy Metabolism, Metabolic Pathways, Key Metabolic Enzymes, Metabolic Adaptation",scope:"Metabolism is frequently defined in biochemistry textbooks as the overall process that allows living systems to acquire and use the free energy they need for their vital functions or the chemical processes that occur within a living organism to maintain life. Behind these definitions are hidden all the aspects of normal and pathological functioning of all processes that the topic ‘Metabolism’ will cover within the Biochemistry Series. Thus all studies on metabolism will be considered for publication.",annualVolume:11413,isOpenForSubmission:!0,coverUrl:"https://cdn.intechopen.com/series_topics/covers/17.jpg",editor:{id:"138626",title:"Dr.",name:"Yannis",middleName:null,surname:"Karamanos",fullName:"Yannis Karamanos",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002g6Jv2QAE/Profile_Picture_1629356660984",institutionString:null,institution:{name:"Artois University",institutionURL:null,country:{name:"France"}}},editorTwo:null,editorThree:null,editorialBoard:[{id:"243049",title:"Dr.",name:"Anca",middleName:null,surname:"Pantea Stoian",fullName:"Anca Pantea Stoian",profilePictureURL:"https://mts.intechopen.com/storage/users/243049/images/system/243049.jpg",institutionString:null,institution:{name:"Carol Davila University of Medicine and Pharmacy",institutionURL:null,country:{name:"Romania"}}},{id:"203824",title:"Dr.",name:"Attilio",middleName:null,surname:"Rigotti",fullName:"Attilio Rigotti",profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",institutionString:null,institution:{name:"Pontifical Catholic University of Chile",institutionURL:null,country:{name:"Chile"}}},{id:"300470",title:"Dr.",name:"Yanfei (Jacob)",middleName:null,surname:"Qi",fullName:"Yanfei (Jacob) Qi",profilePictureURL:"https://mts.intechopen.com/storage/users/300470/images/system/300470.jpg",institutionString:null,institution:{name:"Centenary Institute of Cancer Medicine and Cell Biology",institutionURL:null,country:{name:"Australia"}}}]},{id:"18",title:"Proteomics",keywords:"Mono- and Two-Dimensional Gel Electrophoresis (1-and 2-DE), Liquid Chromatography (LC), Mass Spectrometry/Tandem Mass Spectrometry (MS; MS/MS), Proteins",scope:"With the recognition that the human genome cannot provide answers to the etiology of a disorder, changes in the proteins expressed by a genome became a focus in research. Thus proteomics, an area of research that detects all protein forms expressed in an organism, including splice isoforms and post-translational modifications, is more suitable than genomics for a comprehensive understanding of the biochemical processes that govern life. The most common proteomics applications are currently in the clinical field for the identification, in a variety of biological matrices, of biomarkers for diagnosis and therapeutic intervention of disorders. From the comparison of proteomic profiles of control and disease or different physiological states, which may emerge, changes in protein expression can provide new insights into the roles played by some proteins in human pathologies. Understanding how proteins function and interact with each other is another goal of proteomics that makes this approach even more intriguing. Specialized technology and expertise are required to assess the proteome of any biological sample. Currently, proteomics relies mainly on mass spectrometry (MS) combined with electrophoretic (1 or 2-DE-MS) and/or chromatographic techniques (LC-MS/MS). MS is an excellent tool that has gained popularity in proteomics because of its ability to gather a complex body of information such as cataloging protein expression, identifying protein modification sites, and defining protein interactions. The Proteomics topic aims to attract contributions on all aspects of MS-based proteomics that, by pushing the boundaries of MS capabilities, may address biological problems that have not been resolved yet.",annualVolume:11414,isOpenForSubmission:!0,coverUrl:"https://cdn.intechopen.com/series_topics/covers/18.jpg",editor:{id:"200689",title:"Prof.",name:"Paolo",middleName:null,surname:"Iadarola",fullName:"Paolo Iadarola",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bSCl8QAG/Profile_Picture_1623568118342",institutionString:null,institution:{name:"University of Pavia",institutionURL:null,country:{name:"Italy"}}},editorTwo:{id:"201414",title:"Dr.",name:"Simona",middleName:null,surname:"Viglio",fullName:"Simona Viglio",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRKDHQA4/Profile_Picture_1630402531487",institutionString:null,institution:{name:"University of Pavia",institutionURL:null,country:{name:"Italy"}}},editorThree:null,editorialBoard:[{id:"72288",title:"Dr.",name:"Arli Aditya",middleName:null,surname:"Parikesit",fullName:"Arli Aditya Parikesit",profilePictureURL:"https://mts.intechopen.com/storage/users/72288/images/system/72288.jpg",institutionString:null,institution:{name:"Indonesia International Institute for Life Sciences",institutionURL:null,country:{name:"Indonesia"}}},{id:"40928",title:"Dr.",name:"Cesar",middleName:null,surname:"Lopez-Camarillo",fullName:"Cesar Lopez-Camarillo",profilePictureURL:"https://mts.intechopen.com/storage/users/40928/images/3884_n.png",institutionString:null,institution:{name:"Universidad Autónoma de la Ciudad de México",institutionURL:null,country:{name:"Mexico"}}},{id:"81926",title:"Dr.",name:"Shymaa",middleName:null,surname:"Enany",fullName:"Shymaa Enany",profilePictureURL:"https://mts.intechopen.com/storage/users/81926/images/system/81926.png",institutionString:"Suez Canal University",institution:{name:"Suez Canal University",institutionURL:null,country:{name:"Egypt"}}}]}]}},libraryRecommendation:{success:null,errors:{},institutions:[]},route:{name:"chapter.detail",path:"/chapters/61139",hash:"",query:{},params:{id:"61139"},fullPath:"/chapters/61139",meta:{},from:{name:null,path:"/",hash:"",query:{},params:{},fullPath:"/",meta:{}}}},function(){var e;(e=document.currentScript||document.scripts[document.scripts.length-1]).parentNode.removeChild(e)}()